<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:40d86869-7a63-4cf8-9044-c6fd2cae789e,g:cffef770-2cec-4fbd-a147-b09da8e4c413-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/Cover" xlink:type="simple" xlink:href="abus-20201231.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_03b02438-ff37-40dc-9d23-60873c0d1639" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_3bc380f3-e5d9-496b-9754-0a6fe85923ce" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b02438-ff37-40dc-9d23-60873c0d1639" xlink:to="loc_dei_DocumentType_3bc380f3-e5d9-496b-9754-0a6fe85923ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_851811f1-a036-48ca-9578-ad7fd9562ed5" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b02438-ff37-40dc-9d23-60873c0d1639" xlink:to="loc_dei_DocumentAnnualReport_851811f1-a036-48ca-9578-ad7fd9562ed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_ed95e268-2516-4726-9e86-643964178e8f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b02438-ff37-40dc-9d23-60873c0d1639" xlink:to="loc_dei_DocumentPeriodEndDate_ed95e268-2516-4726-9e86-643964178e8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_79d851bb-0839-499d-9c9e-a580b2ec8506" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b02438-ff37-40dc-9d23-60873c0d1639" xlink:to="loc_dei_CurrentFiscalYearEndDate_79d851bb-0839-499d-9c9e-a580b2ec8506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_b986a6af-d29e-44ad-a77b-ab5524f913c1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b02438-ff37-40dc-9d23-60873c0d1639" xlink:to="loc_dei_DocumentTransitionReport_b986a6af-d29e-44ad-a77b-ab5524f913c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_58429134-f596-47d7-901e-f3b41a00aed0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b02438-ff37-40dc-9d23-60873c0d1639" xlink:to="loc_dei_EntityFileNumber_58429134-f596-47d7-901e-f3b41a00aed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_4cc5876c-b80a-497e-b3e6-f7a8ee1e5d97" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b02438-ff37-40dc-9d23-60873c0d1639" xlink:to="loc_dei_EntityRegistrantName_4cc5876c-b80a-497e-b3e6-f7a8ee1e5d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_74dc4669-2c56-4d49-a862-ec99f28eab62" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b02438-ff37-40dc-9d23-60873c0d1639" xlink:to="loc_dei_AmendmentFlag_74dc4669-2c56-4d49-a862-ec99f28eab62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_aea92041-715a-41b7-b21e-3adc26a71692" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b02438-ff37-40dc-9d23-60873c0d1639" xlink:to="loc_dei_EntityCentralIndexKey_aea92041-715a-41b7-b21e-3adc26a71692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_98cdc3bc-02f2-47b7-b70d-b45c64a884d6" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b02438-ff37-40dc-9d23-60873c0d1639" xlink:to="loc_dei_DocumentFiscalYearFocus_98cdc3bc-02f2-47b7-b70d-b45c64a884d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_70b8720e-2e13-443f-b112-a94e287f17ba" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b02438-ff37-40dc-9d23-60873c0d1639" xlink:to="loc_dei_DocumentFiscalPeriodFocus_70b8720e-2e13-443f-b112-a94e287f17ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_9c3da061-87da-4a97-a00a-897e417b28b7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b02438-ff37-40dc-9d23-60873c0d1639" xlink:to="loc_dei_EntityIncorporationStateCountryCode_9c3da061-87da-4a97-a00a-897e417b28b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_8fb2af98-1378-4758-bfc7-e8131cc1e0ce" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b02438-ff37-40dc-9d23-60873c0d1639" xlink:to="loc_dei_EntityTaxIdentificationNumber_8fb2af98-1378-4758-bfc7-e8131cc1e0ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_96fba00c-431a-4a81-8568-8f0db66d28cb" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b02438-ff37-40dc-9d23-60873c0d1639" xlink:to="loc_dei_EntityAddressAddressLine1_96fba00c-431a-4a81-8568-8f0db66d28cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_e8041e3b-019d-4451-9044-94c753f96a29" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b02438-ff37-40dc-9d23-60873c0d1639" xlink:to="loc_dei_EntityAddressCityOrTown_e8041e3b-019d-4451-9044-94c753f96a29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_d7b12da8-ef78-46ff-8494-ff9bbdd8b7ef" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b02438-ff37-40dc-9d23-60873c0d1639" xlink:to="loc_dei_EntityAddressStateOrProvince_d7b12da8-ef78-46ff-8494-ff9bbdd8b7ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_99a8b0b0-ae51-400a-86e0-1302351714e6" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b02438-ff37-40dc-9d23-60873c0d1639" xlink:to="loc_dei_EntityAddressPostalZipCode_99a8b0b0-ae51-400a-86e0-1302351714e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_d18376ac-eaca-4827-9301-a01dea325390" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b02438-ff37-40dc-9d23-60873c0d1639" xlink:to="loc_dei_CityAreaCode_d18376ac-eaca-4827-9301-a01dea325390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_7bb5f967-3796-4ed3-a177-ada8e8d73754" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b02438-ff37-40dc-9d23-60873c0d1639" xlink:to="loc_dei_LocalPhoneNumber_7bb5f967-3796-4ed3-a177-ada8e8d73754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_06500834-601e-43c9-959d-32d9dbaac4fc" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b02438-ff37-40dc-9d23-60873c0d1639" xlink:to="loc_dei_Security12bTitle_06500834-601e-43c9-959d-32d9dbaac4fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_c1c67474-58d1-462d-a3ef-66658560039d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b02438-ff37-40dc-9d23-60873c0d1639" xlink:to="loc_dei_TradingSymbol_c1c67474-58d1-462d-a3ef-66658560039d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_91f44611-39b4-47f0-ba5d-823b70f0e23e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b02438-ff37-40dc-9d23-60873c0d1639" xlink:to="loc_dei_SecurityExchangeName_91f44611-39b4-47f0-ba5d-823b70f0e23e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_64b9c855-1324-4710-b77f-1070b206b8e0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b02438-ff37-40dc-9d23-60873c0d1639" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_64b9c855-1324-4710-b77f-1070b206b8e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_a4fde9c3-fa4b-4542-80c4-3efa36ccc8d6" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b02438-ff37-40dc-9d23-60873c0d1639" xlink:to="loc_dei_EntityVoluntaryFilers_a4fde9c3-fa4b-4542-80c4-3efa36ccc8d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_851a2bab-1e0e-428e-a659-4900183d292d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b02438-ff37-40dc-9d23-60873c0d1639" xlink:to="loc_dei_EntityCurrentReportingStatus_851a2bab-1e0e-428e-a659-4900183d292d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_fefe9318-8695-482d-b17b-a6eddb4d834f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b02438-ff37-40dc-9d23-60873c0d1639" xlink:to="loc_dei_EntityInteractiveDataCurrent_fefe9318-8695-482d-b17b-a6eddb4d834f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_c35b6f0c-fd4e-494a-94af-01a65f36ae70" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b02438-ff37-40dc-9d23-60873c0d1639" xlink:to="loc_dei_EntityFilerCategory_c35b6f0c-fd4e-494a-94af-01a65f36ae70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_b0cdab98-a3e7-4109-8ac2-afada93aaf2b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b02438-ff37-40dc-9d23-60873c0d1639" xlink:to="loc_dei_EntitySmallBusiness_b0cdab98-a3e7-4109-8ac2-afada93aaf2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_1be4c906-07fd-4264-a9ab-e25482ab3a27" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b02438-ff37-40dc-9d23-60873c0d1639" xlink:to="loc_dei_EntityEmergingGrowthCompany_1be4c906-07fd-4264-a9ab-e25482ab3a27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_de398a2f-53ed-4101-b59d-c25872f93fb3" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b02438-ff37-40dc-9d23-60873c0d1639" xlink:to="loc_dei_IcfrAuditorAttestationFlag_de398a2f-53ed-4101-b59d-c25872f93fb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_96afcef3-4f8d-4ed8-b759-2cb6d058dcc3" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b02438-ff37-40dc-9d23-60873c0d1639" xlink:to="loc_dei_EntityShellCompany_96afcef3-4f8d-4ed8-b759-2cb6d058dcc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_3a40005a-cbbc-4de8-ae5c-a8998e709d7d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b02438-ff37-40dc-9d23-60873c0d1639" xlink:to="loc_dei_EntityPublicFloat_3a40005a-cbbc-4de8-ae5c-a8998e709d7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_5b144091-4ab5-4e36-ab1b-3918015a6970" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b02438-ff37-40dc-9d23-60873c0d1639" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_5b144091-4ab5-4e36-ab1b-3918015a6970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_e300f180-b46c-41bd-8603-e13a2b1aba73" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b02438-ff37-40dc-9d23-60873c0d1639" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_e300f180-b46c-41bd-8603-e13a2b1aba73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_347469f3-92f8-4704-9b92-f57c6b987382" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b02438-ff37-40dc-9d23-60873c0d1639" xlink:to="loc_us-gaap_SharePrice_347469f3-92f8-4704-9b92-f57c6b987382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="abus-20201231.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_47601c7d-7f9a-4c6e-bb28-e423f79b4671" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_edad2d44-9187-4ccd-91ef-92b689c3a6b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_47601c7d-7f9a-4c6e-bb28-e423f79b4671" xlink:to="loc_us-gaap_AssetsAbstract_edad2d44-9187-4ccd-91ef-92b689c3a6b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_30fb6260-a7a7-40f4-a87e-d26c840c6747" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_edad2d44-9187-4ccd-91ef-92b689c3a6b0" xlink:to="loc_us-gaap_AssetsCurrentAbstract_30fb6260-a7a7-40f4-a87e-d26c840c6747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ce640f48-cc28-4842-b451-3a41e8b8be12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_30fb6260-a7a7-40f4-a87e-d26c840c6747" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ce640f48-cc28-4842-b451-3a41e8b8be12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_ad55160c-dadf-417d-b7ec-1e02e604ac45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_30fb6260-a7a7-40f4-a87e-d26c840c6747" xlink:to="loc_us-gaap_ShortTermInvestments_ad55160c-dadf-417d-b7ec-1e02e604ac45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_075889e1-711e-457d-95d9-6c28a9836b73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_30fb6260-a7a7-40f4-a87e-d26c840c6747" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_075889e1-711e-457d-95d9-6c28a9836b73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2b65641a-c174-4e15-afa2-215618b6a5fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_30fb6260-a7a7-40f4-a87e-d26c840c6747" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2b65641a-c174-4e15-afa2-215618b6a5fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_ebff04af-1569-4186-bf0e-be108efd827b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_30fb6260-a7a7-40f4-a87e-d26c840c6747" xlink:to="loc_us-gaap_AssetsCurrent_ebff04af-1569-4186-bf0e-be108efd827b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_78e45194-0f91-489a-9628-fdb4600b5fc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_edad2d44-9187-4ccd-91ef-92b689c3a6b0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_78e45194-0f91-489a-9628-fdb4600b5fc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_9f99b0c9-41d0-41cd-87ab-beb358a2e367" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_edad2d44-9187-4ccd-91ef-92b689c3a6b0" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_9f99b0c9-41d0-41cd-87ab-beb358a2e367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_420993ab-7a18-43d9-944e-5ff3b364a7ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_edad2d44-9187-4ccd-91ef-92b689c3a6b0" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_420993ab-7a18-43d9-944e-5ff3b364a7ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_07c138a8-6d00-424f-9309-24e528bbe76e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_edad2d44-9187-4ccd-91ef-92b689c3a6b0" xlink:to="loc_us-gaap_Assets_07c138a8-6d00-424f-9309-24e528bbe76e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_19dc8c2d-c256-4967-9509-191a6b373425" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_47601c7d-7f9a-4c6e-bb28-e423f79b4671" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_19dc8c2d-c256-4967-9509-191a6b373425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_aab5f922-2ff1-4b1e-b8ae-6bf2a2f560c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_19dc8c2d-c256-4967-9509-191a6b373425" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_aab5f922-2ff1-4b1e-b8ae-6bf2a2f560c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_e5f8b8dd-3a22-4a3e-b7aa-84c6b4d19672" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_aab5f922-2ff1-4b1e-b8ae-6bf2a2f560c3" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_e5f8b8dd-3a22-4a3e-b7aa-84c6b4d19672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_EmployeeStockOptionsLiabilityClassifiedOutstanding_b580ad3e-bf35-490c-9094-d535289dec3a" xlink:href="abus-20201231.xsd#abus_EmployeeStockOptionsLiabilityClassifiedOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_aab5f922-2ff1-4b1e-b8ae-6bf2a2f560c3" xlink:to="loc_abus_EmployeeStockOptionsLiabilityClassifiedOutstanding_b580ad3e-bf35-490c-9094-d535289dec3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_c642d3c9-598a-4060-8f4d-b1f56d2b589b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_aab5f922-2ff1-4b1e-b8ae-6bf2a2f560c3" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_c642d3c9-598a-4060-8f4d-b1f56d2b589b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_08288f4e-e973-4290-b753-4273138dc2ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_aab5f922-2ff1-4b1e-b8ae-6bf2a2f560c3" xlink:to="loc_us-gaap_LiabilitiesCurrent_08288f4e-e973-4290-b753-4273138dc2ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_LiabilityRelatedToSaleOfFutureRoyaltiesNoncurrent_0f55d702-d59e-4283-a486-dcd2293aa31a" xlink:href="abus-20201231.xsd#abus_LiabilityRelatedToSaleOfFutureRoyaltiesNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_19dc8c2d-c256-4967-9509-191a6b373425" xlink:to="loc_abus_LiabilityRelatedToSaleOfFutureRoyaltiesNoncurrent_0f55d702-d59e-4283-a486-dcd2293aa31a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_b71a273a-435f-41c4-b9fa-563c72e94bf7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_19dc8c2d-c256-4967-9509-191a6b373425" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_b71a273a-435f-41c4-b9fa-563c72e94bf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_0322d9ac-41c6-4a75-ad41-8b7d8518694a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_19dc8c2d-c256-4967-9509-191a6b373425" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_0322d9ac-41c6-4a75-ad41-8b7d8518694a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_52e14a25-0fea-4927-bef8-03dd2db73034" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_19dc8c2d-c256-4967-9509-191a6b373425" xlink:to="loc_us-gaap_Liabilities_52e14a25-0fea-4927-bef8-03dd2db73034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_33ea252b-5f33-48ae-8601-791bb36c3af8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_19dc8c2d-c256-4967-9509-191a6b373425" xlink:to="loc_us-gaap_StockholdersEquityAbstract_33ea252b-5f33-48ae-8601-791bb36c3af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockIncludingAdditionalPaidInCapitalNetOfDiscount_3fdc7e12-eea8-45d6-b30d-029eeb6de155" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockIncludingAdditionalPaidInCapitalNetOfDiscount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_33ea252b-5f33-48ae-8601-791bb36c3af8" xlink:to="loc_us-gaap_PreferredStockIncludingAdditionalPaidInCapitalNetOfDiscount_3fdc7e12-eea8-45d6-b30d-029eeb6de155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_5a430545-cb35-4cbe-acc9-fb5b42ef6e3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_33ea252b-5f33-48ae-8601-791bb36c3af8" xlink:to="loc_us-gaap_CommonStockValue_5a430545-cb35-4cbe-acc9-fb5b42ef6e3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_0ccb7f1a-3ad1-4c5b-9d9f-2f7a2cb17232" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_33ea252b-5f33-48ae-8601-791bb36c3af8" xlink:to="loc_us-gaap_AdditionalPaidInCapital_0ccb7f1a-3ad1-4c5b-9d9f-2f7a2cb17232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_176df187-65a3-493e-bb71-de71851a211f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_33ea252b-5f33-48ae-8601-791bb36c3af8" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_176df187-65a3-493e-bb71-de71851a211f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d66fe96c-6767-44af-91a3-357fb5b3c960" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_33ea252b-5f33-48ae-8601-791bb36c3af8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d66fe96c-6767-44af-91a3-357fb5b3c960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_41d61e1d-0476-475a-afb5-bd12a35688a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_33ea252b-5f33-48ae-8601-791bb36c3af8" xlink:to="loc_us-gaap_StockholdersEquity_41d61e1d-0476-475a-afb5-bd12a35688a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_194f09cb-bdd8-4bff-9dd5-230cd4cb38a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_19dc8c2d-c256-4967-9509-191a6b373425" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_194f09cb-bdd8-4bff-9dd5-230cd4cb38a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="abus-20201231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0e628e98-5db4-4bec-9d8d-7e13f75a10ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_672512f6-f7c6-4d50-a7cb-5e8a9d5ca3f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0e628e98-5db4-4bec-9d8d-7e13f75a10ce" xlink:to="loc_us-gaap_PreferredStockSharesIssued_672512f6-f7c6-4d50-a7cb-5e8a9d5ca3f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_9f8d6b3d-02e3-4203-a2e0-f14e77f6f339" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0e628e98-5db4-4bec-9d8d-7e13f75a10ce" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_9f8d6b3d-02e3-4203-a2e0-f14e77f6f339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_9ccaf3b1-3d10-44cb-8add-42adbcaab2ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0e628e98-5db4-4bec-9d8d-7e13f75a10ce" xlink:to="loc_us-gaap_CommonStockSharesIssued_9ccaf3b1-3d10-44cb-8add-42adbcaab2ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_4dbb40fe-1418-47ad-98d1-461629b8d0a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0e628e98-5db4-4bec-9d8d-7e13f75a10ce" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_4dbb40fe-1418-47ad-98d1-461629b8d0a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="simple" xlink:href="abus-20201231.xsd#ConsolidatedStatementsofOperationsandComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_1955c353-4d23-42c5-bb81-d079cdc58c56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_14eb7150-00f0-4485-a53c-f43604126cc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1955c353-4d23-42c5-bb81-d079cdc58c56" xlink:to="loc_us-gaap_StatementTable_14eb7150-00f0-4485-a53c-f43604126cc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_06a00ddc-00d8-4ff4-ac9b-3a2dcde06a06" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_14eb7150-00f0-4485-a53c-f43604126cc2" xlink:to="loc_srt_ProductOrServiceAxis_06a00ddc-00d8-4ff4-ac9b-3a2dcde06a06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_315f73dc-1ab8-4175-9001-b1335b5281a1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_06a00ddc-00d8-4ff4-ac9b-3a2dcde06a06" xlink:to="loc_srt_ProductsAndServicesDomain_315f73dc-1ab8-4175-9001-b1335b5281a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_CollaborationAndContractsMember_98b3fe5d-3f93-43ec-babd-f6155de52b6e" xlink:href="abus-20201231.xsd#abus_CollaborationAndContractsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_315f73dc-1ab8-4175-9001-b1335b5281a1" xlink:to="loc_abus_CollaborationAndContractsMember_98b3fe5d-3f93-43ec-babd-f6155de52b6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_NonCashRoyaltyMember_1932c386-dcba-4de7-b5e5-9d39fdab1e9a" xlink:href="abus-20201231.xsd#abus_NonCashRoyaltyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_315f73dc-1ab8-4175-9001-b1335b5281a1" xlink:to="loc_abus_NonCashRoyaltyMember_1932c386-dcba-4de7-b5e5-9d39fdab1e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_fed490a0-5c42-4ae5-baaf-64582b843c2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_14eb7150-00f0-4485-a53c-f43604126cc2" xlink:to="loc_us-gaap_StatementLineItems_fed490a0-5c42-4ae5-baaf-64582b843c2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_65815c78-0627-4e82-81be-8561e36463f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fed490a0-5c42-4ae5-baaf-64582b843c2a" xlink:to="loc_us-gaap_RevenuesAbstract_65815c78-0627-4e82-81be-8561e36463f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_6d8e5505-c7d6-4d0e-a3ef-2356129f2ee5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_65815c78-0627-4e82-81be-8561e36463f0" xlink:to="loc_us-gaap_Revenues_6d8e5505-c7d6-4d0e-a3ef-2356129f2ee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_577829f6-340a-439e-acb8-1908f8f5cbb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fed490a0-5c42-4ae5-baaf-64582b843c2a" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_577829f6-340a-439e-acb8-1908f8f5cbb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_2d616ccd-0e36-4c3d-a6cc-2f2d45260378" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_577829f6-340a-439e-acb8-1908f8f5cbb6" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_2d616ccd-0e36-4c3d-a6cc-2f2d45260378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_c3e4b549-1502-4704-a45d-9ea88cf385d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_577829f6-340a-439e-acb8-1908f8f5cbb6" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_c3e4b549-1502-4704-a45d-9ea88cf385d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_5e9fdb76-0462-4847-b4cd-9a212f68a71a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_577829f6-340a-439e-acb8-1908f8f5cbb6" xlink:to="loc_us-gaap_Depreciation_5e9fdb76-0462-4847-b4cd-9a212f68a71a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_9c213889-3881-4cc3-9690-7954fdb84aae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_577829f6-340a-439e-acb8-1908f8f5cbb6" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_9c213889-3881-4cc3-9690-7954fdb84aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_3a898adf-76eb-4c37-bfd1-b4b794a14b99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_577829f6-340a-439e-acb8-1908f8f5cbb6" xlink:to="loc_us-gaap_RestructuringCharges_3a898adf-76eb-4c37-bfd1-b4b794a14b99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_3ca64fea-220f-4992-aa29-4311d4e025ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_577829f6-340a-439e-acb8-1908f8f5cbb6" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_3ca64fea-220f-4992-aa29-4311d4e025ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_bf9704f9-010b-422e-b12d-e85c08036c0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_577829f6-340a-439e-acb8-1908f8f5cbb6" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_bf9704f9-010b-422e-b12d-e85c08036c0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalFees_67698334-cab9-4a40-b591-0c7a71f9287e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LegalFees"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_577829f6-340a-439e-acb8-1908f8f5cbb6" xlink:to="loc_us-gaap_LegalFees_67698334-cab9-4a40-b591-0c7a71f9287e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_040f7939-158f-4a09-a1c6-e25603c3fea3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_577829f6-340a-439e-acb8-1908f8f5cbb6" xlink:to="loc_us-gaap_OperatingExpenses_040f7939-158f-4a09-a1c6-e25603c3fea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_1e94d3bc-07f1-4030-951e-4b0801e31fdc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fed490a0-5c42-4ae5-baaf-64582b843c2a" xlink:to="loc_us-gaap_OperatingIncomeLoss_1e94d3bc-07f1-4030-951e-4b0801e31fdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_8151cf7d-9bee-4654-9c64-f90e959f51e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fed490a0-5c42-4ae5-baaf-64582b843c2a" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_8151cf7d-9bee-4654-9c64-f90e959f51e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_51b71789-fc47-4538-8a30-16169061069c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_8151cf7d-9bee-4654-9c64-f90e959f51e8" xlink:to="loc_us-gaap_InvestmentIncomeInterest_51b71789-fc47-4538-8a30-16169061069c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_9a827d96-92bf-4c08-9118-8b995947f248" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_8151cf7d-9bee-4654-9c64-f90e959f51e8" xlink:to="loc_us-gaap_InterestExpense_9a827d96-92bf-4c08-9118-8b995947f248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_ced0fb95-47b3-4c5d-a819-d633d4c55076" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_8151cf7d-9bee-4654-9c64-f90e959f51e8" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_ced0fb95-47b3-4c5d-a819-d633d4c55076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_ea2e1403-bc2a-4843-9bdd-c832ef96b4cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_8151cf7d-9bee-4654-9c64-f90e959f51e8" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_ea2e1403-bc2a-4843-9bdd-c832ef96b4cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_27f3fd7a-ea91-4d1b-90f4-2c981403e0cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_8151cf7d-9bee-4654-9c64-f90e959f51e8" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_27f3fd7a-ea91-4d1b-90f4-2c981403e0cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8b975e7c-6123-4fb4-b79a-5f8e139245e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fed490a0-5c42-4ae5-baaf-64582b843c2a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8b975e7c-6123-4fb4-b79a-5f8e139245e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_0380541a-d08a-41a3-b27a-b128d6460b83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fed490a0-5c42-4ae5-baaf-64582b843c2a" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_0380541a-d08a-41a3-b27a-b128d6460b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_12725dcc-36d5-4688-bc3f-bf081b8d8c2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fed490a0-5c42-4ae5-baaf-64582b843c2a" xlink:to="loc_us-gaap_NetIncomeLoss_12725dcc-36d5-4688-bc3f-bf081b8d8c2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsAndOtherAdjustmentsAbstract_02e1d19c-66ab-4b6a-8194-77c1b2ae79fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendsAndOtherAdjustmentsAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fed490a0-5c42-4ae5-baaf-64582b843c2a" xlink:to="loc_us-gaap_PreferredStockDividendsAndOtherAdjustmentsAbstract_02e1d19c-66ab-4b6a-8194-77c1b2ae79fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsAndOtherAdjustments_5d2733e3-e182-4fb6-8994-57600f15b8d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendsAndOtherAdjustments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PreferredStockDividendsAndOtherAdjustmentsAbstract_02e1d19c-66ab-4b6a-8194-77c1b2ae79fa" xlink:to="loc_us-gaap_PreferredStockDividendsAndOtherAdjustments_5d2733e3-e182-4fb6-8994-57600f15b8d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_afc5a0e0-1137-4a28-b3a8-b70c28ecf0ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fed490a0-5c42-4ae5-baaf-64582b843c2a" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_afc5a0e0-1137-4a28-b3a8-b70c28ecf0ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_9bb6b843-1d45-40c6-87cb-146a1ea16132" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fed490a0-5c42-4ae5-baaf-64582b843c2a" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_9bb6b843-1d45-40c6-87cb-146a1ea16132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_71a085be-10dd-4f67-b859-df91c6b8e942" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_9bb6b843-1d45-40c6-87cb-146a1ea16132" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_71a085be-10dd-4f67-b859-df91c6b8e942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_WeightedAverageNumberOfCommonSharesAbstract_64697422-4c3b-47f9-9125-e5f1e0f514f8" xlink:href="abus-20201231.xsd#abus_WeightedAverageNumberOfCommonSharesAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fed490a0-5c42-4ae5-baaf-64582b843c2a" xlink:to="loc_abus_WeightedAverageNumberOfCommonSharesAbstract_64697422-4c3b-47f9-9125-e5f1e0f514f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_6ebd4e1e-9b30-414c-8548-c3b2f4904cfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_WeightedAverageNumberOfCommonSharesAbstract_64697422-4c3b-47f9-9125-e5f1e0f514f8" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_6ebd4e1e-9b30-414c-8548-c3b2f4904cfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_a7bb4f0f-54ae-4aeb-95ba-1ce9f5b2bda9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fed490a0-5c42-4ae5-baaf-64582b843c2a" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_a7bb4f0f-54ae-4aeb-95ba-1ce9f5b2bda9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_72a41a51-5884-44cf-970e-343eb0f0032c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_a7bb4f0f-54ae-4aeb-95ba-1ce9f5b2bda9" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_72a41a51-5884-44cf-970e-343eb0f0032c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToNoncontrollingInterest_f1d6d819-2f41-4d7b-b887-8b215eba4e1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_a7bb4f0f-54ae-4aeb-95ba-1ce9f5b2bda9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToNoncontrollingInterest_f1d6d819-2f41-4d7b-b887-8b215eba4e1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_988bb496-8129-42ca-8630-6532f25366e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_a7bb4f0f-54ae-4aeb-95ba-1ce9f5b2bda9" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_988bb496-8129-42ca-8630-6532f25366e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/ConsolidatedStatementofStockholdersEquity" xlink:type="simple" xlink:href="abus-20201231.xsd#ConsolidatedStatementofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/ConsolidatedStatementofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_61059a73-73cb-4855-9bea-c4c224bd35b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f3103add-531b-40cc-ad9c-44878e1226c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_61059a73-73cb-4855-9bea-c4c224bd35b3" xlink:to="loc_us-gaap_StatementTable_f3103add-531b-40cc-ad9c-44878e1226c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4c4d6950-24fe-4306-b3c4-4722896da4f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f3103add-531b-40cc-ad9c-44878e1226c0" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4c4d6950-24fe-4306-b3c4-4722896da4f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a2c2b38b-f396-4639-86c4-81ccdc58ba0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4c4d6950-24fe-4306-b3c4-4722896da4f1" xlink:to="loc_us-gaap_EquityComponentDomain_a2c2b38b-f396-4639-86c4-81ccdc58ba0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_a2eb6629-8494-4549-9fb8-9de586670c52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a2c2b38b-f396-4639-86c4-81ccdc58ba0d" xlink:to="loc_us-gaap_PreferredStockMember_a2eb6629-8494-4549-9fb8-9de586670c52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_c6fdd50d-14b7-437f-8e27-0aee1f13885e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a2c2b38b-f396-4639-86c4-81ccdc58ba0d" xlink:to="loc_us-gaap_CommonStockMember_c6fdd50d-14b7-437f-8e27-0aee1f13885e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_0e1d0ca4-064d-4cc6-94db-e4d20c71c8b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a2c2b38b-f396-4639-86c4-81ccdc58ba0d" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_0e1d0ca4-064d-4cc6-94db-e4d20c71c8b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_e6d12345-06cf-4da5-af30-cf7f6697e894" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a2c2b38b-f396-4639-86c4-81ccdc58ba0d" xlink:to="loc_us-gaap_RetainedEarningsMember_e6d12345-06cf-4da5-af30-cf7f6697e894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_73e9e030-7355-4e6d-bb5f-afd49f4a80de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a2c2b38b-f396-4639-86c4-81ccdc58ba0d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_73e9e030-7355-4e6d-bb5f-afd49f4a80de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f47a5c8d-8fab-4d5b-9200-204f9ef9994c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f3103add-531b-40cc-ad9c-44878e1226c0" xlink:to="loc_us-gaap_StatementLineItems_f47a5c8d-8fab-4d5b-9200-204f9ef9994c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ac382d4b-fdd2-4414-960f-47f1ced12c2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f47a5c8d-8fab-4d5b-9200-204f9ef9994c" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ac382d4b-fdd2-4414-960f-47f1ced12c2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_453edec3-9fb0-4317-81c3-6f17fc49864e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ac382d4b-fdd2-4414-960f-47f1ced12c2f" xlink:to="loc_us-gaap_SharesIssued_453edec3-9fb0-4317-81c3-6f17fc49864e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c0414662-be7d-4a2e-878d-52b3c67d199e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ac382d4b-fdd2-4414-960f-47f1ced12c2f" xlink:to="loc_us-gaap_StockholdersEquity_c0414662-be7d-4a2e-878d-52b3c67d199e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockAccretionOfRedemptionDiscount_663de912-db35-4cf0-96ca-728c0dce751e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockAccretionOfRedemptionDiscount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ac382d4b-fdd2-4414-960f-47f1ced12c2f" xlink:to="loc_us-gaap_PreferredStockAccretionOfRedemptionDiscount_663de912-db35-4cf0-96ca-728c0dce751e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f6b37d31-87ad-43b8-bbcb-07c65742c4ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ac382d4b-fdd2-4414-960f-47f1ced12c2f" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f6b37d31-87ad-43b8-bbcb-07c65742c4ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_AdjustmentstoAdditionalPaidinCapitalCertainFairValueAdjustmentstoLiabilityStockOptionAwards_b007fe05-040e-47c1-81a3-68c9e9b6b1b1" xlink:href="abus-20201231.xsd#abus_AdjustmentstoAdditionalPaidinCapitalCertainFairValueAdjustmentstoLiabilityStockOptionAwards"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ac382d4b-fdd2-4414-960f-47f1ced12c2f" xlink:to="loc_abus_AdjustmentstoAdditionalPaidinCapitalCertainFairValueAdjustmentstoLiabilityStockOptionAwards_b007fe05-040e-47c1-81a3-68c9e9b6b1b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_2f03e5ac-3716-4cd5-8324-77c7fad45149" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ac382d4b-fdd2-4414-960f-47f1ced12c2f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_2f03e5ac-3716-4cd5-8324-77c7fad45149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_061bb1fb-292e-4146-b747-6a79ffeaa624" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ac382d4b-fdd2-4414-960f-47f1ced12c2f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_061bb1fb-292e-4146-b747-6a79ffeaa624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_f3e4c443-4e0f-41de-82a1-9fe857e3e76e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ac382d4b-fdd2-4414-960f-47f1ced12c2f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_f3e4c443-4e0f-41de-82a1-9fe857e3e76e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_72e016de-a0e4-4a24-9278-7b5431413788" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ac382d4b-fdd2-4414-960f-47f1ced12c2f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_72e016de-a0e4-4a24-9278-7b5431413788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e2ff2d85-1a29-4ef5-8ee4-db8377d8b649" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ac382d4b-fdd2-4414-960f-47f1ced12c2f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e2ff2d85-1a29-4ef5-8ee4-db8377d8b649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease_1d900e01-58cf-4219-afb4-79490124c977" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ac382d4b-fdd2-4414-960f-47f1ced12c2f" xlink:to="loc_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease_1d900e01-58cf-4219-afb4-79490124c977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_33076ab9-0407-40e2-b670-c7760cd28e11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ac382d4b-fdd2-4414-960f-47f1ced12c2f" xlink:to="loc_us-gaap_NetIncomeLoss_33076ab9-0407-40e2-b670-c7760cd28e11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_0ddcefea-1add-4a85-a175-54f974db43cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ac382d4b-fdd2-4414-960f-47f1ced12c2f" xlink:to="loc_us-gaap_SharesIssued_0ddcefea-1add-4a85-a175-54f974db43cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_45ac84c5-960d-4097-ba36-cbcb13605b23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ac382d4b-fdd2-4414-960f-47f1ced12c2f" xlink:to="loc_us-gaap_StockholdersEquity_45ac84c5-960d-4097-ba36-cbcb13605b23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="abus-20201231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_5ab6b929-3856-4534-876e-9d4524831b83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_cffcac27-88ec-4572-b79e-1508105196ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5ab6b929-3856-4534-876e-9d4524831b83" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_cffcac27-88ec-4572-b79e-1508105196ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_423ce1f5-425a-411a-b458-ae81e4994dd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_cffcac27-88ec-4572-b79e-1508105196ae" xlink:to="loc_us-gaap_NetIncomeLoss_423ce1f5-425a-411a-b458-ae81e4994dd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_bf86042e-9639-49a4-9b33-c4103d41f08f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_cffcac27-88ec-4572-b79e-1508105196ae" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_bf86042e-9639-49a4-9b33-c4103d41f08f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_b6f9b27d-ffd0-42af-822b-c2952afaed4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_bf86042e-9639-49a4-9b33-c4103d41f08f" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_b6f9b27d-ffd0-42af-822b-c2952afaed4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_46bfa5c3-7488-4f0f-8730-681e92d83da4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_bf86042e-9639-49a4-9b33-c4103d41f08f" xlink:to="loc_us-gaap_Depreciation_46bfa5c3-7488-4f0f-8730-681e92d83da4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_5c7f4a6b-353f-414f-b4d1-16f4682bc437" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_bf86042e-9639-49a4-9b33-c4103d41f08f" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_5c7f4a6b-353f-414f-b4d1-16f4682bc437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_b133d684-41e5-4abe-8949-e09399ef0548" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_bf86042e-9639-49a4-9b33-c4103d41f08f" xlink:to="loc_us-gaap_ShareBasedCompensation_b133d684-41e5-4abe-8949-e09399ef0548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_011abfc9-b04c-4795-be70-4f3e5874c113" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_bf86042e-9639-49a4-9b33-c4103d41f08f" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_011abfc9-b04c-4795-be70-4f3e5874c113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3f859af5-c6da-462e-8e22-a48207a620b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_bf86042e-9639-49a4-9b33-c4103d41f08f" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3f859af5-c6da-462e-8e22-a48207a620b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_97dca8a6-a0d8-48b0-b1a5-503c9b6515b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_bf86042e-9639-49a4-9b33-c4103d41f08f" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_97dca8a6-a0d8-48b0-b1a5-503c9b6515b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_d6000b6f-f401-4678-bb3a-1c0cff94ab9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_bf86042e-9639-49a4-9b33-c4103d41f08f" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_d6000b6f-f401-4678-bb3a-1c0cff94ab9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_Netequityinvestmentgainorloss_a106a561-f6ac-447e-9409-72690cbf55c4" xlink:href="abus-20201231.xsd#abus_Netequityinvestmentgainorloss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_bf86042e-9639-49a4-9b33-c4103d41f08f" xlink:to="loc_abus_Netequityinvestmentgainorloss_a106a561-f6ac-447e-9409-72690cbf55c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_NonCashRoyaltyRevenueRelatedToSaleOfFutureRoyalties_b3b1d94f-4108-4a53-802c-33aa90a97a11" xlink:href="abus-20201231.xsd#abus_NonCashRoyaltyRevenueRelatedToSaleOfFutureRoyalties"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_bf86042e-9639-49a4-9b33-c4103d41f08f" xlink:to="loc_abus_NonCashRoyaltyRevenueRelatedToSaleOfFutureRoyalties_b3b1d94f-4108-4a53-802c-33aa90a97a11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_NonCashInterestExpenseRelatedToSaleOfFutureRoyalties_09dbfda3-fa46-4e13-8cab-df15c1b64dd9" xlink:href="abus-20201231.xsd#abus_NonCashInterestExpenseRelatedToSaleOfFutureRoyalties"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_bf86042e-9639-49a4-9b33-c4103d41f08f" xlink:to="loc_abus_NonCashInterestExpenseRelatedToSaleOfFutureRoyalties_09dbfda3-fa46-4e13-8cab-df15c1b64dd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_72fa6a1f-f686-4cef-bd61-0b126689344e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_bf86042e-9639-49a4-9b33-c4103d41f08f" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_72fa6a1f-f686-4cef-bd61-0b126689344e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d38c078b-a6e0-43c7-b1cd-2dd252be6e5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_cffcac27-88ec-4572-b79e-1508105196ae" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d38c078b-a6e0-43c7-b1cd-2dd252be6e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_a0886a89-dda1-4db0-a36d-7e23bcc930b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d38c078b-a6e0-43c7-b1cd-2dd252be6e5b" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_a0886a89-dda1-4db0-a36d-7e23bcc930b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_be185690-d053-4803-9fd6-e37ac944fa23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d38c078b-a6e0-43c7-b1cd-2dd252be6e5b" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_be185690-d053-4803-9fd6-e37ac944fa23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_8e0d768a-fff1-426c-bddd-aec7938a6c9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d38c078b-a6e0-43c7-b1cd-2dd252be6e5b" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_8e0d768a-fff1-426c-bddd-aec7938a6c9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_cd07b0fd-e732-4fee-a1cc-a447b040952b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d38c078b-a6e0-43c7-b1cd-2dd252be6e5b" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_cd07b0fd-e732-4fee-a1cc-a447b040952b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5dd5891d-c831-4d4e-9862-c2218e44aa02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_cffcac27-88ec-4572-b79e-1508105196ae" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5dd5891d-c831-4d4e-9862-c2218e44aa02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e74ac065-a476-41e5-beaf-fc1e7bcf34c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5ab6b929-3856-4534-876e-9d4524831b83" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e74ac065-a476-41e5-beaf-fc1e7bcf34c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_0d17e3c3-529b-41ce-bf6b-7a2e2220bbd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e74ac065-a476-41e5-beaf-fc1e7bcf34c1" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_0d17e3c3-529b-41ce-bf6b-7a2e2220bbd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_470c21bc-ef5a-4a69-81ff-86e2fd5b556f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e74ac065-a476-41e5-beaf-fc1e7bcf34c1" xlink:to="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_470c21bc-ef5a-4a69-81ff-86e2fd5b556f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_89367f99-0e5a-44d0-8712-b7bee805de26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e74ac065-a476-41e5-beaf-fc1e7bcf34c1" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_89367f99-0e5a-44d0-8712-b7bee805de26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_c9c025a9-a6ee-482c-a23d-2c14d388403a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e74ac065-a476-41e5-beaf-fc1e7bcf34c1" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_c9c025a9-a6ee-482c-a23d-2c14d388403a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5324bbf8-562f-49a5-9743-eaceaa3854d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e74ac065-a476-41e5-beaf-fc1e7bcf34c1" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5324bbf8-562f-49a5-9743-eaceaa3854d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e1a31b3b-2fb0-43c4-89d8-3bb13c4abe50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e74ac065-a476-41e5-beaf-fc1e7bcf34c1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e1a31b3b-2fb0-43c4-89d8-3bb13c4abe50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ff0ab1d7-724c-42a6-a28e-a8455d23fca5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5ab6b929-3856-4534-876e-9d4524831b83" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ff0ab1d7-724c-42a6-a28e-a8455d23fca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_ProceedsFromSaleOfFutureRoyaltiesNet_82910cf9-27e1-4758-a8b8-b9c59e4f0b55" xlink:href="abus-20201231.xsd#abus_ProceedsFromSaleOfFutureRoyaltiesNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ff0ab1d7-724c-42a6-a28e-a8455d23fca5" xlink:to="loc_abus_ProceedsFromSaleOfFutureRoyaltiesNet_82910cf9-27e1-4758-a8b8-b9c59e4f0b55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_f6586521-5da7-41da-9364-a3b4d1e3b25c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ff0ab1d7-724c-42a6-a28e-a8455d23fca5" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_f6586521-5da7-41da-9364-a3b4d1e3b25c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_95dad8a4-d73d-4434-a927-8f6432f0536d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ff0ab1d7-724c-42a6-a28e-a8455d23fca5" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_95dad8a4-d73d-4434-a927-8f6432f0536d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8484d5e5-12c1-4a3a-8365-d957f63a8880" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ff0ab1d7-724c-42a6-a28e-a8455d23fca5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8484d5e5-12c1-4a3a-8365-d957f63a8880" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0c06956a-6078-4978-9892-5c1441626022" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5ab6b929-3856-4534-876e-9d4524831b83" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0c06956a-6078-4978-9892-5c1441626022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5b622c78-8aa4-46a7-a359-6237420e1b91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5ab6b929-3856-4534-876e-9d4524831b83" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5b622c78-8aa4-46a7-a359-6237420e1b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7a80c861-2c02-4bf9-86ca-574787f27784" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5ab6b929-3856-4534-876e-9d4524831b83" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7a80c861-2c02-4bf9-86ca-574787f27784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c98cd862-4de6-430d-8970-1cb0d14ea494" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5ab6b929-3856-4534-876e-9d4524831b83" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c98cd862-4de6-430d-8970-1cb0d14ea494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_999b0962-4867-46a4-8622-1e0540991aee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5ab6b929-3856-4534-876e-9d4524831b83" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_999b0962-4867-46a4-8622-1e0540991aee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockCash_48029cc5-4e79-4ce6-a73c-527ea0f1050e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPreferredStockCash"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_999b0962-4867-46a4-8622-1e0540991aee" xlink:to="loc_us-gaap_DividendsPreferredStockCash_48029cc5-4e79-4ce6-a73c-527ea0f1050e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/Organization" xlink:type="simple" xlink:href="abus-20201231.xsd#Organization"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/Organization" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ba729f18-6d14-4bf1-89b1-2d3c19f47cf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_ff1443fc-5d85-4ac3-b9a3-da889e03cde3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ba729f18-6d14-4bf1-89b1-2d3c19f47cf8" xlink:to="loc_us-gaap_NatureOfOperations_ff1443fc-5d85-4ac3-b9a3-da889e03cde3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/OrganizationDetails" xlink:type="simple" xlink:href="abus-20201231.xsd#OrganizationDetails"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/OrganizationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e17de3e7-d401-43bb-9c88-208a7f5ad7e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_NumberOfProducts_f09b1fe6-854c-44e9-b61e-3ed07c28cb76" xlink:href="abus-20201231.xsd#abus_NumberOfProducts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e17de3e7-d401-43bb-9c88-208a7f5ad7e0" xlink:to="loc_abus_NumberOfProducts_f09b1fe6-854c-44e9-b61e-3ed07c28cb76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_0883350b-533a-4cb9-853e-c7d1f20f6cef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e17de3e7-d401-43bb-9c88-208a7f5ad7e0" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_0883350b-533a-4cb9-853e-c7d1f20f6cef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_249ce4e9-8dfa-4734-a3aa-50ad6506675b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e17de3e7-d401-43bb-9c88-208a7f5ad7e0" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_249ce4e9-8dfa-4734-a3aa-50ad6506675b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_2e8ee46c-0149-4f36-a27f-c887469d6c26" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_249ce4e9-8dfa-4734-a3aa-50ad6506675b" xlink:to="loc_srt_CounterpartyNameAxis_2e8ee46c-0149-4f36-a27f-c887469d6c26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_83e3ea58-6ab9-42e8-b5d5-3da3f2c816a9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_2e8ee46c-0149-4f36-a27f-c887469d6c26" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_83e3ea58-6ab9-42e8-b5d5-3da3f2c816a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_JefferiesLLCMember_025e8f37-4cad-46cd-bf46-38a262d54f5f" xlink:href="abus-20201231.xsd#abus_JefferiesLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_83e3ea58-6ab9-42e8-b5d5-3da3f2c816a9" xlink:to="loc_abus_JefferiesLLCMember_025e8f37-4cad-46cd-bf46-38a262d54f5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_f062375f-2bc1-4154-a909-643f7acec8ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_249ce4e9-8dfa-4734-a3aa-50ad6506675b" xlink:to="loc_us-gaap_StatementClassOfStockAxis_f062375f-2bc1-4154-a909-643f7acec8ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_26e1cfe1-91d4-4a2f-8e54-3c5e5e4901de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_f062375f-2bc1-4154-a909-643f7acec8ac" xlink:to="loc_us-gaap_ClassOfStockDomain_26e1cfe1-91d4-4a2f-8e54-3c5e5e4901de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_19171f2b-d2e8-4067-bc59-3ae9cef315ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_26e1cfe1-91d4-4a2f-8e54-3c5e5e4901de" xlink:to="loc_us-gaap_CommonStockMember_19171f2b-d2e8-4067-bc59-3ae9cef315ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_f0ccedbf-1416-4887-aab8-3adbb2bde374" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_249ce4e9-8dfa-4734-a3aa-50ad6506675b" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_f0ccedbf-1416-4887-aab8-3adbb2bde374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_4338267b-391c-4f8b-9daa-592ef9531524" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_f0ccedbf-1416-4887-aab8-3adbb2bde374" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_4338267b-391c-4f8b-9daa-592ef9531524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_OpenMarketSaleAgreementMember_d9b72bcf-a811-43c2-94ac-ce93ba59401d" xlink:href="abus-20201231.xsd#abus_OpenMarketSaleAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_4338267b-391c-4f8b-9daa-592ef9531524" xlink:to="loc_abus_OpenMarketSaleAgreementMember_d9b72bcf-a811-43c2-94ac-ce93ba59401d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_4263dfe7-9091-40da-86d0-110359162638" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_249ce4e9-8dfa-4734-a3aa-50ad6506675b" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_4263dfe7-9091-40da-86d0-110359162638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_f52f4053-5995-4550-8dcf-19fb10282a35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_4263dfe7-9091-40da-86d0-110359162638" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_f52f4053-5995-4550-8dcf-19fb10282a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_0f810887-a0f0-4be9-a3f4-86eed9a7d476" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_f52f4053-5995-4550-8dcf-19fb10282a35" xlink:to="loc_us-gaap_SubsequentEventMember_0f810887-a0f0-4be9-a3f4-86eed9a7d476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_f34c80ad-7db2-47dc-876b-fb0142a3e251" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_249ce4e9-8dfa-4734-a3aa-50ad6506675b" xlink:to="loc_us-gaap_ClassOfStockLineItems_f34c80ad-7db2-47dc-876b-fb0142a3e251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_37b57771-b529-4bf5-a479-08609a4709f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f34c80ad-7db2-47dc-876b-fb0142a3e251" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_37b57771-b529-4bf5-a479-08609a4709f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/Significantaccountingpolicies" xlink:type="simple" xlink:href="abus-20201231.xsd#Significantaccountingpolicies"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/Significantaccountingpolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_fc37e92e-eee9-42dd-94ce-c571ecad66fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_c82068b1-a97f-4619-9aca-134e126d3720" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fc37e92e-eee9-42dd-94ce-c571ecad66fa" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_c82068b1-a97f-4619-9aca-134e126d3720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/SignificantaccountingpoliciesPolicies" xlink:type="simple" xlink:href="abus-20201231.xsd#SignificantaccountingpoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/SignificantaccountingpoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_06abc469-3270-44bd-b484-690c074367a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_49533b86-a1db-4562-8266-b22c04ada6ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_06abc469-3270-44bd-b484-690c074367a6" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_49533b86-a1db-4562-8266-b22c04ada6ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_9da172ef-8d48-4a73-979c-ea581732f2e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_06abc469-3270-44bd-b484-690c074367a6" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_9da172ef-8d48-4a73-979c-ea581732f2e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_b9ff5f89-a1d4-45fa-a7de-ebd94468b778" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_06abc469-3270-44bd-b484-690c074367a6" xlink:to="loc_us-gaap_UseOfEstimates_b9ff5f89-a1d4-45fa-a7de-ebd94468b778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_dfcc1a84-2e32-489f-8842-d34b3027a593" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_06abc469-3270-44bd-b484-690c074367a6" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_dfcc1a84-2e32-489f-8842-d34b3027a593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_4d6ec44b-daa5-4d11-93f7-1464e074459a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_06abc469-3270-44bd-b484-690c074367a6" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_4d6ec44b-daa5-4d11-93f7-1464e074459a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_30983055-cf13-4c02-ac19-edb9b3611e15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_06abc469-3270-44bd-b484-690c074367a6" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_30983055-cf13-4c02-ac19-edb9b3611e15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy_7c9f679c-f0fa-42bb-ae50-32f3343c57bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_06abc469-3270-44bd-b484-690c074367a6" xlink:to="loc_us-gaap_EquityMethodInvestmentsPolicy_7c9f679c-f0fa-42bb-ae50-32f3343c57bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_4f34db9c-df3e-4b4a-a59e-3826499bfba3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_06abc469-3270-44bd-b484-690c074367a6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_4f34db9c-df3e-4b4a-a59e-3826499bfba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_590708b0-e138-4860-883c-774a66bb81dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_06abc469-3270-44bd-b484-690c074367a6" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_590708b0-e138-4860-883c-774a66bb81dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_6f1a966e-2573-44a6-b668-8cd77de32f9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_06abc469-3270-44bd-b484-690c074367a6" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_6f1a966e-2573-44a6-b668-8cd77de32f9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_e17b70b1-e277-4a9c-b140-bc70775219bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_06abc469-3270-44bd-b484-690c074367a6" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_e17b70b1-e277-4a9c-b140-bc70775219bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_e51b2418-73c8-4d53-8283-61985aab4c34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_06abc469-3270-44bd-b484-690c074367a6" xlink:to="loc_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_e51b2418-73c8-4d53-8283-61985aab4c34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_7ee6974e-ac7b-4ddc-89fd-6c2f2be654fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_06abc469-3270-44bd-b484-690c074367a6" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_7ee6974e-ac7b-4ddc-89fd-6c2f2be654fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_e1579806-4ca0-4315-aa72-0d33dde6dd80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_06abc469-3270-44bd-b484-690c074367a6" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_e1579806-4ca0-4315-aa72-0d33dde6dd80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_6e8f6c80-8d94-4f42-b3cc-761cca40fc2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_06abc469-3270-44bd-b484-690c074367a6" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_6e8f6c80-8d94-4f42-b3cc-761cca40fc2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy_85fe52b7-eb7c-47de-acec-c0d9ac45ba32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_06abc469-3270-44bd-b484-690c074367a6" xlink:to="loc_us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy_85fe52b7-eb7c-47de-acec-c0d9ac45ba32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_8b5ef8cb-af23-4d7b-b445-8c0144e90974" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_06abc469-3270-44bd-b484-690c074367a6" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_8b5ef8cb-af23-4d7b-b445-8c0144e90974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_09c33d8f-94e6-4bb5-adcd-748250c88e44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_06abc469-3270-44bd-b484-690c074367a6" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_09c33d8f-94e6-4bb5-adcd-748250c88e44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_ddd79a59-0b67-48e3-86c1-e35fee5ed014" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_06abc469-3270-44bd-b484-690c074367a6" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_ddd79a59-0b67-48e3-86c1-e35fee5ed014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_cf700bd6-1ed6-44f0-8ab1-48a41e5a4d6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_06abc469-3270-44bd-b484-690c074367a6" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_cf700bd6-1ed6-44f0-8ab1-48a41e5a4d6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_452b6827-7272-4721-bfb3-a3f78d8e1382" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_06abc469-3270-44bd-b484-690c074367a6" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_452b6827-7272-4721-bfb3-a3f78d8e1382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/SignificantaccountingpoliciesTables" xlink:type="simple" xlink:href="abus-20201231.xsd#SignificantaccountingpoliciesTables"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/SignificantaccountingpoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b26dc204-da1a-4883-b6d8-0318acc85951" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock_e5ef2767-e1de-478e-abbb-45edf0dc0f2a" xlink:href="abus-20201231.xsd#abus_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b26dc204-da1a-4883-b6d8-0318acc85951" xlink:to="loc_abus_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock_e5ef2767-e1de-478e-abbb-45edf0dc0f2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_282f2b0f-b140-45fd-9a8c-da3f58e8a6b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b26dc204-da1a-4883-b6d8-0318acc85951" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_282f2b0f-b140-45fd-9a8c-da3f58e8a6b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/SignificantaccountingpoliciesNarrativeDetails" xlink:type="simple" xlink:href="abus-20201231.xsd#SignificantaccountingpoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/SignificantaccountingpoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ba420b83-fd89-4ba9-b471-dc971bde749a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_6d3c27eb-46ff-4693-9cd9-1999eb6f5407" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ba420b83-fd89-4ba9-b471-dc971bde749a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_6d3c27eb-46ff-4693-9cd9-1999eb6f5407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_079f90b3-7b1e-4308-b251-f86ca38f55a4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_6d3c27eb-46ff-4693-9cd9-1999eb6f5407" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_079f90b3-7b1e-4308-b251-f86ca38f55a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_328a3636-21ad-45dc-abcf-628eddfa1f30" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_079f90b3-7b1e-4308-b251-f86ca38f55a4" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_328a3636-21ad-45dc-abcf-628eddfa1f30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_GenevantSciencesCorporationMember_6043d8d5-66c7-4c80-ae42-b75458f60048" xlink:href="abus-20201231.xsd#abus_GenevantSciencesCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_328a3636-21ad-45dc-abcf-628eddfa1f30" xlink:to="loc_abus_GenevantSciencesCorporationMember_6043d8d5-66c7-4c80-ae42-b75458f60048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_071ad7ec-ace3-4632-b086-96f71d0dc383" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_6d3c27eb-46ff-4693-9cd9-1999eb6f5407" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_071ad7ec-ace3-4632-b086-96f71d0dc383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bc4b17f2-9571-4b2e-b2ea-3efed537a94d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_071ad7ec-ace3-4632-b086-96f71d0dc383" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bc4b17f2-9571-4b2e-b2ea-3efed537a94d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_b23d41ac-7997-453e-8d34-dddb566c2af8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bc4b17f2-9571-4b2e-b2ea-3efed537a94d" xlink:to="loc_us-gaap_EmployeeStockOptionMember_b23d41ac-7997-453e-8d34-dddb566c2af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_0d88e4af-4947-4247-beb7-94f005ce9a96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bc4b17f2-9571-4b2e-b2ea-3efed537a94d" xlink:to="loc_us-gaap_PreferredStockMember_0d88e4af-4947-4247-beb7-94f005ce9a96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_0472ce76-4f08-452e-a4dd-fe9adbbec5e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GranteeStatusAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_6d3c27eb-46ff-4693-9cd9-1999eb6f5407" xlink:to="loc_us-gaap_GranteeStatusAxis_0472ce76-4f08-452e-a4dd-fe9adbbec5e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_77a76c8f-3ba9-4f8d-8b75-bc0d8f9f832d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GranteeStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusAxis_0472ce76-4f08-452e-a4dd-fe9adbbec5e0" xlink:to="loc_us-gaap_GranteeStatusDomain_77a76c8f-3ba9-4f8d-8b75-bc0d8f9f832d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_208b5d12-7f3c-40ee-8318-d881423e8bd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusDomain_77a76c8f-3ba9-4f8d-8b75-bc0d8f9f832d" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_208b5d12-7f3c-40ee-8318-d881423e8bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_6a178ffd-8fcc-4baf-945d-2812557e46de" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_6d3c27eb-46ff-4693-9cd9-1999eb6f5407" xlink:to="loc_srt_TitleOfIndividualAxis_6a178ffd-8fcc-4baf-945d-2812557e46de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_2a6b1251-ac2a-4675-801a-dc7fcf3b89b1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_6a178ffd-8fcc-4baf-945d-2812557e46de" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_2a6b1251-ac2a-4675-801a-dc7fcf3b89b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_DirectorsAndExecutivesMember_596edbc3-79f9-482a-9681-e355de61fb9a" xlink:href="abus-20201231.xsd#abus_DirectorsAndExecutivesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_2a6b1251-ac2a-4675-801a-dc7fcf3b89b1" xlink:to="loc_abus_DirectorsAndExecutivesMember_596edbc3-79f9-482a-9681-e355de61fb9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6f5de333-b198-4e1a-9af5-f90f9aad65df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_6d3c27eb-46ff-4693-9cd9-1999eb6f5407" xlink:to="loc_us-gaap_AwardTypeAxis_6f5de333-b198-4e1a-9af5-f90f9aad65df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_faf9aa95-ba58-4915-b010-b57a2cbfc08b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_6f5de333-b198-4e1a-9af5-f90f9aad65df" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_faf9aa95-ba58-4915-b010-b57a2cbfc08b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_63ff4979-3ada-48ee-8e65-e80f471b20c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_faf9aa95-ba58-4915-b010-b57a2cbfc08b" xlink:to="loc_us-gaap_EmployeeStockOptionMember_63ff4979-3ada-48ee-8e65-e80f471b20c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_25da643e-44b9-49c8-a057-6d33c68cd082" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_6d3c27eb-46ff-4693-9cd9-1999eb6f5407" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_25da643e-44b9-49c8-a057-6d33c68cd082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_904bcc88-f766-4112-aafe-5d8375114326" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_25da643e-44b9-49c8-a057-6d33c68cd082" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_904bcc88-f766-4112-aafe-5d8375114326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_2c4e5090-6f3f-4adf-af7e-fdccdf69a118" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_25da643e-44b9-49c8-a057-6d33c68cd082" xlink:to="loc_us-gaap_EquityMethodInvestments_2c4e5090-6f3f-4adf-af7e-fdccdf69a118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_69ba20c2-216a-41f2-aeb5-52d442b129f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_25da643e-44b9-49c8-a057-6d33c68cd082" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_69ba20c2-216a-41f2-aeb5-52d442b129f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_1230ce14-f9cc-44c1-a1ae-dcfcc882d779" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_25da643e-44b9-49c8-a057-6d33c68cd082" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_1230ce14-f9cc-44c1-a1ae-dcfcc882d779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_91529e37-26b5-4739-b7d7-9f3392d71125" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_25da643e-44b9-49c8-a057-6d33c68cd082" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_91529e37-26b5-4739-b7d7-9f3392d71125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/SignificantaccountingpoliciesEstimatedusefullivesofpropertyandequipmentDetails" xlink:type="simple" xlink:href="abus-20201231.xsd#SignificantaccountingpoliciesEstimatedusefullivesofpropertyandequipmentDetails"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/SignificantaccountingpoliciesEstimatedusefullivesofpropertyandequipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a2db5b82-5260-4a47-8268-bc2bc16bbd52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_71c7b050-909a-47d7-a5ac-83c8aea9cd77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a2db5b82-5260-4a47-8268-bc2bc16bbd52" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_71c7b050-909a-47d7-a5ac-83c8aea9cd77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_65ea2ea7-812e-4e42-87da-69cc7e95af45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_71c7b050-909a-47d7-a5ac-83c8aea9cd77" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_65ea2ea7-812e-4e42-87da-69cc7e95af45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9ecfb580-d5db-4332-976f-d6e9f47b8ce3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_65ea2ea7-812e-4e42-87da-69cc7e95af45" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9ecfb580-d5db-4332-976f-d6e9f47b8ce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_LaboratoryEquipmentMember_8c0dc1d6-d3fb-49dc-be2d-06dbf9c8ae17" xlink:href="abus-20201231.xsd#abus_LaboratoryEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9ecfb580-d5db-4332-976f-d6e9f47b8ce3" xlink:to="loc_abus_LaboratoryEquipmentMember_8c0dc1d6-d3fb-49dc-be2d-06dbf9c8ae17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_4355330c-c5cf-414e-9e1e-80166006a129" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9ecfb580-d5db-4332-976f-d6e9f47b8ce3" xlink:to="loc_us-gaap_ComputerEquipmentMember_4355330c-c5cf-414e-9e1e-80166006a129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_53f847f4-fc04-449e-bf4e-89b8b6123022" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9ecfb580-d5db-4332-976f-d6e9f47b8ce3" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_53f847f4-fc04-449e-bf4e-89b8b6123022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c255a618-1999-48a3-a38a-ce4e890e7f3d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_71c7b050-909a-47d7-a5ac-83c8aea9cd77" xlink:to="loc_srt_RangeAxis_c255a618-1999-48a3-a38a-ce4e890e7f3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f6aa49e3-ff84-4db5-813f-379fafbf648d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_c255a618-1999-48a3-a38a-ce4e890e7f3d" xlink:to="loc_srt_RangeMember_f6aa49e3-ff84-4db5-813f-379fafbf648d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ff608621-d54d-4bf5-978f-bba486758ab1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f6aa49e3-ff84-4db5-813f-379fafbf648d" xlink:to="loc_srt_MinimumMember_ff608621-d54d-4bf5-978f-bba486758ab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_439e0da3-c6de-45fc-b875-40bdd4cf750c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f6aa49e3-ff84-4db5-813f-379fafbf648d" xlink:to="loc_srt_MaximumMember_439e0da3-c6de-45fc-b875-40bdd4cf750c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7fb8bc90-0166-4ce2-a535-c47c0f48b234" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_71c7b050-909a-47d7-a5ac-83c8aea9cd77" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7fb8bc90-0166-4ce2-a535-c47c0f48b234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_60d92cf7-05f5-49d4-aeaf-942b99649b14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7fb8bc90-0166-4ce2-a535-c47c0f48b234" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_60d92cf7-05f5-49d4-aeaf-942b99649b14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/SignificantaccountingpoliciesComputationofbasicanddilutednetincomelosspercommonshareDetails" xlink:type="simple" xlink:href="abus-20201231.xsd#SignificantaccountingpoliciesComputationofbasicanddilutednetincomelosspercommonshareDetails"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/SignificantaccountingpoliciesComputationofbasicanddilutednetincomelosspercommonshareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_439a2952-8d11-43ca-ab8c-808063e98e74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_cefff612-f95a-451b-855d-1b7bbfd84074" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_439a2952-8d11-43ca-ab8c-808063e98e74" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_cefff612-f95a-451b-855d-1b7bbfd84074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_980a29cd-28e6-4ef1-b78d-7b16bd45ccc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_cefff612-f95a-451b-855d-1b7bbfd84074" xlink:to="loc_us-gaap_StatementClassOfStockAxis_980a29cd-28e6-4ef1-b78d-7b16bd45ccc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_02e59154-57ab-4dd2-8c58-17a45b6c7711" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_980a29cd-28e6-4ef1-b78d-7b16bd45ccc3" xlink:to="loc_us-gaap_ClassOfStockDomain_02e59154-57ab-4dd2-8c58-17a45b6c7711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_cbb728e7-f895-47b1-a8c4-1d4c820993d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_02e59154-57ab-4dd2-8c58-17a45b6c7711" xlink:to="loc_us-gaap_CommonStockMember_cbb728e7-f895-47b1-a8c4-1d4c820993d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_1f78dec2-081d-44c0-a775-fc805fed3e52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_cefff612-f95a-451b-855d-1b7bbfd84074" xlink:to="loc_us-gaap_EarningsPerShareBasicLineItems_1f78dec2-081d-44c0-a775-fc805fed3e52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsAndOtherAdjustments_4c78152a-073b-40df-bdb8-e549d31b8a2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendsAndOtherAdjustments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_1f78dec2-081d-44c0-a775-fc805fed3e52" xlink:to="loc_us-gaap_PreferredStockDividendsAndOtherAdjustments_4c78152a-073b-40df-bdb8-e549d31b8a2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAvailableToCommonShareholdersBasic_0a774007-b559-487d-a5eb-40026a31efc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UndistributedEarningsLossAvailableToCommonShareholdersBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_1f78dec2-081d-44c0-a775-fc805fed3e52" xlink:to="loc_us-gaap_UndistributedEarningsLossAvailableToCommonShareholdersBasic_0a774007-b559-487d-a5eb-40026a31efc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_d4c9bd14-0cfe-4c85-89d1-2969446c8a12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_1f78dec2-081d-44c0-a775-fc805fed3e52" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_d4c9bd14-0cfe-4c85-89d1-2969446c8a12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_8cbc2dde-67f3-425a-9181-b5bf79504cee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_1f78dec2-081d-44c0-a775-fc805fed3e52" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_8cbc2dde-67f3-425a-9181-b5bf79504cee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_8804ee01-917f-46da-a612-d78c724e557e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_1f78dec2-081d-44c0-a775-fc805fed3e52" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_8804ee01-917f-46da-a612-d78c724e557e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/SignificantaccountingpoliciesDetails" xlink:type="simple" xlink:href="abus-20201231.xsd#SignificantaccountingpoliciesDetails"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/SignificantaccountingpoliciesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/Fairvaluemeasurements" xlink:type="simple" xlink:href="abus-20201231.xsd#Fairvaluemeasurements"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/Fairvaluemeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_0563e57b-c3b6-4afc-89cc-9f2f6b3eb773" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_9227dbef-d782-4ff0-a36d-2ee82f6c2370" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0563e57b-c3b6-4afc-89cc-9f2f6b3eb773" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_9227dbef-d782-4ff0-a36d-2ee82f6c2370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/FairvaluemeasurementsTables" xlink:type="simple" xlink:href="abus-20201231.xsd#FairvaluemeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/FairvaluemeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_985bc294-f81b-4a9f-aa13-3b31daad861e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_684bf809-a70e-4112-96f5-b4ae5f9db671" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_985bc294-f81b-4a9f-aa13-3b31daad861e" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_684bf809-a70e-4112-96f5-b4ae5f9db671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_ChangesInFairValueofLiabilityOptionTableTextBlock_ae6fc49a-a9b2-4e4b-8427-6a4d4737b848" xlink:href="abus-20201231.xsd#abus_ChangesInFairValueofLiabilityOptionTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_985bc294-f81b-4a9f-aa13-3b31daad861e" xlink:to="loc_abus_ChangesInFairValueofLiabilityOptionTableTextBlock_ae6fc49a-a9b2-4e4b-8427-6a4d4737b848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_fbd58c9e-4834-4e0b-ae0b-c265e39ba5db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_985bc294-f81b-4a9f-aa13-3b31daad861e" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_fbd58c9e-4834-4e0b-ae0b-c265e39ba5db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/FairvaluemeasurementsNarrativeDetails" xlink:type="simple" xlink:href="abus-20201231.xsd#FairvaluemeasurementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/FairvaluemeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_36afaa43-df9f-4b0a-a7a0-fac325325de3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_a0cfa96f-0b6a-4599-b9ff-e02a37ad873f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_36afaa43-df9f-4b0a-a7a0-fac325325de3" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_a0cfa96f-0b6a-4599-b9ff-e02a37ad873f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_cb7ea7e2-7443-41f6-8c40-777040679c85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_36afaa43-df9f-4b0a-a7a0-fac325325de3" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_cb7ea7e2-7443-41f6-8c40-777040679c85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/FairvaluemeasurementsAssetsandliabilitiesmeasuredatfairvalueonrecurringbasisDetails" xlink:type="simple" xlink:href="abus-20201231.xsd#FairvaluemeasurementsAssetsandliabilitiesmeasuredatfairvalueonrecurringbasisDetails"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/FairvaluemeasurementsAssetsandliabilitiesmeasuredatfairvalueonrecurringbasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_238bf56e-08e0-4c59-a9b6-3f032f7717bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6a9a76ac-10bc-4074-b35c-9362eae24232" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_238bf56e-08e0-4c59-a9b6-3f032f7717bd" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6a9a76ac-10bc-4074-b35c-9362eae24232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ebc774d3-fdd3-4e8e-a57a-74ddef61f5df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6a9a76ac-10bc-4074-b35c-9362eae24232" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ebc774d3-fdd3-4e8e-a57a-74ddef61f5df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_14c65db9-bd99-4ab1-86e1-28d61cefcc24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ebc774d3-fdd3-4e8e-a57a-74ddef61f5df" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_14c65db9-bd99-4ab1-86e1-28d61cefcc24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_74ca1bf8-bdbc-4101-a768-38c866783554" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_14c65db9-bd99-4ab1-86e1-28d61cefcc24" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_74ca1bf8-bdbc-4101-a768-38c866783554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e30012d1-be14-4903-a0ee-6f7d4b261cc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6a9a76ac-10bc-4074-b35c-9362eae24232" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e30012d1-be14-4903-a0ee-6f7d4b261cc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_49f8dfbf-f528-4b13-8f97-b2bf6a684f16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e30012d1-be14-4903-a0ee-6f7d4b261cc2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_49f8dfbf-f528-4b13-8f97-b2bf6a684f16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_6526ce79-e286-496c-803a-f5dde456b33d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_49f8dfbf-f528-4b13-8f97-b2bf6a684f16" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_6526ce79-e286-496c-803a-f5dde456b33d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_c8000115-a4b7-42c8-bb77-f5c50821e843" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_49f8dfbf-f528-4b13-8f97-b2bf6a684f16" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_c8000115-a4b7-42c8-bb77-f5c50821e843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_ba096af6-0f45-4e16-81b7-56b1f7d607af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_49f8dfbf-f528-4b13-8f97-b2bf6a684f16" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_ba096af6-0f45-4e16-81b7-56b1f7d607af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0c0b5aea-1e1a-42b5-88f6-0c8664b14f03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6a9a76ac-10bc-4074-b35c-9362eae24232" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0c0b5aea-1e1a-42b5-88f6-0c8664b14f03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_11be62a0-9359-49e7-af80-eaf879c5a98c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0c0b5aea-1e1a-42b5-88f6-0c8664b14f03" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_11be62a0-9359-49e7-af80-eaf879c5a98c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_bc314473-fcd8-48b9-9e1b-0ad8fe5dc5c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_11be62a0-9359-49e7-af80-eaf879c5a98c" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_bc314473-fcd8-48b9-9e1b-0ad8fe5dc5c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_c16fbad3-8fbf-470c-863f-40f5816b0300" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_11be62a0-9359-49e7-af80-eaf879c5a98c" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_c16fbad3-8fbf-470c-863f-40f5816b0300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_d44716b6-5ced-4a32-8adf-6c5120793bab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_11be62a0-9359-49e7-af80-eaf879c5a98c" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_d44716b6-5ced-4a32-8adf-6c5120793bab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_6536c8fb-a2fd-416a-bf07-fa38481c9a65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0c0b5aea-1e1a-42b5-88f6-0c8664b14f03" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_6536c8fb-a2fd-416a-bf07-fa38481c9a65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_EmployeeStockOptionsLiabilityClassifiedOutstandingFairValueDisclosure_f6aa1276-f82a-4aba-8d6a-f7a2a6a51cd9" xlink:href="abus-20201231.xsd#abus_EmployeeStockOptionsLiabilityClassifiedOutstandingFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_6536c8fb-a2fd-416a-bf07-fa38481c9a65" xlink:to="loc_abus_EmployeeStockOptionsLiabilityClassifiedOutstandingFairValueDisclosure_f6aa1276-f82a-4aba-8d6a-f7a2a6a51cd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_0fa8eb6a-0bf2-48ee-96a7-eed81e8a5141" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_6536c8fb-a2fd-416a-bf07-fa38481c9a65" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_0fa8eb6a-0bf2-48ee-96a7-eed81e8a5141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_488be975-455c-41bc-bea0-517f2192f1bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_6536c8fb-a2fd-416a-bf07-fa38481c9a65" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_488be975-455c-41bc-bea0-517f2192f1bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/FairvaluemeasurementsChangesinfairvalueofliabilitiesclassifiedasstockoptionDetails" xlink:type="simple" xlink:href="abus-20201231.xsd#FairvaluemeasurementsChangesinfairvalueofliabilitiesclassifiedasstockoptionDetails"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/FairvaluemeasurementsChangesinfairvalueofliabilitiesclassifiedasstockoptionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_6bb28f21-69c0-4484-b56e-5399c8691f83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fd0bb36b-e53a-4adf-ba6f-ea7538a8ec71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6bb28f21-69c0-4484-b56e-5399c8691f83" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fd0bb36b-e53a-4adf-ba6f-ea7538a8ec71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f7ae4757-e52a-42c9-993c-47f77c80e90f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fd0bb36b-e53a-4adf-ba6f-ea7538a8ec71" xlink:to="loc_us-gaap_AwardTypeAxis_f7ae4757-e52a-42c9-993c-47f77c80e90f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a62bd340-0a7f-459d-89f5-c8968ca3c898" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_f7ae4757-e52a-42c9-993c-47f77c80e90f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a62bd340-0a7f-459d-89f5-c8968ca3c898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_EmployeeStockOptionLiabilityClassifiedMember_45ec526a-9144-45aa-8050-cfc8767bc785" xlink:href="abus-20201231.xsd#abus_EmployeeStockOptionLiabilityClassifiedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a62bd340-0a7f-459d-89f5-c8968ca3c898" xlink:to="loc_abus_EmployeeStockOptionLiabilityClassifiedMember_45ec526a-9144-45aa-8050-cfc8767bc785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_61504efb-e877-4024-ac56-14eea0f55088" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fd0bb36b-e53a-4adf-ba6f-ea7538a8ec71" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_61504efb-e877-4024-ac56-14eea0f55088" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward_33c26fb4-10d9-44b8-8a17-c29e8f8bf4a0" xlink:href="abus-20201231.xsd#abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_61504efb-e877-4024-ac56-14eea0f55088" xlink:to="loc_abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward_33c26fb4-10d9-44b8-8a17-c29e8f8bf4a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_EmployeeStockOptionsLiabilityClassifiedOutstandingFairValueDisclosure_69d430af-a8ec-4acb-8aa5-470b186ca18d" xlink:href="abus-20201231.xsd#abus_EmployeeStockOptionsLiabilityClassifiedOutstandingFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward_33c26fb4-10d9-44b8-8a17-c29e8f8bf4a0" xlink:to="loc_abus_EmployeeStockOptionsLiabilityClassifiedOutstandingFairValueDisclosure_69d430af-a8ec-4acb-8aa5-470b186ca18d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisesinPeriodFairValue_9c5063f2-cc90-4279-b53f-b2d9b0587084" xlink:href="abus-20201231.xsd#abus_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisesinPeriodFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward_33c26fb4-10d9-44b8-8a17-c29e8f8bf4a0" xlink:to="loc_abus_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisesinPeriodFairValue_9c5063f2-cc90-4279-b53f-b2d9b0587084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_IncreaseDecreaseinFairValueofLiabilityClassifiedOptions_5a431d5c-1c80-41bf-adc1-c09ac1941a15" xlink:href="abus-20201231.xsd#abus_IncreaseDecreaseinFairValueofLiabilityClassifiedOptions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward_33c26fb4-10d9-44b8-8a17-c29e8f8bf4a0" xlink:to="loc_abus_IncreaseDecreaseinFairValueofLiabilityClassifiedOptions_5a431d5c-1c80-41bf-adc1-c09ac1941a15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_EmployeeStockOptionsLiabilityClassifiedOutstandingFairValueDisclosure_afce49a4-d0e0-4c7b-ab9a-e4a6e3979c81" xlink:href="abus-20201231.xsd#abus_EmployeeStockOptionsLiabilityClassifiedOutstandingFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward_33c26fb4-10d9-44b8-8a17-c29e8f8bf4a0" xlink:to="loc_abus_EmployeeStockOptionsLiabilityClassifiedOutstandingFairValueDisclosure_afce49a4-d0e0-4c7b-ab9a-e4a6e3979c81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/FairvaluemeasurementsChangesinfairvalueofcontingentconsiderationDetails" xlink:type="simple" xlink:href="abus-20201231.xsd#FairvaluemeasurementsChangesinfairvalueofcontingentconsiderationDetails"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/FairvaluemeasurementsChangesinfairvalueofcontingentconsiderationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_56af278c-0b17-4732-a0f5-6b209d85a8d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward_6949a519-ca45-4d7e-a3fe-9c84f6fffcd8" xlink:href="abus-20201231.xsd#abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_56af278c-0b17-4732-a0f5-6b209d85a8d3" xlink:to="loc_abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward_6949a519-ca45-4d7e-a3fe-9c84f6fffcd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_235f29dc-ac66-4368-91d6-bbeed9d51f2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward_6949a519-ca45-4d7e-a3fe-9c84f6fffcd8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_235f29dc-ac66-4368-91d6-bbeed9d51f2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_7e5a0aac-6aa6-4c21-ac73-fea802dcf346" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward_6949a519-ca45-4d7e-a3fe-9c84f6fffcd8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_7e5a0aac-6aa6-4c21-ac73-fea802dcf346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_d2d58d08-9776-4d67-92ee-99d34158858c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward_6949a519-ca45-4d7e-a3fe-9c84f6fffcd8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_d2d58d08-9776-4d67-92ee-99d34158858c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/Investmentsinmarketablesecurities" xlink:type="simple" xlink:href="abus-20201231.xsd#Investmentsinmarketablesecurities"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/Investmentsinmarketablesecurities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_dab8455d-6a1e-4c3c-be08-c27d19a5f85e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_23458ef2-ba0d-4e05-adc5-e78817cb759e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_dab8455d-6a1e-4c3c-be08-c27d19a5f85e" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_23458ef2-ba0d-4e05-adc5-e78817cb759e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/InvestmentsinmarketablesecuritiesTables" xlink:type="simple" xlink:href="abus-20201231.xsd#InvestmentsinmarketablesecuritiesTables"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/InvestmentsinmarketablesecuritiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_16d86919-040b-4473-b46f-e998338122b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock_b2e12afa-f47c-4e6f-b962-224e4dafac22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_16d86919-040b-4473-b46f-e998338122b9" xlink:to="loc_us-gaap_MarketableSecuritiesTextBlock_b2e12afa-f47c-4e6f-b962-224e4dafac22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/InvestmentsinmarketablesecuritiesDetails" xlink:type="simple" xlink:href="abus-20201231.xsd#InvestmentsinmarketablesecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/InvestmentsinmarketablesecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_90b49b50-b671-4e80-a178-7d9a257653eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_31ae64c1-3971-4630-8ad4-fe1db56c4d95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_90b49b50-b671-4e80-a178-7d9a257653eb" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_31ae64c1-3971-4630-8ad4-fe1db56c4d95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_09404cdc-6beb-4c5c-bd6c-dad74606ed9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_31ae64c1-3971-4630-8ad4-fe1db56c4d95" xlink:to="loc_us-gaap_FinancialInstrumentAxis_09404cdc-6beb-4c5c-bd6c-dad74606ed9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2bfc0426-d657-4560-a417-7112f093c53d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_09404cdc-6beb-4c5c-bd6c-dad74606ed9a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2bfc0426-d657-4560-a417-7112f093c53d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_0725f7f3-5720-44dd-8e32-f9e0e690f6d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2bfc0426-d657-4560-a417-7112f093c53d" xlink:to="loc_us-gaap_MoneyMarketFundsMember_0725f7f3-5720-44dd-8e32-f9e0e690f6d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_USGovernmentAgencyBondsMember_033631f4-4fe5-41fc-96d4-c9730df095ec" xlink:href="abus-20201231.xsd#abus_USGovernmentAgencyBondsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2bfc0426-d657-4560-a417-7112f093c53d" xlink:to="loc_abus_USGovernmentAgencyBondsMember_033631f4-4fe5-41fc-96d4-c9730df095ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryBillSecuritiesMember_ff57cf3b-1c30-4bae-9d54-183e258e6dcd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasuryBillSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2bfc0426-d657-4560-a417-7112f093c53d" xlink:to="loc_us-gaap_USTreasuryBillSecuritiesMember_ff57cf3b-1c30-4bae-9d54-183e258e6dcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_USGovernmentBondsMember_9962740c-cb17-4ff8-a2ce-ad64ee2cbf64" xlink:href="abus-20201231.xsd#abus_USGovernmentBondsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2bfc0426-d657-4560-a417-7112f093c53d" xlink:to="loc_abus_USGovernmentBondsMember_9962740c-cb17-4ff8-a2ce-ad64ee2cbf64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_6b2afbd0-50e4-42b3-b31e-6009580b1a89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_31ae64c1-3971-4630-8ad4-fe1db56c4d95" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_6b2afbd0-50e4-42b3-b31e-6009580b1a89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_9ef746be-9cca-4748-a2b6-c4b1a405bb28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_6b2afbd0-50e4-42b3-b31e-6009580b1a89" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_9ef746be-9cca-4748-a2b6-c4b1a405bb28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsMember_4d953b1b-e46e-4771-b634-fb5d1446d935" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_9ef746be-9cca-4748-a2b6-c4b1a405bb28" xlink:to="loc_us-gaap_CashEquivalentsMember_4d953b1b-e46e-4771-b634-fb5d1446d935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9e0a2152-7c3e-4aac-a082-958fdbdba833" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_31ae64c1-3971-4630-8ad4-fe1db56c4d95" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9e0a2152-7c3e-4aac-a082-958fdbdba833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_57837da3-3284-4e9e-a074-cb2097c47812" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9e0a2152-7c3e-4aac-a082-958fdbdba833" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_57837da3-3284-4e9e-a074-cb2097c47812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_58345dc8-9bde-4930-b114-cce4c3b5b955" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9e0a2152-7c3e-4aac-a082-958fdbdba833" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_58345dc8-9bde-4930-b114-cce4c3b5b955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_4d19f2c1-4fd2-4d97-92da-914e06a455eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9e0a2152-7c3e-4aac-a082-958fdbdba833" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_4d19f2c1-4fd2-4d97-92da-914e06a455eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_f4370462-25e0-4112-b6f1-e300754315ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9e0a2152-7c3e-4aac-a082-958fdbdba833" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_f4370462-25e0-4112-b6f1-e300754315ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_93aeae8e-9099-4a03-8a9f-bc9a32241006" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9e0a2152-7c3e-4aac-a082-958fdbdba833" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_93aeae8e-9099-4a03-8a9f-bc9a32241006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_563cbbab-f96a-4482-b0b1-857d3815f198" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9e0a2152-7c3e-4aac-a082-958fdbdba833" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_563cbbab-f96a-4482-b0b1-857d3815f198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/InvestmentinGenevant" xlink:type="simple" xlink:href="abus-20201231.xsd#InvestmentinGenevant"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/InvestmentinGenevant" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_ae4b0db7-4dd9-4531-91c0-d4fb983362d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_b690e829-83b5-4954-af33-0978ef9102ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_ae4b0db7-4dd9-4531-91c0-d4fb983362d6" xlink:to="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_b690e829-83b5-4954-af33-0978ef9102ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/InvestmentinGenevantDetails" xlink:type="simple" xlink:href="abus-20201231.xsd#InvestmentinGenevantDetails"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/InvestmentinGenevantDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_77626127-918a-418f-a675-8619de9c15e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_89432aee-90ca-42a8-87f8-7028f81e2b05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_77626127-918a-418f-a675-8619de9c15e7" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_89432aee-90ca-42a8-87f8-7028f81e2b05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0e9d702e-5fc5-4eff-92ab-7751d8a0acad" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_89432aee-90ca-42a8-87f8-7028f81e2b05" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0e9d702e-5fc5-4eff-92ab-7751d8a0acad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_8798a924-4be1-4b07-ba1b-835bc287e875" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0e9d702e-5fc5-4eff-92ab-7751d8a0acad" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_8798a924-4be1-4b07-ba1b-835bc287e875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_GenevantSciencesCorporationMember_ae873829-281b-4802-92b7-c5fad54a6d4f" xlink:href="abus-20201231.xsd#abus_GenevantSciencesCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8798a924-4be1-4b07-ba1b-835bc287e875" xlink:to="loc_abus_GenevantSciencesCorporationMember_ae873829-281b-4802-92b7-c5fad54a6d4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_5c67c496-8e03-48d3-9abe-dd74a5edb73f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_89432aee-90ca-42a8-87f8-7028f81e2b05" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_5c67c496-8e03-48d3-9abe-dd74a5edb73f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_SubLicensingRevenuePercentage_7ac16883-d2f1-4569-88b8-93ccb27a3284" xlink:href="abus-20201231.xsd#abus_SubLicensingRevenuePercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_5c67c496-8e03-48d3-9abe-dd74a5edb73f" xlink:to="loc_abus_SubLicensingRevenuePercentage_7ac16883-d2f1-4569-88b8-93ccb27a3284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_ffb9b65b-266e-49b1-8c0d-b3a352dcbb4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_5c67c496-8e03-48d3-9abe-dd74a5edb73f" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_ffb9b65b-266e-49b1-8c0d-b3a352dcbb4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_7fbe65f2-7881-46e4-98ee-2ccb00de34c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_5c67c496-8e03-48d3-9abe-dd74a5edb73f" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_7fbe65f2-7881-46e4-98ee-2ccb00de34c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_d54d9f63-c321-43e5-b776-e44b1f0ee959" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_5c67c496-8e03-48d3-9abe-dd74a5edb73f" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_d54d9f63-c321-43e5-b776-e44b1f0ee959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_Netequityinvestmentgainorloss_4fc732ab-97c2-476a-b4f4-0f082278f2f7" xlink:href="abus-20201231.xsd#abus_Netequityinvestmentgainorloss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_5c67c496-8e03-48d3-9abe-dd74a5edb73f" xlink:to="loc_abus_Netequityinvestmentgainorloss_4fc732ab-97c2-476a-b4f4-0f082278f2f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_5f82072a-e089-449a-bc86-fa3d355c11b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_5c67c496-8e03-48d3-9abe-dd74a5edb73f" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_5f82072a-e089-449a-bc86-fa3d355c11b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_ca1207fd-f9dc-48f1-8bf2-bbf6cc127826" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_5c67c496-8e03-48d3-9abe-dd74a5edb73f" xlink:to="loc_us-gaap_EquityMethodInvestments_ca1207fd-f9dc-48f1-8bf2-bbf6cc127826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/Leases" xlink:type="simple" xlink:href="abus-20201231.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_34d5d8c9-a803-4bc5-8d0e-e2cd0fb8c544" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_788d73ff-61cf-49da-baf1-04688a659a6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_34d5d8c9-a803-4bc5-8d0e-e2cd0fb8c544" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_788d73ff-61cf-49da-baf1-04688a659a6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/LeasesTables" xlink:type="simple" xlink:href="abus-20201231.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_de355c25-3a07-47ef-834d-978668654d98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_241c6287-19c5-40d7-a568-27563760259e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_de355c25-3a07-47ef-834d-978668654d98" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_241c6287-19c5-40d7-a568-27563760259e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_3b56c1f3-4251-41c8-91bd-8846ee2ac3cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_de355c25-3a07-47ef-834d-978668654d98" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_3b56c1f3-4251-41c8-91bd-8846ee2ac3cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="abus-20201231.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_479e3cbb-a947-48fe-9ebc-34d3cc1de832" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_a60bf4d2-db26-4240-9ad0-c4724b193d3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_479e3cbb-a947-48fe-9ebc-34d3cc1de832" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_a60bf4d2-db26-4240-9ad0-c4724b193d3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermAxis_6d3cca7f-8a1b-4bd1-b0eb-31adcefffc5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseContractualTermAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_a60bf4d2-db26-4240-9ad0-c4724b193d3a" xlink:to="loc_us-gaap_LeaseContractualTermAxis_6d3cca7f-8a1b-4bd1-b0eb-31adcefffc5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain_ed55b4b0-a663-4604-9c35-9ffb8f3ba2d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermAxis_6d3cca7f-8a1b-4bd1-b0eb-31adcefffc5b" xlink:to="loc_us-gaap_LeaseContractualTermDomain_ed55b4b0-a663-4604-9c35-9ffb8f3ba2d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_CorporateHeadquartersLocated701VeteransCircleWarminsterPennsylvaniaMember_fb7792c8-7ff5-4256-bbc6-eaabe17c7135" xlink:href="abus-20201231.xsd#abus_CorporateHeadquartersLocated701VeteransCircleWarminsterPennsylvaniaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermDomain_ed55b4b0-a663-4604-9c35-9ffb8f3ba2d0" xlink:to="loc_abus_CorporateHeadquartersLocated701VeteransCircleWarminsterPennsylvaniaMember_fb7792c8-7ff5-4256-bbc6-eaabe17c7135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_OfficesLocatedat626JacksonvilleRd.WarminsterPennsylvaniaMember_8cdaa889-1948-4a5e-be56-d9c3ffa6a7c3" xlink:href="abus-20201231.xsd#abus_OfficesLocatedat626JacksonvilleRd.WarminsterPennsylvaniaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermDomain_ed55b4b0-a663-4604-9c35-9ffb8f3ba2d0" xlink:to="loc_abus_OfficesLocatedat626JacksonvilleRd.WarminsterPennsylvaniaMember_8cdaa889-1948-4a5e-be56-d9c3ffa6a7c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_SubleaseBurnabyFacilityMember_b6839954-0641-4e97-b847-7f6b9c6cc596" xlink:href="abus-20201231.xsd#abus_SubleaseBurnabyFacilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermDomain_ed55b4b0-a663-4604-9c35-9ffb8f3ba2d0" xlink:to="loc_abus_SubleaseBurnabyFacilityMember_b6839954-0641-4e97-b847-7f6b9c6cc596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_32e17214-ea08-4948-aaaa-c0be30c2e3dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_a60bf4d2-db26-4240-9ad0-c4724b193d3a" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_32e17214-ea08-4948-aaaa-c0be30c2e3dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_LesseeOperatingLeaseNumberofLeases_54bc641d-2ad1-4db6-8de9-1f7765fefdfd" xlink:href="abus-20201231.xsd#abus_LesseeOperatingLeaseNumberofLeases"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_32e17214-ea08-4948-aaaa-c0be30c2e3dc" xlink:to="loc_abus_LesseeOperatingLeaseNumberofLeases_54bc641d-2ad1-4db6-8de9-1f7765fefdfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_LesseeOperatingLeaseNumberOfRenewalOptions_4957e57f-9cef-4756-af11-de1d9c3bd038" xlink:href="abus-20201231.xsd#abus_LesseeOperatingLeaseNumberOfRenewalOptions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_32e17214-ea08-4948-aaaa-c0be30c2e3dc" xlink:to="loc_abus_LesseeOperatingLeaseNumberOfRenewalOptions_4957e57f-9cef-4756-af11-de1d9c3bd038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeaseRenewalTerm_3ef9ef6f-42e7-4607-8416-a39fa35fece4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LessorOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_32e17214-ea08-4948-aaaa-c0be30c2e3dc" xlink:to="loc_us-gaap_LessorOperatingLeaseRenewalTerm_3ef9ef6f-42e7-4607-8416-a39fa35fece4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseDiscountRate_1afbe73a-cf0d-46cc-ae98-3b3a444b1ab0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseDiscountRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_32e17214-ea08-4948-aaaa-c0be30c2e3dc" xlink:to="loc_us-gaap_LesseeOperatingLeaseDiscountRate_1afbe73a-cf0d-46cc-ae98-3b3a444b1ab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_519d0ed2-32bf-46a5-8255-59b4c55c591d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_32e17214-ea08-4948-aaaa-c0be30c2e3dc" xlink:to="loc_us-gaap_OperatingLeaseExpense_519d0ed2-32bf-46a5-8255-59b4c55c591d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_FixedLeaseCost_0b3d444d-32e6-461c-b95f-485cf5f28c27" xlink:href="abus-20201231.xsd#abus_FixedLeaseCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_32e17214-ea08-4948-aaaa-c0be30c2e3dc" xlink:to="loc_abus_FixedLeaseCost_0b3d444d-32e6-461c-b95f-485cf5f28c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_a5a1c743-6443-40d9-9019-52358844bd0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_32e17214-ea08-4948-aaaa-c0be30c2e3dc" xlink:to="loc_us-gaap_VariableLeaseCost_a5a1c743-6443-40d9-9019-52358844bd0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_b1e8e0d1-3ac1-426e-83fe-2a785a05a1ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_32e17214-ea08-4948-aaaa-c0be30c2e3dc" xlink:to="loc_us-gaap_SubleaseIncome_b1e8e0d1-3ac1-426e-83fe-2a785a05a1ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/LeasesLeasecostDetails" xlink:type="simple" xlink:href="abus-20201231.xsd#LeasesLeasecostDetails"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/LeasesLeasecostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_ea43ee81-869b-4f02-8954-bacd604da48e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_a0368fa0-5e4c-40df-b0f2-d47f42c0973b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ea43ee81-869b-4f02-8954-bacd604da48e" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_a0368fa0-5e4c-40df-b0f2-d47f42c0973b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_79accd2b-5b3f-4d4b-a191-207ca8ed5ac5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ea43ee81-869b-4f02-8954-bacd604da48e" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_79accd2b-5b3f-4d4b-a191-207ca8ed5ac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_dbf08b28-0a6a-45f7-be14-fccab6e57649" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ea43ee81-869b-4f02-8954-bacd604da48e" xlink:to="loc_us-gaap_OperatingLeasePayments_dbf08b28-0a6a-45f7-be14-fccab6e57649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/LeasesMaturityofleaseliabilityDetails" xlink:type="simple" xlink:href="abus-20201231.xsd#LeasesMaturityofleaseliabilityDetails"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/LeasesMaturityofleaseliabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_5a386e66-8d5f-45cd-97dc-205612b289b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_66580ae4-812f-457b-ae51-2d7a651d7219" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5a386e66-8d5f-45cd-97dc-205612b289b4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_66580ae4-812f-457b-ae51-2d7a651d7219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_3c737c9b-a3a3-4d98-bd55-ed11e86fa6b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5a386e66-8d5f-45cd-97dc-205612b289b4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_3c737c9b-a3a3-4d98-bd55-ed11e86fa6b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_b9353ac9-ca9f-45a4-a5ee-5e0e025159b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5a386e66-8d5f-45cd-97dc-205612b289b4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_b9353ac9-ca9f-45a4-a5ee-5e0e025159b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_be9e65bd-14e8-4225-a76a-f414d897f135" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5a386e66-8d5f-45cd-97dc-205612b289b4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_be9e65bd-14e8-4225-a76a-f414d897f135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_659461cf-62e5-45be-af63-79bbc3a1c961" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5a386e66-8d5f-45cd-97dc-205612b289b4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_659461cf-62e5-45be-af63-79bbc3a1c961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_f0cf492d-2fa1-403d-872e-db47bd531fc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5a386e66-8d5f-45cd-97dc-205612b289b4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_f0cf492d-2fa1-403d-872e-db47bd531fc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3e463563-2f08-4974-8fec-a2826220ed7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5a386e66-8d5f-45cd-97dc-205612b289b4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3e463563-2f08-4974-8fec-a2826220ed7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_53d09800-b524-4165-aad1-8a2f501b8c56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5a386e66-8d5f-45cd-97dc-205612b289b4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_53d09800-b524-4165-aad1-8a2f501b8c56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_22543f77-58de-4d76-8071-2df23ec04a45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5a386e66-8d5f-45cd-97dc-205612b289b4" xlink:to="loc_us-gaap_OperatingLeaseLiability_22543f77-58de-4d76-8071-2df23ec04a45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/LeasesMaturityofleaseliabilityDetails_1" xlink:type="simple" xlink:href="abus-20201231.xsd#LeasesMaturityofleaseliabilityDetails_1"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/LeasesMaturityofleaseliabilityDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/Propertyandequipment" xlink:type="simple" xlink:href="abus-20201231.xsd#Propertyandequipment"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/Propertyandequipment" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_11cd3be3-0890-4992-be3d-40151d1fbb7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_f843d501-057a-471b-916f-804b3616a8f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_11cd3be3-0890-4992-be3d-40151d1fbb7e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_f843d501-057a-471b-916f-804b3616a8f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/PropertyandequipmentTables" xlink:type="simple" xlink:href="abus-20201231.xsd#PropertyandequipmentTables"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/PropertyandequipmentTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c5369ff1-3ee5-45ad-982f-bfa21d286dee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_1a0fb58f-b45a-4734-bd95-a0e6e1601b48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c5369ff1-3ee5-45ad-982f-bfa21d286dee" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_1a0fb58f-b45a-4734-bd95-a0e6e1601b48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/PropertyandequipmentScheduleDetails" xlink:type="simple" xlink:href="abus-20201231.xsd#PropertyandequipmentScheduleDetails"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/PropertyandequipmentScheduleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_abaed76c-5db6-4efa-9226-2f9312cae179" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8e386bfa-8a43-4376-8a8f-1b1e95e16afe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_abaed76c-5db6-4efa-9226-2f9312cae179" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8e386bfa-8a43-4376-8a8f-1b1e95e16afe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bd8a91e0-310a-488b-a4b0-92d5568fa7da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8e386bfa-8a43-4376-8a8f-1b1e95e16afe" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bd8a91e0-310a-488b-a4b0-92d5568fa7da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4d72c806-0822-46e2-9a17-8dc909ec0c6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bd8a91e0-310a-488b-a4b0-92d5568fa7da" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4d72c806-0822-46e2-9a17-8dc909ec0c6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_LaboratoryEquipmentMember_649027ad-cc0d-4612-be6c-de2f31eb51be" xlink:href="abus-20201231.xsd#abus_LaboratoryEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4d72c806-0822-46e2-9a17-8dc909ec0c6a" xlink:to="loc_abus_LaboratoryEquipmentMember_649027ad-cc0d-4612-be6c-de2f31eb51be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_c246120d-1119-4ef0-a6eb-c4e511be346d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4d72c806-0822-46e2-9a17-8dc909ec0c6a" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_c246120d-1119-4ef0-a6eb-c4e511be346d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_c1fbbdbe-13af-4020-9429-b559244be848" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4d72c806-0822-46e2-9a17-8dc909ec0c6a" xlink:to="loc_us-gaap_ComputerEquipmentMember_c1fbbdbe-13af-4020-9429-b559244be848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3ad90b1c-fa07-44b9-bc04-33b618685772" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8e386bfa-8a43-4376-8a8f-1b1e95e16afe" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3ad90b1c-fa07-44b9-bc04-33b618685772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_9a8c37da-9fcd-4823-957c-8e465d3af3e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3ad90b1c-fa07-44b9-bc04-33b618685772" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_9a8c37da-9fcd-4823-957c-8e465d3af3e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_96ba99c0-5d81-4ecc-8451-8fd5e69dfb8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3ad90b1c-fa07-44b9-bc04-33b618685772" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_96ba99c0-5d81-4ecc-8451-8fd5e69dfb8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_ce262deb-d87f-4d7a-8957-3c3f397c383a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3ad90b1c-fa07-44b9-bc04-33b618685772" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_ce262deb-d87f-4d7a-8957-3c3f397c383a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/PropertyandequipmentNarrativeDetails" xlink:type="simple" xlink:href="abus-20201231.xsd#PropertyandequipmentNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/PropertyandequipmentNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_d3e318df-d911-49c3-a079-fdc64d49ab6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisposals_343c671e-8e0b-4b35-8419-bb21f8a36ed8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisposals"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_d3e318df-d911-49c3-a079-fdc64d49ab6d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisposals_343c671e-8e0b-4b35-8419-bb21f8a36ed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNet_3bd802cf-ed4c-4433-a78e-f3417f07f990" xlink:href="abus-20201231.xsd#abus_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_d3e318df-d911-49c3-a079-fdc64d49ab6d" xlink:to="loc_abus_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNet_3bd802cf-ed4c-4433-a78e-f3417f07f990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/Intangibleassetsandgoodwill" xlink:type="simple" xlink:href="abus-20201231.xsd#Intangibleassetsandgoodwill"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/Intangibleassetsandgoodwill" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_03a2ad2c-e59f-437e-abf3-4d2eb6bfcdd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_476cd55e-eaf3-4c33-9b40-ef17756faf4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_03a2ad2c-e59f-437e-abf3-4d2eb6bfcdd9" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_476cd55e-eaf3-4c33-9b40-ef17756faf4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/IntangibleassetsandgoodwillDetails" xlink:type="simple" xlink:href="abus-20201231.xsd#IntangibleassetsandgoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/IntangibleassetsandgoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_33dd2bef-94ec-410d-953d-f76d6e013cc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_dfd215c5-8ef2-4fdb-ae6c-d456daf25528" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_33dd2bef-94ec-410d-953d-f76d6e013cc3" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_dfd215c5-8ef2-4fdb-ae6c-d456daf25528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_86239a3b-c8ed-49fe-bb02-6c5216e670bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_dfd215c5-8ef2-4fdb-ae6c-d456daf25528" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_86239a3b-c8ed-49fe-bb02-6c5216e670bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_5e1ad628-3214-4083-accb-7e07e9b0ea8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_86239a3b-c8ed-49fe-bb02-6c5216e670bc" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_5e1ad628-3214-4083-accb-7e07e9b0ea8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_InProcessResearchandDevelopmentcccDNASterilizersMember_0b0f35f0-9c07-4588-bf34-e20b5b595702" xlink:href="abus-20201231.xsd#abus_InProcessResearchandDevelopmentcccDNASterilizersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_5e1ad628-3214-4083-accb-7e07e9b0ea8e" xlink:to="loc_abus_InProcessResearchandDevelopmentcccDNASterilizersMember_0b0f35f0-9c07-4588-bf34-e20b5b595702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_2f3a8074-e0c5-407b-814a-e5dbee4765eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_dfd215c5-8ef2-4fdb-ae6c-d456daf25528" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_2f3a8074-e0c5-407b-814a-e5dbee4765eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_43f425bc-ce08-40a5-9dad-296a3a44ccd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_2f3a8074-e0c5-407b-814a-e5dbee4765eb" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_43f425bc-ce08-40a5-9dad-296a3a44ccd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_e31f989f-54b4-4366-8da6-7c8581936a97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_2f3a8074-e0c5-407b-814a-e5dbee4765eb" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_e31f989f-54b4-4366-8da6-7c8581936a97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_d263b19b-c0b6-4b94-a427-d693b037b490" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_2f3a8074-e0c5-407b-814a-e5dbee4765eb" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_d263b19b-c0b6-4b94-a427-d693b037b490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_f8fffdc6-d06d-4167-99ac-9bf3bf37949d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_2f3a8074-e0c5-407b-814a-e5dbee4765eb" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_f8fffdc6-d06d-4167-99ac-9bf3bf37949d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_662dafb6-ceb5-4309-b1e1-c9a05fb7007c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_2f3a8074-e0c5-407b-814a-e5dbee4765eb" xlink:to="loc_us-gaap_Goodwill_662dafb6-ceb5-4309-b1e1-c9a05fb7007c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/Accountspayableandaccruedliabilities" xlink:type="simple" xlink:href="abus-20201231.xsd#Accountspayableandaccruedliabilities"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/Accountspayableandaccruedliabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_aaded11d-cf50-48ee-b389-38e4b8cf5c68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_ea2143d9-9b52-427c-a133-f59ca9767959" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_aaded11d-cf50-48ee-b389-38e4b8cf5c68" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_ea2143d9-9b52-427c-a133-f59ca9767959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/AccountspayableandaccruedliabilitiesTables" xlink:type="simple" xlink:href="abus-20201231.xsd#AccountspayableandaccruedliabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/AccountspayableandaccruedliabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_10118969-4608-447c-9e23-cb0c8311ad58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_da7245c0-2987-49e2-b7e7-f091ad387517" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_10118969-4608-447c-9e23-cb0c8311ad58" xlink:to="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_da7245c0-2987-49e2-b7e7-f091ad387517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/AccountspayableandaccruedliabilitiesDetails" xlink:type="simple" xlink:href="abus-20201231.xsd#AccountspayableandaccruedliabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/AccountspayableandaccruedliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_583e9db7-08df-43af-8aab-09bf20009c3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_0dd96907-a022-429f-b428-6b378e54f413" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_583e9db7-08df-43af-8aab-09bf20009c3d" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_0dd96907-a022-429f-b428-6b378e54f413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_AccruedPayrollCurrent_29ec0c0e-a785-45fe-b391-5515fce5f54d" xlink:href="abus-20201231.xsd#abus_AccruedPayrollCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_583e9db7-08df-43af-8aab-09bf20009c3d" xlink:to="loc_abus_AccruedPayrollCurrent_29ec0c0e-a785-45fe-b391-5515fce5f54d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_AccruedResearchandDevelopmentCurrent_8aa7b785-007a-4de5-8446-390b50488a68" xlink:href="abus-20201231.xsd#abus_AccruedResearchandDevelopmentCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_583e9db7-08df-43af-8aab-09bf20009c3d" xlink:to="loc_abus_AccruedResearchandDevelopmentCurrent_8aa7b785-007a-4de5-8446-390b50488a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_9d3c2138-d85c-49e1-a292-73709f3d770a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_583e9db7-08df-43af-8aab-09bf20009c3d" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_9d3c2138-d85c-49e1-a292-73709f3d770a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_3070f5c3-3b4c-4b53-a094-c6a1b11e9d12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_583e9db7-08df-43af-8aab-09bf20009c3d" xlink:to="loc_us-gaap_RestructuringReserve_3070f5c3-3b4c-4b53-a094-c6a1b11e9d12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_cac5767f-ec90-47bd-ad1d-a03e7a608d99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_583e9db7-08df-43af-8aab-09bf20009c3d" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_cac5767f-ec90-47bd-ad1d-a03e7a608d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_cb42ea4e-aee8-48c3-bb85-95c575b8d04b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_583e9db7-08df-43af-8aab-09bf20009c3d" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_cb42ea4e-aee8-48c3-bb85-95c575b8d04b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/Saleoffutureroyalties" xlink:type="simple" xlink:href="abus-20201231.xsd#Saleoffutureroyalties"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/Saleoffutureroyalties" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_9c32c766-6f37-4c8a-b948-1529c30b00b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_LiabilitiesRelatedToSaleOfFutureRoyaltiesTextBlock_d319e2d1-a733-4977-b922-c201d95074e8" xlink:href="abus-20201231.xsd#abus_LiabilitiesRelatedToSaleOfFutureRoyaltiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_9c32c766-6f37-4c8a-b948-1529c30b00b9" xlink:to="loc_abus_LiabilitiesRelatedToSaleOfFutureRoyaltiesTextBlock_d319e2d1-a733-4977-b922-c201d95074e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/SaleoffutureroyaltiesTables" xlink:type="simple" xlink:href="abus-20201231.xsd#SaleoffutureroyaltiesTables"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/SaleoffutureroyaltiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_8e518571-d974-44f4-a7b1-f657e43a0d2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_LiabilitiesRelatedToSaleOfFutureRoyaltiesRollForwardTableTextBlock_b4bdd92f-438b-470c-be3e-f0146cd0d1dd" xlink:href="abus-20201231.xsd#abus_LiabilitiesRelatedToSaleOfFutureRoyaltiesRollForwardTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_8e518571-d974-44f4-a7b1-f657e43a0d2e" xlink:to="loc_abus_LiabilitiesRelatedToSaleOfFutureRoyaltiesRollForwardTableTextBlock_b4bdd92f-438b-470c-be3e-f0146cd0d1dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/SaleoffutureroyaltiesNarrativeDetails" xlink:type="simple" xlink:href="abus-20201231.xsd#SaleoffutureroyaltiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/SaleoffutureroyaltiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_812a2134-2971-4623-97a7-61a29ffd97ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AirlineProductsAndServicesTable_5f8ae203-83f5-4e20-8603-5a652070fec5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AirlineProductsAndServicesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_812a2134-2971-4623-97a7-61a29ffd97ab" xlink:to="loc_us-gaap_AirlineProductsAndServicesTable_5f8ae203-83f5-4e20-8603-5a652070fec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_b7098b40-f11a-4857-ab2d-2bb71ae0f519" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AirlineProductsAndServicesTable_5f8ae203-83f5-4e20-8603-5a652070fec5" xlink:to="loc_srt_CounterpartyNameAxis_b7098b40-f11a-4857-ab2d-2bb71ae0f519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0b09e307-c54f-48d5-92a2-ee9043cbd8f8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_b7098b40-f11a-4857-ab2d-2bb71ae0f519" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0b09e307-c54f-48d5-92a2-ee9043cbd8f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_OMERSMember_338a3ff7-f8a5-437e-8968-f3cdfdab1e38" xlink:href="abus-20201231.xsd#abus_OMERSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0b09e307-c54f-48d5-92a2-ee9043cbd8f8" xlink:to="loc_abus_OMERSMember_338a3ff7-f8a5-437e-8968-f3cdfdab1e38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9907a132-1040-4551-b34b-a4b0a4fc4a55" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AirlineProductsAndServicesTable_5f8ae203-83f5-4e20-8603-5a652070fec5" xlink:to="loc_srt_RangeAxis_9907a132-1040-4551-b34b-a4b0a4fc4a55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_340e6c6f-7744-420d-8340-bd714c8968d9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_9907a132-1040-4551-b34b-a4b0a4fc4a55" xlink:to="loc_srt_RangeMember_340e6c6f-7744-420d-8340-bd714c8968d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4ade586e-3001-470c-a756-3b64c8c0dc4b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_340e6c6f-7744-420d-8340-bd714c8968d9" xlink:to="loc_srt_MinimumMember_4ade586e-3001-470c-a756-3b64c8c0dc4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f40e6b4c-72fa-4c5b-9f1b-544a9a0a8c4e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_340e6c6f-7744-420d-8340-bd714c8968d9" xlink:to="loc_srt_MaximumMember_f40e6b4c-72fa-4c5b-9f1b-544a9a0a8c4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_OtherLiabilitiesDisclosureLineItems_9e37bca9-ecdf-43a9-b7f0-06218b9f5c71" xlink:href="abus-20201231.xsd#abus_OtherLiabilitiesDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AirlineProductsAndServicesTable_5f8ae203-83f5-4e20-8603-5a652070fec5" xlink:to="loc_abus_OtherLiabilitiesDisclosureLineItems_9e37bca9-ecdf-43a9-b7f0-06218b9f5c71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_RoyaltyPercentageofInterestSold_568e698a-655f-473c-8a74-cdf7a0d8b256" xlink:href="abus-20201231.xsd#abus_RoyaltyPercentageofInterestSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_OtherLiabilitiesDisclosureLineItems_9e37bca9-ecdf-43a9-b7f0-06218b9f5c71" xlink:to="loc_abus_RoyaltyPercentageofInterestSold_568e698a-655f-473c-8a74-cdf7a0d8b256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_RoyaltyInterestSoldPercentageOfSalesAnnualRevenueThresholdOfHighestTier_fa545cc8-d0a0-4574-9038-105c6e0fed47" xlink:href="abus-20201231.xsd#abus_RoyaltyInterestSoldPercentageOfSalesAnnualRevenueThresholdOfHighestTier"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_OtherLiabilitiesDisclosureLineItems_9e37bca9-ecdf-43a9-b7f0-06218b9f5c71" xlink:to="loc_abus_RoyaltyInterestSoldPercentageOfSalesAnnualRevenueThresholdOfHighestTier_fa545cc8-d0a0-4574-9038-105c6e0fed47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_GrossProceedsFromRoyaltyInterestSold_d03a0bb4-8648-45b2-a7a9-29677cd83dc2" xlink:href="abus-20201231.xsd#abus_GrossProceedsFromRoyaltyInterestSold"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_OtherLiabilitiesDisclosureLineItems_9e37bca9-ecdf-43a9-b7f0-06218b9f5c71" xlink:to="loc_abus_GrossProceedsFromRoyaltyInterestSold_d03a0bb4-8648-45b2-a7a9-29677cd83dc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_RoyaltyInterestSoldMaximumRoyaltiesForBuyer_92ab1433-4993-47e7-80fa-d7ab9348562e" xlink:href="abus-20201231.xsd#abus_RoyaltyInterestSoldMaximumRoyaltiesForBuyer"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_OtherLiabilitiesDisclosureLineItems_9e37bca9-ecdf-43a9-b7f0-06218b9f5c71" xlink:to="loc_abus_RoyaltyInterestSoldMaximumRoyaltiesForBuyer_92ab1433-4993-47e7-80fa-d7ab9348562e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_RoyaltyGuaranteesCommitmentsPercentage_bc26e22a-6e73-462b-a72e-6b623e438071" xlink:href="abus-20201231.xsd#abus_RoyaltyGuaranteesCommitmentsPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_OtherLiabilitiesDisclosureLineItems_9e37bca9-ecdf-43a9-b7f0-06218b9f5c71" xlink:to="loc_abus_RoyaltyGuaranteesCommitmentsPercentage_bc26e22a-6e73-462b-a72e-6b623e438071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_RoyaltyPayable_1a961ff6-8c89-4c96-84ab-52114d95a586" xlink:href="abus-20201231.xsd#abus_RoyaltyPayable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_OtherLiabilitiesDisclosureLineItems_9e37bca9-ecdf-43a9-b7f0-06218b9f5c71" xlink:to="loc_abus_RoyaltyPayable_1a961ff6-8c89-4c96-84ab-52114d95a586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_TransactionCostsRelatedToSaleOfFutureRoyalties_4658933c-987e-4557-a599-f1525d65c59d" xlink:href="abus-20201231.xsd#abus_TransactionCostsRelatedToSaleOfFutureRoyalties"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_OtherLiabilitiesDisclosureLineItems_9e37bca9-ecdf-43a9-b7f0-06218b9f5c71" xlink:to="loc_abus_TransactionCostsRelatedToSaleOfFutureRoyalties_4658933c-987e-4557-a599-f1525d65c59d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_EffectiveAnnualInterestRateOfRoyaltyLiability_786b639c-7008-4004-93f0-38c71df46a15" xlink:href="abus-20201231.xsd#abus_EffectiveAnnualInterestRateOfRoyaltyLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_OtherLiabilitiesDisclosureLineItems_9e37bca9-ecdf-43a9-b7f0-06218b9f5c71" xlink:to="loc_abus_EffectiveAnnualInterestRateOfRoyaltyLiability_786b639c-7008-4004-93f0-38c71df46a15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_NonCashRoyaltyRevenueRelatedToSaleOfFutureRoyalties_6468ae05-df5c-4902-9778-2586cd0ba3ce" xlink:href="abus-20201231.xsd#abus_NonCashRoyaltyRevenueRelatedToSaleOfFutureRoyalties"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_OtherLiabilitiesDisclosureLineItems_9e37bca9-ecdf-43a9-b7f0-06218b9f5c71" xlink:to="loc_abus_NonCashRoyaltyRevenueRelatedToSaleOfFutureRoyalties_6468ae05-df5c-4902-9778-2586cd0ba3ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_LiabilityFromSaleOfFutureRoyaltiesNonCashExpense_e1cb1265-2296-4b50-bf38-3f5faba712c6" xlink:href="abus-20201231.xsd#abus_LiabilityFromSaleOfFutureRoyaltiesNonCashExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_OtherLiabilitiesDisclosureLineItems_9e37bca9-ecdf-43a9-b7f0-06218b9f5c71" xlink:to="loc_abus_LiabilityFromSaleOfFutureRoyaltiesNonCashExpense_e1cb1265-2296-4b50-bf38-3f5faba712c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/SaleoffutureroyaltiesActivityDetails" xlink:type="simple" xlink:href="abus-20201231.xsd#SaleoffutureroyaltiesActivityDetails"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/SaleoffutureroyaltiesActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_f08da4ed-fbc3-4392-b528-ef8d37c9c286" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AirlineProductsAndServicesTable_4f1d6bc9-d1c0-4fcb-a3ab-d5091ae76be1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AirlineProductsAndServicesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_f08da4ed-fbc3-4392-b528-ef8d37c9c286" xlink:to="loc_us-gaap_AirlineProductsAndServicesTable_4f1d6bc9-d1c0-4fcb-a3ab-d5091ae76be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_938441e5-fa7c-48d0-afbe-b52df81ef08c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AirlineProductsAndServicesTable_4f1d6bc9-d1c0-4fcb-a3ab-d5091ae76be1" xlink:to="loc_srt_CounterpartyNameAxis_938441e5-fa7c-48d0-afbe-b52df81ef08c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_09fb6e6e-2c91-4874-baf0-d30c4a83b3e1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_938441e5-fa7c-48d0-afbe-b52df81ef08c" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_09fb6e6e-2c91-4874-baf0-d30c4a83b3e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_OMERSMember_27b71fa5-88c5-4534-bffe-1fc50ba4abc9" xlink:href="abus-20201231.xsd#abus_OMERSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_09fb6e6e-2c91-4874-baf0-d30c4a83b3e1" xlink:to="loc_abus_OMERSMember_27b71fa5-88c5-4534-bffe-1fc50ba4abc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems_0e68d847-a27d-43ad-b705-a10e4062b365" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AirlineProductsAndServicesTable_4f1d6bc9-d1c0-4fcb-a3ab-d5091ae76be1" xlink:to="loc_us-gaap_ProductInformationLineItems_0e68d847-a27d-43ad-b705-a10e4062b365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_LiabilityRelatedToFutureRoyaltiesRollForward_94c0cdac-0632-4939-91cb-a1db686fbd8e" xlink:href="abus-20201231.xsd#abus_LiabilityRelatedToFutureRoyaltiesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_0e68d847-a27d-43ad-b705-a10e4062b365" xlink:to="loc_abus_LiabilityRelatedToFutureRoyaltiesRollForward_94c0cdac-0632-4939-91cb-a1db686fbd8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_LiabilityRelatedToSaleOfFutureRoyaltiesNoncurrent_9bbe4c4a-3042-4821-b15f-a49864279b11" xlink:href="abus-20201231.xsd#abus_LiabilityRelatedToSaleOfFutureRoyaltiesNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_LiabilityRelatedToFutureRoyaltiesRollForward_94c0cdac-0632-4939-91cb-a1db686fbd8e" xlink:to="loc_abus_LiabilityRelatedToSaleOfFutureRoyaltiesNoncurrent_9bbe4c4a-3042-4821-b15f-a49864279b11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_RoyaltiesInitialRecognitionOfLiability_79593205-b0f1-4be4-accc-d09b044612f0" xlink:href="abus-20201231.xsd#abus_RoyaltiesInitialRecognitionOfLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_LiabilityRelatedToFutureRoyaltiesRollForward_94c0cdac-0632-4939-91cb-a1db686fbd8e" xlink:to="loc_abus_RoyaltiesInitialRecognitionOfLiability_79593205-b0f1-4be4-accc-d09b044612f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_TransactionCostsRelatedToSaleOfFutureRoyalties_da9f9d7a-396c-480d-baac-5abab1eb8c3f" xlink:href="abus-20201231.xsd#abus_TransactionCostsRelatedToSaleOfFutureRoyalties"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_LiabilityRelatedToFutureRoyaltiesRollForward_94c0cdac-0632-4939-91cb-a1db686fbd8e" xlink:to="loc_abus_TransactionCostsRelatedToSaleOfFutureRoyalties_da9f9d7a-396c-480d-baac-5abab1eb8c3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_LiabilityFromSaleOfFutureRoyaltiesNonCashRoyaltyIncome_9f549e9f-73dc-4ff3-a95f-daea4e44f3c3" xlink:href="abus-20201231.xsd#abus_LiabilityFromSaleOfFutureRoyaltiesNonCashRoyaltyIncome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_LiabilityRelatedToFutureRoyaltiesRollForward_94c0cdac-0632-4939-91cb-a1db686fbd8e" xlink:to="loc_abus_LiabilityFromSaleOfFutureRoyaltiesNonCashRoyaltyIncome_9f549e9f-73dc-4ff3-a95f-daea4e44f3c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_LiabilityFromSaleOfFutureRoyaltiesNonCashExpense_18b3d3e1-5a26-466b-90fc-e98717bd8789" xlink:href="abus-20201231.xsd#abus_LiabilityFromSaleOfFutureRoyaltiesNonCashExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_LiabilityRelatedToFutureRoyaltiesRollForward_94c0cdac-0632-4939-91cb-a1db686fbd8e" xlink:to="loc_abus_LiabilityFromSaleOfFutureRoyaltiesNonCashExpense_18b3d3e1-5a26-466b-90fc-e98717bd8789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_LiabilityRelatedToSaleOfFutureRoyaltiesNoncurrent_65063cf0-5081-49f4-92c6-9b7f2a611678" xlink:href="abus-20201231.xsd#abus_LiabilityRelatedToSaleOfFutureRoyaltiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_LiabilityRelatedToFutureRoyaltiesRollForward_94c0cdac-0632-4939-91cb-a1db686fbd8e" xlink:to="loc_abus_LiabilityRelatedToSaleOfFutureRoyaltiesNoncurrent_65063cf0-5081-49f4-92c6-9b7f2a611678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/Contingenciesandcommitments" xlink:type="simple" xlink:href="abus-20201231.xsd#Contingenciesandcommitments"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/Contingenciesandcommitments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0797875a-1392-416b-abc9-9ba82bcecb36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_402be62b-c794-4052-8ef3-ff2933fd107c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0797875a-1392-416b-abc9-9ba82bcecb36" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_402be62b-c794-4052-8ef3-ff2933fd107c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/ContingenciesandcommitmentsDetails" xlink:type="simple" xlink:href="abus-20201231.xsd#ContingenciesandcommitmentsDetails"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/ContingenciesandcommitmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f128a18e-f6d8-4f07-99c4-bc88c8801e48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_ContingenciesandCommitmentsTable_22c837d5-e6ee-47aa-9e04-8f67be45a4be" xlink:href="abus-20201231.xsd#abus_ContingenciesandCommitmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f128a18e-f6d8-4f07-99c4-bc88c8801e48" xlink:to="loc_abus_ContingenciesandCommitmentsTable_22c837d5-e6ee-47aa-9e04-8f67be45a4be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_2537940a-a58e-4254-8c37-176ccad81a7c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsTable_22c837d5-e6ee-47aa-9e04-8f67be45a4be" xlink:to="loc_srt_LitigationCaseAxis_2537940a-a58e-4254-8c37-176ccad81a7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_f6197a85-4e37-4f17-bef4-5a271532cebd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_2537940a-a58e-4254-8c37-176ccad81a7c" xlink:to="loc_srt_LitigationCaseTypeDomain_f6197a85-4e37-4f17-bef4-5a271532cebd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_ArbitrationWithTheUniversityOfBritishColumbiaMember_d4cd02bf-c3da-4c10-b27b-e92cef4a1bca" xlink:href="abus-20201231.xsd#abus_ArbitrationWithTheUniversityOfBritishColumbiaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_f6197a85-4e37-4f17-bef4-5a271532cebd" xlink:to="loc_abus_ArbitrationWithTheUniversityOfBritishColumbiaMember_d4cd02bf-c3da-4c10-b27b-e92cef4a1bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_ArbitrationWithTheUniversityOfBritishColumbiaMember_b3230cd4-2559-4fcb-9005-d792f6931697" xlink:href="abus-20201231.xsd#abus_ArbitrationWithTheUniversityOfBritishColumbiaMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_b78ba671-7172-4b81-8f2d-5e16da19fbef" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsTable_22c837d5-e6ee-47aa-9e04-8f67be45a4be" xlink:to="loc_srt_ProductOrServiceAxis_b78ba671-7172-4b81-8f2d-5e16da19fbef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c1a31906-7b3e-49b2-8729-2b9c40249306" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_b78ba671-7172-4b81-8f2d-5e16da19fbef" xlink:to="loc_srt_ProductsAndServicesDomain_c1a31906-7b3e-49b2-8729-2b9c40249306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_f675b900-aaaa-4113-911e-3272c92fc3dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c1a31906-7b3e-49b2-8729-2b9c40249306" xlink:to="loc_us-gaap_RoyaltyMember_f675b900-aaaa-4113-911e-3272c92fc3dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ded2c1ab-7787-479d-87f7-40a7463b71f5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsTable_22c837d5-e6ee-47aa-9e04-8f67be45a4be" xlink:to="loc_srt_RangeAxis_ded2c1ab-7787-479d-87f7-40a7463b71f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_050c6a5c-29b5-44e6-82f5-8e30ed8e0966" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_ded2c1ab-7787-479d-87f7-40a7463b71f5" xlink:to="loc_srt_RangeMember_050c6a5c-29b5-44e6-82f5-8e30ed8e0966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f84bc830-cbe4-4b4f-832d-4583c68c6e88" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_050c6a5c-29b5-44e6-82f5-8e30ed8e0966" xlink:to="loc_srt_MinimumMember_f84bc830-cbe4-4b4f-832d-4583c68c6e88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_e511097b-c10a-475c-845d-1a1f83e7e04e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsTable_22c837d5-e6ee-47aa-9e04-8f67be45a4be" xlink:to="loc_srt_CounterpartyNameAxis_e511097b-c10a-475c-845d-1a1f83e7e04e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1dc8c522-ed63-4600-9cf0-2faf96b6eb52" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_e511097b-c10a-475c-845d-1a1f83e7e04e" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1dc8c522-ed63-4600-9cf0-2faf96b6eb52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_BlumbergandDrexelMember_50dd8e7f-5271-46e9-ba9c-bae2373654e1" xlink:href="abus-20201231.xsd#abus_BlumbergandDrexelMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1dc8c522-ed63-4600-9cf0-2faf96b6eb52" xlink:to="loc_abus_BlumbergandDrexelMember_50dd8e7f-5271-46e9-ba9c-bae2373654e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_12879cef-b151-428f-bf10-72a2b98b2d70" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsTable_22c837d5-e6ee-47aa-9e04-8f67be45a4be" xlink:to="loc_dei_LegalEntityAxis_12879cef-b151-428f-bf10-72a2b98b2d70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_dc2efa10-b1fc-43d5-9764-64bd4d391ac2" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_12879cef-b151-428f-bf10-72a2b98b2d70" xlink:to="loc_dei_EntityDomain_dc2efa10-b1fc-43d5-9764-64bd4d391ac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_ArbutusInc.Member_aa6d3464-17cd-4411-9ddf-cbef172dd12a" xlink:href="abus-20201231.xsd#abus_ArbutusInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_dc2efa10-b1fc-43d5-9764-64bd4d391ac2" xlink:to="loc_abus_ArbutusInc.Member_aa6d3464-17cd-4411-9ddf-cbef172dd12a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d4fa11ad-23bb-4672-96e6-dc8a7783abe3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsTable_22c837d5-e6ee-47aa-9e04-8f67be45a4be" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d4fa11ad-23bb-4672-96e6-dc8a7783abe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_85f822bb-87cd-4288-b280-61ec226ac306" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d4fa11ad-23bb-4672-96e6-dc8a7783abe3" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_85f822bb-87cd-4288-b280-61ec226ac306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_30fb5414-9bf6-4c24-8920-6690013f90f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_85f822bb-87cd-4288-b280-61ec226ac306" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_30fb5414-9bf6-4c24-8920-6690013f90f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d327f1bf-b901-478b-ae93-ec770f8e4980" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsTable_22c837d5-e6ee-47aa-9e04-8f67be45a4be" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d327f1bf-b901-478b-ae93-ec770f8e4980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f1c65bef-784f-48cf-84d4-67a4199107b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d327f1bf-b901-478b-ae93-ec770f8e4980" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f1c65bef-784f-48cf-84d4-67a4199107b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_EnantigenMember_7265bf76-610f-46a3-9f7b-00048a0495bc" xlink:href="abus-20201231.xsd#abus_EnantigenMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f1c65bef-784f-48cf-84d4-67a4199107b2" xlink:to="loc_abus_EnantigenMember_7265bf76-610f-46a3-9f7b-00048a0495bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_ContingenciesandCommitmentsLineItems_a29f82d9-689d-4c92-8f0b-2f8af49b6e08" xlink:href="abus-20201231.xsd#abus_ContingenciesandCommitmentsLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsTable_22c837d5-e6ee-47aa-9e04-8f67be45a4be" xlink:to="loc_abus_ContingenciesandCommitmentsLineItems_a29f82d9-689d-4c92-8f0b-2f8af49b6e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_PercentOfCostsFundedByTPC_d268181a-9404-4012-b292-b2bce756c953" xlink:href="abus-20201231.xsd#abus_PercentOfCostsFundedByTPC"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_a29f82d9-689d-4c92-8f0b-2f8af49b6e08" xlink:to="loc_abus_PercentOfCostsFundedByTPC_d268181a-9404-4012-b292-b2bce756c953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_MaximumContributionForProduct_1f582c44-f43e-4670-9f13-1561b9dba2bf" xlink:href="abus-20201231.xsd#abus_MaximumContributionForProduct"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_a29f82d9-689d-4c92-8f0b-2f8af49b6e08" xlink:to="loc_abus_MaximumContributionForProduct_1f582c44-f43e-4670-9f13-1561b9dba2bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_CumulativeContributionforProduct_dca10431-6750-4e03-9d74-248c2e789f1a" xlink:href="abus-20201231.xsd#abus_CumulativeContributionforProduct"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_a29f82d9-689d-4c92-8f0b-2f8af49b6e08" xlink:to="loc_abus_CumulativeContributionforProduct_dca10431-6750-4e03-9d74-248c2e789f1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_RoyaltyGuaranteesCommitmentsPercentage_0cd467d0-e892-4441-9443-20fb3037bd29" xlink:href="abus-20201231.xsd#abus_RoyaltyGuaranteesCommitmentsPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_a29f82d9-689d-4c92-8f0b-2f8af49b6e08" xlink:to="loc_abus_RoyaltyGuaranteesCommitmentsPercentage_0cd467d0-e892-4441-9443-20fb3037bd29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_60a064e3-6137-4861-9ad2-abada099fe31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_a29f82d9-689d-4c92-8f0b-2f8af49b6e08" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_60a064e3-6137-4861-9ad2-abada099fe31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_RoyaltiesPaidOrAccrued_3b9f4ca3-412f-4e77-a7bc-e5eaab1eaa77" xlink:href="abus-20201231.xsd#abus_RoyaltiesPaidOrAccrued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_a29f82d9-689d-4c92-8f0b-2f8af49b6e08" xlink:to="loc_abus_RoyaltiesPaidOrAccrued_3b9f4ca3-412f-4e77-a7bc-e5eaab1eaa77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligation_6cef463b-7b6e-4cfa-9a04-b219e39ca633" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_a29f82d9-689d-4c92-8f0b-2f8af49b6e08" xlink:to="loc_us-gaap_ContractualObligation_6cef463b-7b6e-4cfa-9a04-b219e39ca633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_f190a830-c521-48f1-88d2-ee554a3b822b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_a29f82d9-689d-4c92-8f0b-2f8af49b6e08" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_f190a830-c521-48f1-88d2-ee554a3b822b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementInterest_bcd0d167-e281-4b55-8531-04aed085fc40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_a29f82d9-689d-4c92-8f0b-2f8af49b6e08" xlink:to="loc_us-gaap_LitigationSettlementInterest_bcd0d167-e281-4b55-8531-04aed085fc40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyLossInPeriod_59acd22c-c47b-46b2-9bf9-279f9ac94bca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyLossInPeriod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_a29f82d9-689d-4c92-8f0b-2f8af49b6e08" xlink:to="loc_us-gaap_LossContingencyLossInPeriod_59acd22c-c47b-46b2-9bf9-279f9ac94bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_9f9c4f05-5c74-42cf-9359-b1bc8f173278" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_a29f82d9-689d-4c92-8f0b-2f8af49b6e08" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_9f9c4f05-5c74-42cf-9359-b1bc8f173278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_955e7101-dd33-4930-be86-4dbf5db477c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_a29f82d9-689d-4c92-8f0b-2f8af49b6e08" xlink:to="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_955e7101-dd33-4930-be86-4dbf5db477c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_a0170b96-0879-407f-a23c-b387be6add77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_a29f82d9-689d-4c92-8f0b-2f8af49b6e08" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_a0170b96-0879-407f-a23c-b387be6add77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_LicenseAgreementMaximumDevelopmentAndRegulatoryMilestonePaymentsPerLicense_8eca6b18-fc56-4896-905d-a39571e54c5b" xlink:href="abus-20201231.xsd#abus_LicenseAgreementMaximumDevelopmentAndRegulatoryMilestonePaymentsPerLicense"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_a29f82d9-689d-4c92-8f0b-2f8af49b6e08" xlink:to="loc_abus_LicenseAgreementMaximumDevelopmentAndRegulatoryMilestonePaymentsPerLicense_8eca6b18-fc56-4896-905d-a39571e54c5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_LicenseAgreementMaximumDevelopmentAndRegulatoryMilestonePaymentsPerRoyalty_1f565c56-d484-40c9-b3c2-23fc7e5b2c30" xlink:href="abus-20201231.xsd#abus_LicenseAgreementMaximumDevelopmentAndRegulatoryMilestonePaymentsPerRoyalty"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_a29f82d9-689d-4c92-8f0b-2f8af49b6e08" xlink:to="loc_abus_LicenseAgreementMaximumDevelopmentAndRegulatoryMilestonePaymentsPerRoyalty_1f565c56-d484-40c9-b3c2-23fc7e5b2c30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_a2d17ecb-e4ca-47d9-a913-bdbc13edbe23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_a29f82d9-689d-4c92-8f0b-2f8af49b6e08" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_a2d17ecb-e4ca-47d9-a913-bdbc13edbe23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_b439d86c-ef0b-48a5-9e29-e27c8453559b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_a29f82d9-689d-4c92-8f0b-2f8af49b6e08" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_b439d86c-ef0b-48a5-9e29-e27c8453559b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/Collaborationscontractsandlicensingagreements" xlink:type="simple" xlink:href="abus-20201231.xsd#Collaborationscontractsandlicensingagreements"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/Collaborationscontractsandlicensingagreements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_598be82a-0f9a-4d25-b8a1-d480d6b8661b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_4452ba69-75da-471e-af9f-5d026e38ed63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_598be82a-0f9a-4d25-b8a1-d480d6b8661b" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_4452ba69-75da-471e-af9f-5d026e38ed63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/CollaborationscontractsandlicensingagreementsTables" xlink:type="simple" xlink:href="abus-20201231.xsd#CollaborationscontractsandlicensingagreementsTables"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/CollaborationscontractsandlicensingagreementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_fb6dd1f6-976d-4678-b714-75cbabe596d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock_7e2dbcde-b457-4ad1-aa5e-5e4aaef98a7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_fb6dd1f6-976d-4678-b714-75cbabe596d4" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock_7e2dbcde-b457-4ad1-aa5e-5e4aaef98a7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/CollaborationscontractsandlicensingagreementsNarrativeDetails" xlink:type="simple" xlink:href="abus-20201231.xsd#CollaborationscontractsandlicensingagreementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/CollaborationscontractsandlicensingagreementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_99f3e26d-6d25-4054-a72d-9c411a03aaca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_18fc574e-3858-4660-b5a0-5d40174962ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_99f3e26d-6d25-4054-a72d-9c411a03aaca" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_18fc574e-3858-4660-b5a0-5d40174962ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_fadfac8c-f95e-4c90-9f82-52fc48d14658" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_18fc574e-3858-4660-b5a0-5d40174962ce" xlink:to="loc_srt_CounterpartyNameAxis_fadfac8c-f95e-4c90-9f82-52fc48d14658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6c744e5f-859e-4371-908e-63f894ca2d14" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_fadfac8c-f95e-4c90-9f82-52fc48d14658" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6c744e5f-859e-4371-908e-63f894ca2d14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_AssemblyBiosciencesIncMember_1ae98c86-acbe-4976-9840-038153cda403" xlink:href="abus-20201231.xsd#abus_AssemblyBiosciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6c744e5f-859e-4371-908e-63f894ca2d14" xlink:to="loc_abus_AssemblyBiosciencesIncMember_1ae98c86-acbe-4976-9840-038153cda403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_OMERSMember_ee9ab60b-bfdb-474c-a669-c16e1d28849a" xlink:href="abus-20201231.xsd#abus_OMERSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6c744e5f-859e-4371-908e-63f894ca2d14" xlink:to="loc_abus_OMERSMember_ee9ab60b-bfdb-474c-a669-c16e1d28849a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_GritstoneMember_beaf25b1-1f1c-46fa-b0d2-e2cc87baff7b" xlink:href="abus-20201231.xsd#abus_GritstoneMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6c744e5f-859e-4371-908e-63f894ca2d14" xlink:to="loc_abus_GritstoneMember_beaf25b1-1f1c-46fa-b0d2-e2cc87baff7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_TalonTherapeuticsMember_2fffe3d5-0f23-453e-a8f7-76074578775a" xlink:href="abus-20201231.xsd#abus_TalonTherapeuticsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6c744e5f-859e-4371-908e-63f894ca2d14" xlink:to="loc_abus_TalonTherapeuticsMember_2fffe3d5-0f23-453e-a8f7-76074578775a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_833f5b60-482f-4f69-b369-ca080ae14dc0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_18fc574e-3858-4660-b5a0-5d40174962ce" xlink:to="loc_srt_ProductOrServiceAxis_833f5b60-482f-4f69-b369-ca080ae14dc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_3036671b-84ed-404a-8ff3-df66fe9352c1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_833f5b60-482f-4f69-b369-ca080ae14dc0" xlink:to="loc_srt_ProductsAndServicesDomain_3036671b-84ed-404a-8ff3-df66fe9352c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseMember_551f52fd-0d70-47e0-8145-a521c53ebf92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_3036671b-84ed-404a-8ff3-df66fe9352c1" xlink:to="loc_us-gaap_LicenseMember_551f52fd-0d70-47e0-8145-a521c53ebf92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_NonCashRoyaltyMember_67456383-084c-457f-81e7-d92ca82b2ee2" xlink:href="abus-20201231.xsd#abus_NonCashRoyaltyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_3036671b-84ed-404a-8ff3-df66fe9352c1" xlink:to="loc_abus_NonCashRoyaltyMember_67456383-084c-457f-81e7-d92ca82b2ee2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_26633b7b-9cf9-445d-9893-5a0f2704723f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_18fc574e-3858-4660-b5a0-5d40174962ce" xlink:to="loc_srt_RangeAxis_26633b7b-9cf9-445d-9893-5a0f2704723f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0cbe2835-79ce-4193-ae43-f27b9f5371dc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_26633b7b-9cf9-445d-9893-5a0f2704723f" xlink:to="loc_srt_RangeMember_0cbe2835-79ce-4193-ae43-f27b9f5371dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2c959924-c69f-411a-a89d-a33d40f9353a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0cbe2835-79ce-4193-ae43-f27b9f5371dc" xlink:to="loc_srt_MinimumMember_2c959924-c69f-411a-a89d-a33d40f9353a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f51d4762-ccea-4c96-ad5a-4b2b0e1ba2ee" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0cbe2835-79ce-4193-ae43-f27b9f5371dc" xlink:to="loc_srt_MaximumMember_f51d4762-ccea-4c96-ad5a-4b2b0e1ba2ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7e553977-a7b4-4937-8c1c-ff466b574200" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_18fc574e-3858-4660-b5a0-5d40174962ce" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7e553977-a7b4-4937-8c1c-ff466b574200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_a31501ae-8556-436e-a815-7c0e8eee728d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7e553977-a7b4-4937-8c1c-ff466b574200" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_a31501ae-8556-436e-a815-7c0e8eee728d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_GenevantSciencesCorporationMember_dcd92126-5a07-4782-bd81-4c30ec9c2333" xlink:href="abus-20201231.xsd#abus_GenevantSciencesCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a31501ae-8556-436e-a815-7c0e8eee728d" xlink:to="loc_abus_GenevantSciencesCorporationMember_dcd92126-5a07-4782-bd81-4c30ec9c2333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_2dba73a2-d4ef-4281-a053-bd11581a9379" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_18fc574e-3858-4660-b5a0-5d40174962ce" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_2dba73a2-d4ef-4281-a053-bd11581a9379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_ab6b3b5c-ae2e-4892-ad92-0f2eb4cd67a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_2dba73a2-d4ef-4281-a053-bd11581a9379" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_ab6b3b5c-ae2e-4892-ad92-0f2eb4cd67a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_MarqiboCommercialSalesMember_4cf68dfa-ee4a-46d5-a7eb-1432990ca789" xlink:href="abus-20201231.xsd#abus_MarqiboCommercialSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_ab6b3b5c-ae2e-4892-ad92-0f2eb4cd67a0" xlink:to="loc_abus_MarqiboCommercialSalesMember_4cf68dfa-ee4a-46d5-a7eb-1432990ca789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a3bb585f-c258-44a4-aae0-350172f2df4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_18fc574e-3858-4660-b5a0-5d40174962ce" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a3bb585f-c258-44a4-aae0-350172f2df4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostAndExpenseOperating_3fd4940b-1852-493e-ae3d-9d81cca4f7c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a3bb585f-c258-44a4-aae0-350172f2df4b" xlink:to="loc_us-gaap_OtherCostAndExpenseOperating_3fd4940b-1852-493e-ae3d-9d81cca4f7c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_AlnylamEntitlements_6fb0965b-d3c1-43f5-9968-73130b67d968" xlink:href="abus-20201231.xsd#abus_AlnylamEntitlements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a3bb585f-c258-44a4-aae0-350172f2df4b" xlink:to="loc_abus_AlnylamEntitlements_6fb0965b-d3c1-43f5-9968-73130b67d968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_RoyaltyPercentageofInterestSold_b78f7ff8-23ea-48be-8104-0fe51e4b36ba" xlink:href="abus-20201231.xsd#abus_RoyaltyPercentageofInterestSold"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a3bb585f-c258-44a4-aae0-350172f2df4b" xlink:to="loc_abus_RoyaltyPercentageofInterestSold_b78f7ff8-23ea-48be-8104-0fe51e4b36ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_RoyaltyInterestSoldPercentageOfSalesAnnualRevenueThresholdOfHighestTier_a37d3c37-29cf-4c66-b017-db494e52c9c3" xlink:href="abus-20201231.xsd#abus_RoyaltyInterestSoldPercentageOfSalesAnnualRevenueThresholdOfHighestTier"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a3bb585f-c258-44a4-aae0-350172f2df4b" xlink:to="loc_abus_RoyaltyInterestSoldPercentageOfSalesAnnualRevenueThresholdOfHighestTier_a37d3c37-29cf-4c66-b017-db494e52c9c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_GrossProceedsFromRoyaltyInterestSold_330a8c67-0fa0-4cd3-9808-66006181170e" xlink:href="abus-20201231.xsd#abus_GrossProceedsFromRoyaltyInterestSold"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a3bb585f-c258-44a4-aae0-350172f2df4b" xlink:to="loc_abus_GrossProceedsFromRoyaltyInterestSold_330a8c67-0fa0-4cd3-9808-66006181170e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_RoyaltyInterestSoldMaximumRoyaltiesForBuyer_98b2ce52-8863-4b36-9e1a-344601ff6511" xlink:href="abus-20201231.xsd#abus_RoyaltyInterestSoldMaximumRoyaltiesForBuyer"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a3bb585f-c258-44a4-aae0-350172f2df4b" xlink:to="loc_abus_RoyaltyInterestSoldMaximumRoyaltiesForBuyer_98b2ce52-8863-4b36-9e1a-344601ff6511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_RoyaltyGuaranteesCommitmentsPercentage_0c73f0d5-7da7-40ec-8668-6bab40555395" xlink:href="abus-20201231.xsd#abus_RoyaltyGuaranteesCommitmentsPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a3bb585f-c258-44a4-aae0-350172f2df4b" xlink:to="loc_abus_RoyaltyGuaranteesCommitmentsPercentage_0c73f0d5-7da7-40ec-8668-6bab40555395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_RoyaltyPayable_3a9628ed-0f2b-4aeb-87da-c9ee63c7b534" xlink:href="abus-20201231.xsd#abus_RoyaltyPayable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a3bb585f-c258-44a4-aae0-350172f2df4b" xlink:to="loc_abus_RoyaltyPayable_3a9628ed-0f2b-4aeb-87da-c9ee63c7b534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_EquityMethodInvestmentPercentageOfRevenueEntitled_39bc980b-97fb-4a1e-856f-84a368b137c7" xlink:href="abus-20201231.xsd#abus_EquityMethodInvestmentPercentageOfRevenueEntitled"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a3bb585f-c258-44a4-aae0-350172f2df4b" xlink:to="loc_abus_EquityMethodInvestmentPercentageOfRevenueEntitled_39bc980b-97fb-4a1e-856f-84a368b137c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_NumberOfChemotherapyProductsWithWorldwideLicenses_af7c239e-23ea-4f1a-8417-9777dc129a59" xlink:href="abus-20201231.xsd#abus_NumberOfChemotherapyProductsWithWorldwideLicenses"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a3bb585f-c258-44a4-aae0-350172f2df4b" xlink:to="loc_abus_NumberOfChemotherapyProductsWithWorldwideLicenses_af7c239e-23ea-4f1a-8417-9777dc129a59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_8a748ea5-1a8a-45a7-8509-682e2a9ebd24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a3bb585f-c258-44a4-aae0-350172f2df4b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_8a748ea5-1a8a-45a7-8509-682e2a9ebd24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_PotentialContractFundingAmount_086209f6-ebb1-4126-98c8-f3ebf7263d56" xlink:href="abus-20201231.xsd#abus_PotentialContractFundingAmount"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a3bb585f-c258-44a4-aae0-350172f2df4b" xlink:to="loc_abus_PotentialContractFundingAmount_086209f6-ebb1-4126-98c8-f3ebf7263d56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/CollaborationscontractsandlicensingagreementsSummaryofrevenuesDetails" xlink:type="simple" xlink:href="abus-20201231.xsd#CollaborationscontractsandlicensingagreementsSummaryofrevenuesDetails"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/CollaborationscontractsandlicensingagreementsSummaryofrevenuesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5e1a3c4e-1e67-4205-9544-39780e2e2b48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_de22f379-2b7f-4718-88b4-d1184c4d7cb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5e1a3c4e-1e67-4205-9544-39780e2e2b48" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_de22f379-2b7f-4718-88b4-d1184c4d7cb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f83dcb8e-190d-4d0f-8c2c-bd21cd1f9964" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_de22f379-2b7f-4718-88b4-d1184c4d7cb8" xlink:to="loc_srt_ProductOrServiceAxis_f83dcb8e-190d-4d0f-8c2c-bd21cd1f9964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_7d8595ab-24b9-4b12-a83c-006c071afc60" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_f83dcb8e-190d-4d0f-8c2c-bd21cd1f9964" xlink:to="loc_srt_ProductsAndServicesDomain_7d8595ab-24b9-4b12-a83c-006c071afc60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseMember_35a7d9d1-c015-49c3-b387-c665adf95d28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7d8595ab-24b9-4b12-a83c-006c071afc60" xlink:to="loc_us-gaap_LicenseMember_35a7d9d1-c015-49c3-b387-c665adf95d28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_NonCashRoyaltyMember_b504c100-1564-467e-a866-c82900e775b4" xlink:href="abus-20201231.xsd#abus_NonCashRoyaltyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7d8595ab-24b9-4b12-a83c-006c071afc60" xlink:to="loc_abus_NonCashRoyaltyMember_b504c100-1564-467e-a866-c82900e775b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_9f0314f3-48a9-43af-83c0-d3e27f699c92" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_de22f379-2b7f-4718-88b4-d1184c4d7cb8" xlink:to="loc_srt_CounterpartyNameAxis_9f0314f3-48a9-43af-83c0-d3e27f699c92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5793bddf-41c1-4c2f-94b7-88cdcddfc15b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_9f0314f3-48a9-43af-83c0-d3e27f699c92" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5793bddf-41c1-4c2f-94b7-88cdcddfc15b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_AcuitasTherapeuticsInc.Member_aee2d3b9-083a-4f9f-9334-1dfa228f3623" xlink:href="abus-20201231.xsd#abus_AcuitasTherapeuticsInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5793bddf-41c1-4c2f-94b7-88cdcddfc15b" xlink:to="loc_abus_AcuitasTherapeuticsInc.Member_aee2d3b9-083a-4f9f-9334-1dfa228f3623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_GritstoneMember_e4a2a871-b246-4e79-a0a1-a73fea20686b" xlink:href="abus-20201231.xsd#abus_GritstoneMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5793bddf-41c1-4c2f-94b7-88cdcddfc15b" xlink:to="loc_abus_GritstoneMember_e4a2a871-b246-4e79-a0a1-a73fea20686b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_AcrotechBiopharmaLLCMember_4f9ff26b-d114-4766-ae00-9aad93914447" xlink:href="abus-20201231.xsd#abus_AcrotechBiopharmaLLCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5793bddf-41c1-4c2f-94b7-88cdcddfc15b" xlink:to="loc_abus_AcrotechBiopharmaLLCMember_4f9ff26b-d114-4766-ae00-9aad93914447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_AlnylamPharmaceuticalsIncMember_27884b3e-f546-4acb-8148-e78ce1105286" xlink:href="abus-20201231.xsd#abus_AlnylamPharmaceuticalsIncMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5793bddf-41c1-4c2f-94b7-88cdcddfc15b" xlink:to="loc_abus_AlnylamPharmaceuticalsIncMember_27884b3e-f546-4acb-8148-e78ce1105286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_fe5778b6-1400-4284-86b9-906e4ac17074" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_de22f379-2b7f-4718-88b4-d1184c4d7cb8" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_fe5778b6-1400-4284-86b9-906e4ac17074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_d47fada8-ccc1-4f7c-b56f-90c7b50bbfe7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_fe5778b6-1400-4284-86b9-906e4ac17074" xlink:to="loc_us-gaap_Revenues_d47fada8-ccc1-4f7c-b56f-90c7b50bbfe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/Shareholdersequity" xlink:type="simple" xlink:href="abus-20201231.xsd#Shareholdersequity"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/Shareholdersequity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_89622b1c-54a3-40ee-9515-f11aaf9c452a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_f76591bf-798e-4522-bcc4-fa05fff81354" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_89622b1c-54a3-40ee-9515-f11aaf9c452a" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_f76591bf-798e-4522-bcc4-fa05fff81354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/ShareholdersequityDetails" xlink:type="simple" xlink:href="abus-20201231.xsd#ShareholdersequityDetails"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/ShareholdersequityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_a01baa31-e6e9-4137-b13d-6a2c503a3e55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_34026964-6717-48ad-afec-2f628e32468c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a01baa31-e6e9-4137-b13d-6a2c503a3e55" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_34026964-6717-48ad-afec-2f628e32468c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_757e8a7c-0077-41a5-93a1-5c31f6680e95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_34026964-6717-48ad-afec-2f628e32468c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_757e8a7c-0077-41a5-93a1-5c31f6680e95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7dc2e517-ecf4-42a0-bac6-68b5b254c4ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_757e8a7c-0077-41a5-93a1-5c31f6680e95" xlink:to="loc_us-gaap_EquityComponentDomain_7dc2e517-ecf4-42a0-bac6-68b5b254c4ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_b2e3bc7f-c79c-4b38-843d-f0b7f25413e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7dc2e517-ecf4-42a0-bac6-68b5b254c4ff" xlink:to="loc_us-gaap_PreferredStockMember_b2e3bc7f-c79c-4b38-843d-f0b7f25413e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_feb375f2-0a15-4b76-ac3c-b388acbd6d67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_34026964-6717-48ad-afec-2f628e32468c" xlink:to="loc_us-gaap_StatementClassOfStockAxis_feb375f2-0a15-4b76-ac3c-b388acbd6d67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_26acc93f-33a4-425d-9dc1-4b381d4a72e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_feb375f2-0a15-4b76-ac3c-b388acbd6d67" xlink:to="loc_us-gaap_ClassOfStockDomain_26acc93f-33a4-425d-9dc1-4b381d4a72e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_acba2ddc-aef8-4a4b-ac9a-136bb3bbf682" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_26acc93f-33a4-425d-9dc1-4b381d4a72e6" xlink:to="loc_us-gaap_CommonStockMember_acba2ddc-aef8-4a4b-ac9a-136bb3bbf682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_da3b114b-3235-44ba-b512-3ca1630de68a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_26acc93f-33a4-425d-9dc1-4b381d4a72e6" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_da3b114b-3235-44ba-b512-3ca1630de68a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_0c22b6ff-1b8b-4440-b672-448916649309" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_34026964-6717-48ad-afec-2f628e32468c" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_0c22b6ff-1b8b-4440-b672-448916649309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_f71f6741-b309-43bc-9024-0eed44de8a6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_0c22b6ff-1b8b-4440-b672-448916649309" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_f71f6741-b309-43bc-9024-0eed44de8a6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_OpenMarketSaleAgreementMember_55a49179-f00f-4617-84d5-50934cc46cbd" xlink:href="abus-20201231.xsd#abus_OpenMarketSaleAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_f71f6741-b309-43bc-9024-0eed44de8a6c" xlink:to="loc_abus_OpenMarketSaleAgreementMember_55a49179-f00f-4617-84d5-50934cc46cbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_6b43a513-21c7-4d66-98a2-118b956c7620" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_34026964-6717-48ad-afec-2f628e32468c" xlink:to="loc_srt_CounterpartyNameAxis_6b43a513-21c7-4d66-98a2-118b956c7620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cc02d5a5-a4f9-4427-a247-5b92700d8550" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_6b43a513-21c7-4d66-98a2-118b956c7620" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cc02d5a5-a4f9-4427-a247-5b92700d8550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_JefferiesLLCMember_b26171a5-ed91-4bcf-80f8-219ed60ee771" xlink:href="abus-20201231.xsd#abus_JefferiesLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cc02d5a5-a4f9-4427-a247-5b92700d8550" xlink:to="loc_abus_JefferiesLLCMember_b26171a5-ed91-4bcf-80f8-219ed60ee771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_RoivantSciencesLtdMember_471c53b7-eabd-4705-8299-9b08db6e25ea" xlink:href="abus-20201231.xsd#abus_RoivantSciencesLtdMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cc02d5a5-a4f9-4427-a247-5b92700d8550" xlink:to="loc_abus_RoivantSciencesLtdMember_471c53b7-eabd-4705-8299-9b08db6e25ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_ba60a7cd-a1af-4e44-927c-2d8a8df1c1d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_34026964-6717-48ad-afec-2f628e32468c" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_ba60a7cd-a1af-4e44-927c-2d8a8df1c1d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_8c039be4-2a94-4431-9256-ab72008b168d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_ba60a7cd-a1af-4e44-927c-2d8a8df1c1d5" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_8c039be4-2a94-4431-9256-ab72008b168d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_f7be95ee-c04d-4061-9794-eab2cb60d972" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_8c039be4-2a94-4431-9256-ab72008b168d" xlink:to="loc_us-gaap_SubsequentEventMember_f7be95ee-c04d-4061-9794-eab2cb60d972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_6dd61c88-10e6-46ae-b39a-d63b588c49d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_34026964-6717-48ad-afec-2f628e32468c" xlink:to="loc_us-gaap_ClassOfStockLineItems_6dd61c88-10e6-46ae-b39a-d63b588c49d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_eee2da21-671c-4476-a613-70c691f02552" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_6dd61c88-10e6-46ae-b39a-d63b588c49d9" xlink:to="loc_us-gaap_SharesIssued_eee2da21-671c-4476-a613-70c691f02552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesSubscriptions_5ee69585-ef3e-4030-bf4c-81a3fbd9e7e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesSubscriptions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_6dd61c88-10e6-46ae-b39a-d63b588c49d9" xlink:to="loc_us-gaap_CommonStockSharesSubscriptions_5ee69585-ef3e-4030-bf4c-81a3fbd9e7e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_d38dcd65-4a79-4228-83e6-9f536acec50f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_6dd61c88-10e6-46ae-b39a-d63b588c49d9" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_d38dcd65-4a79-4228-83e6-9f536acec50f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_9932401d-0569-469d-9aa8-fee24bef794c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_6dd61c88-10e6-46ae-b39a-d63b588c49d9" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_9932401d-0569-469d-9aa8-fee24bef794c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_4996822d-4aa9-4102-9e4f-aab2e9450c2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_6dd61c88-10e6-46ae-b39a-d63b588c49d9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_4996822d-4aa9-4102-9e4f-aab2e9450c2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_5ab931e0-382f-436f-8533-ffa3c92412ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_6dd61c88-10e6-46ae-b39a-d63b588c49d9" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_5ab931e0-382f-436f-8533-ffa3c92412ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_PremiumonClosingStockPrice_6aa5e480-d647-4dc8-8558-375c92ec1ac9" xlink:href="abus-20201231.xsd#abus_PremiumonClosingStockPrice"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_6dd61c88-10e6-46ae-b39a-d63b588c49d9" xlink:to="loc_abus_PremiumonClosingStockPrice_6aa5e480-d647-4dc8-8558-375c92ec1ac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_c68493c5-5b3d-4a0d-a5f4-94f4539c838b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_6dd61c88-10e6-46ae-b39a-d63b588c49d9" xlink:to="loc_us-gaap_SharePrice_c68493c5-5b3d-4a0d-a5f4-94f4539c838b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_c8a5e520-9eef-4097-be04-c7cd4dcf819b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_6dd61c88-10e6-46ae-b39a-d63b588c49d9" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_c8a5e520-9eef-4097-be04-c7cd4dcf819b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_NoncontrollingInterestOwnershipPercentageByNoncontrollingOwnersAfterConversion_99578a9d-3677-467d-b5d3-ba9f3b3d22b1" xlink:href="abus-20201231.xsd#abus_NoncontrollingInterestOwnershipPercentageByNoncontrollingOwnersAfterConversion"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_6dd61c88-10e6-46ae-b39a-d63b588c49d9" xlink:to="loc_abus_NoncontrollingInterestOwnershipPercentageByNoncontrollingOwnersAfterConversion_99578a9d-3677-467d-b5d3-ba9f3b3d22b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_NoncontrollingInterestInvestmentCommitmentPeriod_d5f5895e-cce0-430a-a13b-8606c4ee6d28" xlink:href="abus-20201231.xsd#abus_NoncontrollingInterestInvestmentCommitmentPeriod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_6dd61c88-10e6-46ae-b39a-d63b588c49d9" xlink:to="loc_abus_NoncontrollingInterestInvestmentCommitmentPeriod_d5f5895e-cce0-430a-a13b-8606c4ee6d28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_NoncontrollingInterestMaximumOwnershipPercentagebyNoncontrollingOwners_118e0af2-cc32-4b33-83cb-ed91557766b7" xlink:href="abus-20201231.xsd#abus_NoncontrollingInterestMaximumOwnershipPercentagebyNoncontrollingOwners"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_6dd61c88-10e6-46ae-b39a-d63b588c49d9" xlink:to="loc_abus_NoncontrollingInterestMaximumOwnershipPercentagebyNoncontrollingOwners_118e0af2-cc32-4b33-83cb-ed91557766b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_2731eb90-cb7f-4523-8e54-4051b9bda2aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_6dd61c88-10e6-46ae-b39a-d63b588c49d9" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_2731eb90-cb7f-4523-8e54-4051b9bda2aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_ConvertiblePreferredStockSharesOfCommonStockIssueduponConversion_11a3fb11-7e5e-465e-9407-5c16c5c0182e" xlink:href="abus-20201231.xsd#abus_ConvertiblePreferredStockSharesOfCommonStockIssueduponConversion"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_6dd61c88-10e6-46ae-b39a-d63b588c49d9" xlink:to="loc_abus_ConvertiblePreferredStockSharesOfCommonStockIssueduponConversion_11a3fb11-7e5e-465e-9407-5c16c5c0182e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/Stockbasedcompensation" xlink:type="simple" xlink:href="abus-20201231.xsd#Stockbasedcompensation"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/Stockbasedcompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_61ec72b8-f588-4f5f-b3b4-2d5de362b9ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_ee7e8ffd-5402-4937-8611-4e8323737a7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_61ec72b8-f588-4f5f-b3b4-2d5de362b9ce" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_ee7e8ffd-5402-4937-8611-4e8323737a7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/StockbasedcompensationTables" xlink:type="simple" xlink:href="abus-20201231.xsd#StockbasedcompensationTables"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/StockbasedcompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_70ace38c-8fa5-4062-a381-0ef21929b7f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e3e52ba3-db4c-4fb6-922d-53e951b196cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_70ace38c-8fa5-4062-a381-0ef21929b7f8" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e3e52ba3-db4c-4fb6-922d-53e951b196cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_898c0d48-123d-4df5-b709-df00280d8443" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e3e52ba3-db4c-4fb6-922d-53e951b196cd" xlink:to="loc_us-gaap_AwardTypeAxis_898c0d48-123d-4df5-b709-df00280d8443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_035d5e60-96a7-431b-81df-6517c7731021" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_898c0d48-123d-4df5-b709-df00280d8443" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_035d5e60-96a7-431b-81df-6517c7731021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_EmployeeStockOptionLiabilityClassifiedMember_9aa47f2c-a984-4448-83e1-2862cc51ee95" xlink:href="abus-20201231.xsd#abus_EmployeeStockOptionLiabilityClassifiedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_035d5e60-96a7-431b-81df-6517c7731021" xlink:to="loc_abus_EmployeeStockOptionLiabilityClassifiedMember_9aa47f2c-a984-4448-83e1-2862cc51ee95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_934c95f5-dd6c-43da-b358-46d0bb6cd7f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e3e52ba3-db4c-4fb6-922d-53e951b196cd" xlink:to="loc_us-gaap_PlanNameAxis_934c95f5-dd6c-43da-b358-46d0bb6cd7f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_901811ce-6d20-429f-83f1-26dc482bc588" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_934c95f5-dd6c-43da-b358-46d0bb6cd7f2" xlink:to="loc_us-gaap_PlanNameDomain_901811ce-6d20-429f-83f1-26dc482bc588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_ArbutusPlansMember_a9a3ef34-ab2a-4d25-9b81-69dc68350b2c" xlink:href="abus-20201231.xsd#abus_ArbutusPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_901811ce-6d20-429f-83f1-26dc482bc588" xlink:to="loc_abus_ArbutusPlansMember_a9a3ef34-ab2a-4d25-9b81-69dc68350b2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_OnCoreOptionPlanMember_3bb1e590-f151-485b-b33d-af0f3ff017af" xlink:href="abus-20201231.xsd#abus_OnCoreOptionPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_901811ce-6d20-429f-83f1-26dc482bc588" xlink:to="loc_abus_OnCoreOptionPlanMember_3bb1e590-f151-485b-b33d-af0f3ff017af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2b220648-8382-4cf0-b408-7e5afdc29f04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e3e52ba3-db4c-4fb6-922d-53e951b196cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2b220648-8382-4cf0-b408-7e5afdc29f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_6fd76879-337b-4a20-93d1-018e4c5c5354" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2b220648-8382-4cf0-b408-7e5afdc29f04" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_6fd76879-337b-4a20-93d1-018e4c5c5354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_85bf68cd-df6c-4041-93de-0f74ee4c6681" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2b220648-8382-4cf0-b408-7e5afdc29f04" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_85bf68cd-df6c-4041-93de-0f74ee4c6681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_777fcbd6-9bb7-4e20-b2fa-cdc214769095" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2b220648-8382-4cf0-b408-7e5afdc29f04" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_777fcbd6-9bb7-4e20-b2fa-cdc214769095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_5ba31d1c-26c3-46ac-98a9-8585336ca6cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2b220648-8382-4cf0-b408-7e5afdc29f04" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_5ba31d1c-26c3-46ac-98a9-8585336ca6cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_e4100cbd-1943-4e46-986f-f99bff882cc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2b220648-8382-4cf0-b408-7e5afdc29f04" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_e4100cbd-1943-4e46-986f-f99bff882cc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/StockbasedcompensationNarrativeDetails" xlink:type="simple" xlink:href="abus-20201231.xsd#StockbasedcompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/StockbasedcompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_72f1920d-d2e6-46cd-9d7f-59c110049a16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dcce6cca-5603-4c63-b4e8-110cc99e78a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_72f1920d-d2e6-46cd-9d7f-59c110049a16" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dcce6cca-5603-4c63-b4e8-110cc99e78a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_ad6a1b18-43e1-45fb-8759-b561919d5549" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dcce6cca-5603-4c63-b4e8-110cc99e78a3" xlink:to="loc_us-gaap_AwardTypeAxis_ad6a1b18-43e1-45fb-8759-b561919d5549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3a273a64-9b73-4d85-a8b2-6761735d6e10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_ad6a1b18-43e1-45fb-8759-b561919d5549" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3a273a64-9b73-4d85-a8b2-6761735d6e10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_8fe70b08-68fc-4817-963e-fb453eab54a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3a273a64-9b73-4d85-a8b2-6761735d6e10" xlink:to="loc_us-gaap_EmployeeStockOptionMember_8fe70b08-68fc-4817-963e-fb453eab54a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_EmployeeStockOptionLiabilityClassifiedMember_7e2edcd8-dc2b-42ed-a6e7-d7720627aeef" xlink:href="abus-20201231.xsd#abus_EmployeeStockOptionLiabilityClassifiedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3a273a64-9b73-4d85-a8b2-6761735d6e10" xlink:to="loc_abus_EmployeeStockOptionLiabilityClassifiedMember_7e2edcd8-dc2b-42ed-a6e7-d7720627aeef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_0add0e27-88f5-4417-bf23-0bfc475831a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3a273a64-9b73-4d85-a8b2-6761735d6e10" xlink:to="loc_us-gaap_PerformanceSharesMember_0add0e27-88f5-4417-bf23-0bfc475831a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_43b2c66e-cbd7-4411-b775-ce4b6b7196c8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dcce6cca-5603-4c63-b4e8-110cc99e78a3" xlink:to="loc_srt_RangeAxis_43b2c66e-cbd7-4411-b775-ce4b6b7196c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5316f534-2127-4a56-9146-53b936e411dc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_43b2c66e-cbd7-4411-b775-ce4b6b7196c8" xlink:to="loc_srt_RangeMember_5316f534-2127-4a56-9146-53b936e411dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1a67e784-7a22-469d-93fa-45e10457209c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5316f534-2127-4a56-9146-53b936e411dc" xlink:to="loc_srt_MinimumMember_1a67e784-7a22-469d-93fa-45e10457209c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f0c43471-ef52-4355-9f33-b8701abb8759" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5316f534-2127-4a56-9146-53b936e411dc" xlink:to="loc_srt_MaximumMember_f0c43471-ef52-4355-9f33-b8701abb8759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_9104d0cf-eaec-4010-95bf-63d20d80c2c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dcce6cca-5603-4c63-b4e8-110cc99e78a3" xlink:to="loc_us-gaap_PlanNameAxis_9104d0cf-eaec-4010-95bf-63d20d80c2c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_92043a6f-26be-4238-ac82-3be06e53d5e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_9104d0cf-eaec-4010-95bf-63d20d80c2c7" xlink:to="loc_us-gaap_PlanNameDomain_92043a6f-26be-4238-ac82-3be06e53d5e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_A2016And2011PlansMember_ccd0167e-2823-482e-9fbf-cfd068caa7c4" xlink:href="abus-20201231.xsd#abus_A2016And2011PlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_92043a6f-26be-4238-ac82-3be06e53d5e2" xlink:to="loc_abus_A2016And2011PlansMember_ccd0167e-2823-482e-9fbf-cfd068caa7c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_CollierPlanMember_e000ba71-9e57-423c-812c-d5df6dc1871b" xlink:href="abus-20201231.xsd#abus_CollierPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_92043a6f-26be-4238-ac82-3be06e53d5e2" xlink:to="loc_abus_CollierPlanMember_e000ba71-9e57-423c-812c-d5df6dc1871b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_ArbutusPlansMember_07d42291-31d1-4896-88aa-36461fd96cb5" xlink:href="abus-20201231.xsd#abus_ArbutusPlansMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_92043a6f-26be-4238-ac82-3be06e53d5e2" xlink:to="loc_abus_ArbutusPlansMember_07d42291-31d1-4896-88aa-36461fd96cb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_OnCoreOptionPlanMember_61581255-d210-4083-ae1a-b7ba68e6df89" xlink:href="abus-20201231.xsd#abus_OnCoreOptionPlanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_92043a6f-26be-4238-ac82-3be06e53d5e2" xlink:to="loc_abus_OnCoreOptionPlanMember_61581255-d210-4083-ae1a-b7ba68e6df89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_98282de0-c503-4930-b076-dbf33e15c444" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dcce6cca-5603-4c63-b4e8-110cc99e78a3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_98282de0-c503-4930-b076-dbf33e15c444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_8d3ea475-c4a6-4e95-927d-d986ebf459d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_98282de0-c503-4930-b076-dbf33e15c444" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_8d3ea475-c4a6-4e95-927d-d986ebf459d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e8d9f221-57ab-4fc5-be30-0e261798a3ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_98282de0-c503-4930-b076-dbf33e15c444" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e8d9f221-57ab-4fc5-be30-0e261798a3ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_0b52458d-f59c-43ba-8ce4-f5d04b91b19a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_98282de0-c503-4930-b076-dbf33e15c444" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_0b52458d-f59c-43ba-8ce4-f5d04b91b19a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_98a4a2fc-219c-4ec1-a3d9-c2e82c6cceaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_98282de0-c503-4930-b076-dbf33e15c444" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_98a4a2fc-219c-4ec1-a3d9-c2e82c6cceaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_cb9b7f51-ac99-4bec-b194-f7eb66ce6fdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_98282de0-c503-4930-b076-dbf33e15c444" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_cb9b7f51-ac99-4bec-b194-f7eb66ce6fdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1c4f546e-d333-4ed3-90ba-93becf95a96e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_98282de0-c503-4930-b076-dbf33e15c444" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1c4f546e-d333-4ed3-90ba-93becf95a96e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_189d7034-10c5-4076-b379-104101a3ec97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_98282de0-c503-4930-b076-dbf33e15c444" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_189d7034-10c5-4076-b379-104101a3ec97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPSharesInESOP_e42fd5fc-ed17-44cf-8282-7d44d6bb927e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPSharesInESOP"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_98282de0-c503-4930-b076-dbf33e15c444" xlink:to="loc_us-gaap_EmployeeStockOwnershipPlanESOPSharesInESOP_e42fd5fc-ed17-44cf-8282-7d44d6bb927e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_CommonStockDiscountOnSharesPercentage_2f25dac7-e931-41b1-87fc-98a3ae4dcaf4" xlink:href="abus-20201231.xsd#abus_CommonStockDiscountOnSharesPercentage"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_98282de0-c503-4930-b076-dbf33e15c444" xlink:to="loc_abus_CommonStockDiscountOnSharesPercentage_2f25dac7-e931-41b1-87fc-98a3ae4dcaf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense_a94f85eb-de7f-4eda-a1cc-8169edc30369" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_98282de0-c503-4930-b076-dbf33e15c444" xlink:to="loc_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense_a94f85eb-de7f-4eda-a1cc-8169edc30369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense_d47a9340-bbfb-4f51-b0e5-f4372558228c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_98282de0-c503-4930-b076-dbf33e15c444" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense_d47a9340-bbfb-4f51-b0e5-f4372558228c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_cdd5d496-acdf-4781-9e55-c946a9117228" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_98282de0-c503-4930-b076-dbf33e15c444" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_cdd5d496-acdf-4781-9e55-c946a9117228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_4042186e-ac84-4271-92c3-fcde0a9d9eea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_98282de0-c503-4930-b076-dbf33e15c444" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_4042186e-ac84-4271-92c3-fcde0a9d9eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_b10f2bd9-c5ae-4a5d-b44e-178e536a362e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_98282de0-c503-4930-b076-dbf33e15c444" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_b10f2bd9-c5ae-4a5d-b44e-178e536a362e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/StockbasedcompensationStockoptionactivityundertheArbutusPlanDetails" xlink:type="simple" xlink:href="abus-20201231.xsd#StockbasedcompensationStockoptionactivityundertheArbutusPlanDetails"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/StockbasedcompensationStockoptionactivityundertheArbutusPlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2a7b97ab-f7f2-42db-b7b3-4d19c64f9657" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_21c50d6f-7ce1-4666-8e16-291dcb7f49d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2a7b97ab-f7f2-42db-b7b3-4d19c64f9657" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_21c50d6f-7ce1-4666-8e16-291dcb7f49d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_47f70075-d7d7-4461-a2a7-c3abac5f83b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_21c50d6f-7ce1-4666-8e16-291dcb7f49d0" xlink:to="loc_us-gaap_PlanNameAxis_47f70075-d7d7-4461-a2a7-c3abac5f83b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_fac642db-6c42-4a71-85cf-1a78846c2872" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_47f70075-d7d7-4461-a2a7-c3abac5f83b3" xlink:to="loc_us-gaap_PlanNameDomain_fac642db-6c42-4a71-85cf-1a78846c2872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_ArbutusPlansMember_c9219a30-6634-4a41-b77f-7851fc3e3aa9" xlink:href="abus-20201231.xsd#abus_ArbutusPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_fac642db-6c42-4a71-85cf-1a78846c2872" xlink:to="loc_abus_ArbutusPlansMember_c9219a30-6634-4a41-b77f-7851fc3e3aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_13e6b18e-d5a5-4fe8-846f-18389c5824e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_21c50d6f-7ce1-4666-8e16-291dcb7f49d0" xlink:to="loc_us-gaap_StatementClassOfStockAxis_13e6b18e-d5a5-4fe8-846f-18389c5824e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a72b9afa-fa29-40c1-aadb-755687fc8eac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_13e6b18e-d5a5-4fe8-846f-18389c5824e6" xlink:to="loc_us-gaap_ClassOfStockDomain_a72b9afa-fa29-40c1-aadb-755687fc8eac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_c462e3bb-008a-4b7a-857d-d38d2dad9563" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_a72b9afa-fa29-40c1-aadb-755687fc8eac" xlink:to="loc_us-gaap_EmployeeStockOptionMember_c462e3bb-008a-4b7a-857d-d38d2dad9563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_VestedMember_5c281f0e-ea90-4fa5-874c-20d4ff738d44" xlink:href="abus-20201231.xsd#abus_VestedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_a72b9afa-fa29-40c1-aadb-755687fc8eac" xlink:to="loc_abus_VestedMember_5c281f0e-ea90-4fa5-874c-20d4ff738d44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_NonvestedMember_c49d27ba-b8b9-4e87-b4f3-7b0d479f11aa" xlink:href="abus-20201231.xsd#abus_NonvestedMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_a72b9afa-fa29-40c1-aadb-755687fc8eac" xlink:to="loc_abus_NonvestedMember_c49d27ba-b8b9-4e87-b4f3-7b0d479f11aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d1403897-a78f-4e14-a076-cf9e16016a9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_21c50d6f-7ce1-4666-8e16-291dcb7f49d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d1403897-a78f-4e14-a076-cf9e16016a9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_803f5d65-a56e-4699-b09f-911b96eb0c51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d1403897-a78f-4e14-a076-cf9e16016a9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_803f5d65-a56e-4699-b09f-911b96eb0c51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6d73b68b-d995-4e0f-8e03-b04d0f74179c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_803f5d65-a56e-4699-b09f-911b96eb0c51" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6d73b68b-d995-4e0f-8e03-b04d0f74179c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_93d7552e-0c69-4100-b98d-f32207d15999" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_803f5d65-a56e-4699-b09f-911b96eb0c51" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_93d7552e-0c69-4100-b98d-f32207d15999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8a1c4540-0a95-4fef-8655-564db2e9a3ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_803f5d65-a56e-4699-b09f-911b96eb0c51" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8a1c4540-0a95-4fef-8655-564db2e9a3ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_f800c8de-b118-484a-893c-2703dc0201a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_803f5d65-a56e-4699-b09f-911b96eb0c51" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_f800c8de-b118-484a-893c-2703dc0201a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_629983d0-f045-4c7c-b4d4-5ba6c823210e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_803f5d65-a56e-4699-b09f-911b96eb0c51" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_629983d0-f045-4c7c-b4d4-5ba6c823210e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4194e463-e961-4a32-a0eb-d576637355e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_803f5d65-a56e-4699-b09f-911b96eb0c51" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4194e463-e961-4a32-a0eb-d576637355e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f070ca6e-99ce-4974-8d1e-46d0c96b141c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d1403897-a78f-4e14-a076-cf9e16016a9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f070ca6e-99ce-4974-8d1e-46d0c96b141c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7e391f2a-506e-4874-9c04-893d6869c1e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f070ca6e-99ce-4974-8d1e-46d0c96b141c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7e391f2a-506e-4874-9c04-893d6869c1e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_e6c2fbc0-30a1-4632-8e42-e66b1952c7ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f070ca6e-99ce-4974-8d1e-46d0c96b141c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_e6c2fbc0-30a1-4632-8e42-e66b1952c7ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_870450c3-c23c-4734-8a2b-c6e55843b51f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f070ca6e-99ce-4974-8d1e-46d0c96b141c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_870450c3-c23c-4734-8a2b-c6e55843b51f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_2a3244fb-7058-4035-86bc-04b7c4f234ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f070ca6e-99ce-4974-8d1e-46d0c96b141c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_2a3244fb-7058-4035-86bc-04b7c4f234ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsVestedInPeriodWeightedAverageFairValue_ed38a621-3f78-43ad-b907-1377984883d7" xlink:href="abus-20201231.xsd#abus_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsVestedInPeriodWeightedAverageFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f070ca6e-99ce-4974-8d1e-46d0c96b141c" xlink:to="loc_abus_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsVestedInPeriodWeightedAverageFairValue_ed38a621-3f78-43ad-b907-1377984883d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3bcb7d6e-5d4d-4511-82ca-931545c79f86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f070ca6e-99ce-4974-8d1e-46d0c96b141c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3bcb7d6e-5d4d-4511-82ca-931545c79f86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/StockbasedcompensationStockoptionsoutstandingundertheArbutusPlanDetails" xlink:type="simple" xlink:href="abus-20201231.xsd#StockbasedcompensationStockoptionsoutstandingundertheArbutusPlanDetails"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/StockbasedcompensationStockoptionsoutstandingundertheArbutusPlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8f366377-64f0-41e4-aa9f-b55e54477eb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_984e3c98-fe00-4f57-959f-224c472443f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8f366377-64f0-41e4-aa9f-b55e54477eb0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_984e3c98-fe00-4f57-959f-224c472443f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_e9588488-40cb-4c05-8cc6-bded58e2b704" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_984e3c98-fe00-4f57-959f-224c472443f3" xlink:to="loc_us-gaap_PlanNameAxis_e9588488-40cb-4c05-8cc6-bded58e2b704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_536ad9cb-aa3e-4e88-94c2-33585786780b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_e9588488-40cb-4c05-8cc6-bded58e2b704" xlink:to="loc_us-gaap_PlanNameDomain_536ad9cb-aa3e-4e88-94c2-33585786780b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_ArbutusPlansMember_5d606e8b-4955-4ca2-a641-532623a7ba98" xlink:href="abus-20201231.xsd#abus_ArbutusPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_536ad9cb-aa3e-4e88-94c2-33585786780b" xlink:to="loc_abus_ArbutusPlansMember_5d606e8b-4955-4ca2-a641-532623a7ba98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_23a2a08d-860d-4d0b-a5c6-f6d3c15e431b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_984e3c98-fe00-4f57-959f-224c472443f3" xlink:to="loc_us-gaap_AwardTypeAxis_23a2a08d-860d-4d0b-a5c6-f6d3c15e431b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b58b94d2-9bbe-4e65-83ac-5a7c7f78db30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_23a2a08d-860d-4d0b-a5c6-f6d3c15e431b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b58b94d2-9bbe-4e65-83ac-5a7c7f78db30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_dc7e0021-12f9-45a4-82f4-6d71e01f8038" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b58b94d2-9bbe-4e65-83ac-5a7c7f78db30" xlink:to="loc_us-gaap_EmployeeStockOptionMember_dc7e0021-12f9-45a4-82f4-6d71e01f8038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_VestedMember_a72764ee-1e4b-4f57-ace3-7be8b94b255e" xlink:href="abus-20201231.xsd#abus_VestedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b58b94d2-9bbe-4e65-83ac-5a7c7f78db30" xlink:to="loc_abus_VestedMember_a72764ee-1e4b-4f57-ace3-7be8b94b255e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_5b7f1ccc-6edc-4bdc-911b-8ca229341886" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_984e3c98-fe00-4f57-959f-224c472443f3" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_5b7f1ccc-6edc-4bdc-911b-8ca229341886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_80a6b3cc-3bb3-4bb0-ad7f-7e909d7ee618" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_5b7f1ccc-6edc-4bdc-911b-8ca229341886" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_80a6b3cc-3bb3-4bb0-ad7f-7e909d7ee618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e12cc96c-573b-4007-8139-25234ad4b87d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_5b7f1ccc-6edc-4bdc-911b-8ca229341886" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e12cc96c-573b-4007-8139-25234ad4b87d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_726165da-7fa3-48d7-9f55-5afbe564206a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_5b7f1ccc-6edc-4bdc-911b-8ca229341886" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_726165da-7fa3-48d7-9f55-5afbe564206a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_183cea1f-98aa-4b7e-baff-ca014a04d3c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_5b7f1ccc-6edc-4bdc-911b-8ca229341886" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_183cea1f-98aa-4b7e-baff-ca014a04d3c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/StockbasedcompensationValuationassumptionsforstockoptionsundertheArbutusPlanDetails" xlink:type="simple" xlink:href="abus-20201231.xsd#StockbasedcompensationValuationassumptionsforstockoptionsundertheArbutusPlanDetails"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/StockbasedcompensationValuationassumptionsforstockoptionsundertheArbutusPlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6668f74b-e26e-44c0-9746-31aa841c19f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dad8b9e7-d07b-427a-9c1b-57fe10688d6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6668f74b-e26e-44c0-9746-31aa841c19f6" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dad8b9e7-d07b-427a-9c1b-57fe10688d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_9c41c2b9-7320-4ed0-9cbf-8c7f8f4b7709" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dad8b9e7-d07b-427a-9c1b-57fe10688d6c" xlink:to="loc_us-gaap_PlanNameAxis_9c41c2b9-7320-4ed0-9cbf-8c7f8f4b7709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_981f1e66-1054-4a7f-aacd-db64c64107e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_9c41c2b9-7320-4ed0-9cbf-8c7f8f4b7709" xlink:to="loc_us-gaap_PlanNameDomain_981f1e66-1054-4a7f-aacd-db64c64107e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_ArbutusPlansMember_c13092de-efa4-4fac-a55c-16018a5dded1" xlink:href="abus-20201231.xsd#abus_ArbutusPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_981f1e66-1054-4a7f-aacd-db64c64107e5" xlink:to="loc_abus_ArbutusPlansMember_c13092de-efa4-4fac-a55c-16018a5dded1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bdec2f54-4a09-40f3-a5bd-3c309a73dd96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dad8b9e7-d07b-427a-9c1b-57fe10688d6c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bdec2f54-4a09-40f3-a5bd-3c309a73dd96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_67c59bb2-4ae4-465c-904c-7b2acd8fb418" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bdec2f54-4a09-40f3-a5bd-3c309a73dd96" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_67c59bb2-4ae4-465c-904c-7b2acd8fb418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_aa304399-8a77-40e7-89f6-b492472ae06f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bdec2f54-4a09-40f3-a5bd-3c309a73dd96" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_aa304399-8a77-40e7-89f6-b492472ae06f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c6b8a714-18d1-4b21-9ec1-81e6c9fdd9ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bdec2f54-4a09-40f3-a5bd-3c309a73dd96" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c6b8a714-18d1-4b21-9ec1-81e6c9fdd9ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_bf616fc5-ae7d-4b28-aa96-fbb739ad94b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bdec2f54-4a09-40f3-a5bd-3c309a73dd96" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_bf616fc5-ae7d-4b28-aa96-fbb739ad94b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/StockbasedcompensationStockoptionactivityforliabilityclassifiedoptionsDetails" xlink:type="simple" xlink:href="abus-20201231.xsd#StockbasedcompensationStockoptionactivityforliabilityclassifiedoptionsDetails"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/StockbasedcompensationStockoptionactivityforliabilityclassifiedoptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1bea12cc-3398-4015-8ddf-1e4b049aa655" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b40100ff-1b80-4c7a-9653-deee0db630af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1bea12cc-3398-4015-8ddf-1e4b049aa655" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b40100ff-1b80-4c7a-9653-deee0db630af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_d51cf58b-56de-4e59-a8a5-dad86519065d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b40100ff-1b80-4c7a-9653-deee0db630af" xlink:to="loc_us-gaap_AwardTypeAxis_d51cf58b-56de-4e59-a8a5-dad86519065d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bfa4fddc-d7e8-4120-8d5c-14b1efd03a7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_d51cf58b-56de-4e59-a8a5-dad86519065d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bfa4fddc-d7e8-4120-8d5c-14b1efd03a7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_EmployeeStockOptionLiabilityClassifiedMember_c2687fd7-1593-4f18-a19b-ae54eec0e1f5" xlink:href="abus-20201231.xsd#abus_EmployeeStockOptionLiabilityClassifiedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bfa4fddc-d7e8-4120-8d5c-14b1efd03a7e" xlink:to="loc_abus_EmployeeStockOptionLiabilityClassifiedMember_c2687fd7-1593-4f18-a19b-ae54eec0e1f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1364d947-b28d-47c7-81c3-c217a352f047" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b40100ff-1b80-4c7a-9653-deee0db630af" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1364d947-b28d-47c7-81c3-c217a352f047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_cc935e4c-b913-43cc-b214-afc047f97cf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1364d947-b28d-47c7-81c3-c217a352f047" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_cc935e4c-b913-43cc-b214-afc047f97cf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_996ad827-eebe-4181-99db-c894283b0b80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_cc935e4c-b913-43cc-b214-afc047f97cf3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_996ad827-eebe-4181-99db-c894283b0b80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_7a336e01-303e-4f3c-a096-0033f75b035b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_cc935e4c-b913-43cc-b214-afc047f97cf3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_7a336e01-303e-4f3c-a096-0033f75b035b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_11b3cf28-4005-4100-9830-26a6663c5a00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_cc935e4c-b913-43cc-b214-afc047f97cf3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_11b3cf28-4005-4100-9830-26a6663c5a00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_66d2b12d-e6fd-4b66-8967-57b51b048963" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_cc935e4c-b913-43cc-b214-afc047f97cf3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_66d2b12d-e6fd-4b66-8967-57b51b048963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7016f4c5-1ffe-4c8f-8ea1-e2269a4d4c00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1364d947-b28d-47c7-81c3-c217a352f047" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7016f4c5-1ffe-4c8f-8ea1-e2269a4d4c00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_91884094-dad4-4124-8e14-6659b79a640a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7016f4c5-1ffe-4c8f-8ea1-e2269a4d4c00" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_91884094-dad4-4124-8e14-6659b79a640a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_596f72b5-bb30-48b6-a0de-272bdd5365a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7016f4c5-1ffe-4c8f-8ea1-e2269a4d4c00" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_596f72b5-bb30-48b6-a0de-272bdd5365a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_9cb4b550-2c7b-4117-aae1-25e2de3a0bd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7016f4c5-1ffe-4c8f-8ea1-e2269a4d4c00" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_9cb4b550-2c7b-4117-aae1-25e2de3a0bd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_002fba8e-1444-4906-8e27-77f56935df64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7016f4c5-1ffe-4c8f-8ea1-e2269a4d4c00" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_002fba8e-1444-4906-8e27-77f56935df64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_5adeceee-f90f-49ef-8cad-d5e84cde9aed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1364d947-b28d-47c7-81c3-c217a352f047" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_5adeceee-f90f-49ef-8cad-d5e84cde9aed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_f995e84e-d253-4c44-b766-d67783761880" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1364d947-b28d-47c7-81c3-c217a352f047" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_f995e84e-d253-4c44-b766-d67783761880" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/StockbasedcompensationValuationassumptionsforliabilityclassifiedoptionsDetails" xlink:type="simple" xlink:href="abus-20201231.xsd#StockbasedcompensationValuationassumptionsforliabilityclassifiedoptionsDetails"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/StockbasedcompensationValuationassumptionsforliabilityclassifiedoptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_72dc64bc-e433-47ae-a130-6e2e58e604bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3bad47e6-db5e-4a95-8c3f-86704fb9431c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_72dc64bc-e433-47ae-a130-6e2e58e604bb" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3bad47e6-db5e-4a95-8c3f-86704fb9431c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_22a9370c-f620-4f82-a882-d3e23e8d763f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3bad47e6-db5e-4a95-8c3f-86704fb9431c" xlink:to="loc_us-gaap_AwardTypeAxis_22a9370c-f620-4f82-a882-d3e23e8d763f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a2b612a3-8edf-4a28-8c8e-f36ccd293fa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_22a9370c-f620-4f82-a882-d3e23e8d763f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a2b612a3-8edf-4a28-8c8e-f36ccd293fa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_EmployeeStockOptionLiabilityClassifiedMember_20bd3e36-2257-4429-bd69-195e6e4a5e2a" xlink:href="abus-20201231.xsd#abus_EmployeeStockOptionLiabilityClassifiedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a2b612a3-8edf-4a28-8c8e-f36ccd293fa3" xlink:to="loc_abus_EmployeeStockOptionLiabilityClassifiedMember_20bd3e36-2257-4429-bd69-195e6e4a5e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_180452d8-1f16-402b-ac40-6171b79214f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3bad47e6-db5e-4a95-8c3f-86704fb9431c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_180452d8-1f16-402b-ac40-6171b79214f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_20ef8494-7842-4b65-a96e-cbd653e01727" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_180452d8-1f16-402b-ac40-6171b79214f9" xlink:to="loc_us-gaap_SharePrice_20ef8494-7842-4b65-a96e-cbd653e01727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_8d0061c3-0b6a-4016-97c5-d248b2268cba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_180452d8-1f16-402b-ac40-6171b79214f9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_8d0061c3-0b6a-4016-97c5-d248b2268cba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_770ece7b-7dfb-4d6b-b10a-709c0f977f9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_180452d8-1f16-402b-ac40-6171b79214f9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_770ece7b-7dfb-4d6b-b10a-709c0f977f9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_f60120a4-7ad4-4e2b-addd-3c2abfb124cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_180452d8-1f16-402b-ac40-6171b79214f9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_f60120a4-7ad4-4e2b-addd-3c2abfb124cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_07994519-9b22-4cca-8836-79021f951c48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_180452d8-1f16-402b-ac40-6171b79214f9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_07994519-9b22-4cca-8836-79021f951c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingFairValuePrice_f5a0a4d6-373d-4ba1-a101-639fd0a2be23" xlink:href="abus-20201231.xsd#abus_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingFairValuePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_180452d8-1f16-402b-ac40-6171b79214f9" xlink:to="loc_abus_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingFairValuePrice_f5a0a4d6-373d-4ba1-a101-639fd0a2be23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_EmployeeStockOptionsLiabilityClassifiedOutstandingFairValueDisclosure_358bfda6-c49f-427a-9a0d-8e0bf388719c" xlink:href="abus-20201231.xsd#abus_EmployeeStockOptionsLiabilityClassifiedOutstandingFairValueDisclosure"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_180452d8-1f16-402b-ac40-6171b79214f9" xlink:to="loc_abus_EmployeeStockOptionsLiabilityClassifiedOutstandingFairValueDisclosure_358bfda6-c49f-427a-9a0d-8e0bf388719c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/StockbasedcompensationOutstandingoptionsundertheOncoreOptionPlanDetails" xlink:type="simple" xlink:href="abus-20201231.xsd#StockbasedcompensationOutstandingoptionsundertheOncoreOptionPlanDetails"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/StockbasedcompensationOutstandingoptionsundertheOncoreOptionPlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_afa8ba17-b67e-4787-8143-1ef96bcd4313" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f50fe26b-5484-44e4-aafa-987bb8c8892c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_afa8ba17-b67e-4787-8143-1ef96bcd4313" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f50fe26b-5484-44e4-aafa-987bb8c8892c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_4705c160-bece-47bf-8f9c-f19add60791e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f50fe26b-5484-44e4-aafa-987bb8c8892c" xlink:to="loc_us-gaap_PlanNameAxis_4705c160-bece-47bf-8f9c-f19add60791e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_8b085335-9199-4dbc-af2a-4ba8d378ea2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_4705c160-bece-47bf-8f9c-f19add60791e" xlink:to="loc_us-gaap_PlanNameDomain_8b085335-9199-4dbc-af2a-4ba8d378ea2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_OnCoreOptionPlanMember_cfae4ebb-6cb9-4df0-a882-2f5435df72fb" xlink:href="abus-20201231.xsd#abus_OnCoreOptionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_8b085335-9199-4dbc-af2a-4ba8d378ea2a" xlink:to="loc_abus_OnCoreOptionPlanMember_cfae4ebb-6cb9-4df0-a882-2f5435df72fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_af5334f0-f60c-4cfa-a3d9-c42e51340b86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f50fe26b-5484-44e4-aafa-987bb8c8892c" xlink:to="loc_us-gaap_AwardTypeAxis_af5334f0-f60c-4cfa-a3d9-c42e51340b86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bbb0d51c-bfa1-486b-ae0c-dff829dc145d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_af5334f0-f60c-4cfa-a3d9-c42e51340b86" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bbb0d51c-bfa1-486b-ae0c-dff829dc145d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_EquivalentNumberOfCompanyCommonSharesMember_aa097221-d2e6-44ac-af70-09c5005b325f" xlink:href="abus-20201231.xsd#abus_EquivalentNumberOfCompanyCommonSharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bbb0d51c-bfa1-486b-ae0c-dff829dc145d" xlink:to="loc_abus_EquivalentNumberOfCompanyCommonSharesMember_aa097221-d2e6-44ac-af70-09c5005b325f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4b36ba45-c9bf-4182-84b5-0496361898a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f50fe26b-5484-44e4-aafa-987bb8c8892c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4b36ba45-c9bf-4182-84b5-0496361898a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d925d6fd-8de9-4c35-9f84-5876b1adb203" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4b36ba45-c9bf-4182-84b5-0496361898a7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d925d6fd-8de9-4c35-9f84-5876b1adb203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_163ac005-6038-4eaa-9437-6dcc449c8d15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d925d6fd-8de9-4c35-9f84-5876b1adb203" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_163ac005-6038-4eaa-9437-6dcc449c8d15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_054d980e-ac29-44f4-b4e9-2e43930c2ca6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d925d6fd-8de9-4c35-9f84-5876b1adb203" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_054d980e-ac29-44f4-b4e9-2e43930c2ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_19ca0f79-7f6e-40f7-9d57-c2771743ca42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d925d6fd-8de9-4c35-9f84-5876b1adb203" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_19ca0f79-7f6e-40f7-9d57-c2771743ca42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_78ae6b8c-585f-4471-91b0-b8b56a267ed1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d925d6fd-8de9-4c35-9f84-5876b1adb203" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_78ae6b8c-585f-4471-91b0-b8b56a267ed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_aea24f5f-f0e3-4968-991d-7395127c9828" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4b36ba45-c9bf-4182-84b5-0496361898a7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_aea24f5f-f0e3-4968-991d-7395127c9828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f1ac6bca-c721-462a-8056-87b7ee63dadb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_aea24f5f-f0e3-4968-991d-7395127c9828" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f1ac6bca-c721-462a-8056-87b7ee63dadb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_0ba14e04-2297-45cb-b879-610da964e534" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_aea24f5f-f0e3-4968-991d-7395127c9828" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_0ba14e04-2297-45cb-b879-610da964e534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_6bdc77d7-3782-42a0-a797-01406128e558" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_aea24f5f-f0e3-4968-991d-7395127c9828" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_6bdc77d7-3782-42a0-a797-01406128e558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3475f97b-17e7-4b4d-9a8d-26bc46f6aafd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_aea24f5f-f0e3-4968-991d-7395127c9828" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3475f97b-17e7-4b4d-9a8d-26bc46f6aafd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_cbe296ef-7929-4bff-8b02-14eda9220f4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4b36ba45-c9bf-4182-84b5-0496361898a7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_cbe296ef-7929-4bff-8b02-14eda9220f4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_0fac8246-a807-48a2-b643-a218edf5d81d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4b36ba45-c9bf-4182-84b5-0496361898a7" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_0fac8246-a807-48a2-b643-a218edf5d81d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_fd3a9969-3f59-438b-83fa-d5930b4c394d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4b36ba45-c9bf-4182-84b5-0496361898a7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_fd3a9969-3f59-438b-83fa-d5930b4c394d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/StockbasedcompensationStockbasedcompensationexpenseDetails" xlink:type="simple" xlink:href="abus-20201231.xsd#StockbasedcompensationStockbasedcompensationexpenseDetails"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/StockbasedcompensationStockbasedcompensationexpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4c4f6d82-0e66-461d-8185-11e43b279c29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_64b44206-b335-4a9d-844b-d6e2601a2ed0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4c4f6d82-0e66-461d-8185-11e43b279c29" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_64b44206-b335-4a9d-844b-d6e2601a2ed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_41856db8-6680-43ff-99a8-a74f8cfe6a08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_64b44206-b335-4a9d-844b-d6e2601a2ed0" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_41856db8-6680-43ff-99a8-a74f8cfe6a08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_04f3817e-4025-47b2-a5f8-fd124569643c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_41856db8-6680-43ff-99a8-a74f8cfe6a08" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_04f3817e-4025-47b2-a5f8-fd124569643c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_606f8f1f-5edb-42eb-81e6-559bbe5fbb14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_04f3817e-4025-47b2-a5f8-fd124569643c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_606f8f1f-5edb-42eb-81e6-559bbe5fbb14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_76ca5e5b-316d-4246-89ea-b8428582eaa1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_04f3817e-4025-47b2-a5f8-fd124569643c" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_76ca5e5b-316d-4246-89ea-b8428582eaa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_320422c9-36ce-4897-9c88-f04340375c4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_64b44206-b335-4a9d-844b-d6e2601a2ed0" xlink:to="loc_us-gaap_PlanNameAxis_320422c9-36ce-4897-9c88-f04340375c4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_ddfd6278-c54f-41ed-b3e8-a8dd8a971f04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_320422c9-36ce-4897-9c88-f04340375c4f" xlink:to="loc_us-gaap_PlanNameDomain_ddfd6278-c54f-41ed-b3e8-a8dd8a971f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_OnCoreOptionPlanMember_d29e793c-1e62-4ae8-af7e-370558156acc" xlink:href="abus-20201231.xsd#abus_OnCoreOptionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_ddfd6278-c54f-41ed-b3e8-a8dd8a971f04" xlink:to="loc_abus_OnCoreOptionPlanMember_d29e793c-1e62-4ae8-af7e-370558156acc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b19a3e9d-6128-4208-b447-4278066ef52d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_64b44206-b335-4a9d-844b-d6e2601a2ed0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b19a3e9d-6128-4208-b447-4278066ef52d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_b80a92d7-8815-4162-955f-fb19082316b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b19a3e9d-6128-4208-b447-4278066ef52d" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_b80a92d7-8815-4162-955f-fb19082316b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_037579bf-42f1-49e9-806f-03594d252600" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b19a3e9d-6128-4208-b447-4278066ef52d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_037579bf-42f1-49e9-806f-03594d252600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/Incometaxes" xlink:type="simple" xlink:href="abus-20201231.xsd#Incometaxes"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/Incometaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_dc859a7d-39cf-422c-bf8a-ae2f50b0f4e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_07dc96d6-4442-4714-85b5-b05b7293269b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_dc859a7d-39cf-422c-bf8a-ae2f50b0f4e4" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_07dc96d6-4442-4714-85b5-b05b7293269b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/IncometaxesTables" xlink:type="simple" xlink:href="abus-20201231.xsd#IncometaxesTables"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/IncometaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_ea87a69e-6db4-40ff-9507-06d561a03d74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_8f3607a8-8243-4bd8-8c77-2b255c268e44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ea87a69e-6db4-40ff-9507-06d561a03d74" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_8f3607a8-8243-4bd8-8c77-2b255c268e44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_3cfc955e-60b3-49c5-ab81-4702c798612e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ea87a69e-6db4-40ff-9507-06d561a03d74" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_3cfc955e-60b3-49c5-ab81-4702c798612e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/IncometaxesNarrativeDetails" xlink:type="simple" xlink:href="abus-20201231.xsd#IncometaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/IncometaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_6805c476-2ba9-4f51-afa4-fc155204ee5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_IncomeTaxesTable_db6fb5c5-58d6-4595-b499-b945f5fc09c8" xlink:href="abus-20201231.xsd#abus_IncomeTaxesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6805c476-2ba9-4f51-afa4-fc155204ee5f" xlink:to="loc_abus_IncomeTaxesTable_db6fb5c5-58d6-4595-b499-b945f5fc09c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_97a79965-8b54-42fd-ba90-d1c15a4c8d9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_IncomeTaxesTable_db6fb5c5-58d6-4595-b499-b945f5fc09c8" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_97a79965-8b54-42fd-ba90-d1c15a4c8d9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_0057f7a9-367c-4ad3-8f8f-2a11c00e5584" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_97a79965-8b54-42fd-ba90-d1c15a4c8d9b" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_0057f7a9-367c-4ad3-8f8f-2a11c00e5584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCreditMember_1262ff24-c673-4e0b-87db-28130ddbbf51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_0057f7a9-367c-4ad3-8f8f-2a11c00e5584" xlink:to="loc_us-gaap_InvestmentCreditMember_1262ff24-c673-4e0b-87db-28130ddbbf51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember_ac1e57bd-d2ba-4cbd-ba56-857490078c6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_0057f7a9-367c-4ad3-8f8f-2a11c00e5584" xlink:to="loc_us-gaap_ResearchMember_ac1e57bd-d2ba-4cbd-ba56-857490078c6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_IncomeTaxesDetailsLineItems_d8a25324-31e8-4aa8-9a34-e753e1001ed8" xlink:href="abus-20201231.xsd#abus_IncomeTaxesDetailsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_IncomeTaxesTable_db6fb5c5-58d6-4595-b499-b945f5fc09c8" xlink:to="loc_abus_IncomeTaxesDetailsLineItems_d8a25324-31e8-4aa8-9a34-e753e1001ed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_ffaafdba-4093-49cb-b481-885985223477" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_IncomeTaxesDetailsLineItems_d8a25324-31e8-4aa8-9a34-e753e1001ed8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_ffaafdba-4093-49cb-b481-885985223477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_f242c049-d946-4ee8-8ed6-b17132f326de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_IncomeTaxesDetailsLineItems_d8a25324-31e8-4aa8-9a34-e753e1001ed8" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_f242c049-d946-4ee8-8ed6-b17132f326de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_26893f71-e56b-4939-bf58-201c154ae329" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_IncomeTaxesDetailsLineItems_d8a25324-31e8-4aa8-9a34-e753e1001ed8" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_26893f71-e56b-4939-bf58-201c154ae329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_6244b3d4-438e-4dcc-be9b-30ef27d8a743" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_IncomeTaxesDetailsLineItems_d8a25324-31e8-4aa8-9a34-e753e1001ed8" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_6244b3d4-438e-4dcc-be9b-30ef27d8a743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_3465eff5-4aef-40b9-8e2a-02775dddf831" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_IncomeTaxesDetailsLineItems_d8a25324-31e8-4aa8-9a34-e753e1001ed8" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_3465eff5-4aef-40b9-8e2a-02775dddf831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_947f8987-bbac-448e-a9e3-ce357624c6a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_IncomeTaxesDetailsLineItems_d8a25324-31e8-4aa8-9a34-e753e1001ed8" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_947f8987-bbac-448e-a9e3-ce357624c6a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_7198618f-d9ad-40d1-b4ed-47ada4b9f3e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_IncomeTaxesDetailsLineItems_d8a25324-31e8-4aa8-9a34-e753e1001ed8" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_7198618f-d9ad-40d1-b4ed-47ada4b9f3e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_032cdb5a-1adc-434c-9da4-7af0577afbf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_IncomeTaxesDetailsLineItems_d8a25324-31e8-4aa8-9a34-e753e1001ed8" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_032cdb5a-1adc-434c-9da4-7af0577afbf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/IncometaxesIncometaxreconciliationDetails" xlink:type="simple" xlink:href="abus-20201231.xsd#IncometaxesIncometaxreconciliationDetails"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/IncometaxesIncometaxreconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_09275ea6-7a54-4478-a3ff-51851aa6c8b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_75fa5adf-0494-43dc-8f2a-328201ce9e08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_09275ea6-7a54-4478-a3ff-51851aa6c8b9" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_75fa5adf-0494-43dc-8f2a-328201ce9e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_2e2532a9-4e39-4ecf-8fef-8ca27f2b2be3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_09275ea6-7a54-4478-a3ff-51851aa6c8b9" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_2e2532a9-4e39-4ecf-8fef-8ca27f2b2be3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_ef3733f1-dd70-46d1-9b72-b3bd32299b4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_09275ea6-7a54-4478-a3ff-51851aa6c8b9" xlink:to="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_ef3733f1-dd70-46d1-9b72-b3bd32299b4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_4f3d6216-2fa1-464a-8556-ee2e4a1c3348" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_09275ea6-7a54-4478-a3ff-51851aa6c8b9" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_4f3d6216-2fa1-464a-8556-ee2e4a1c3348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_8409f3ae-2c77-46e5-97eb-42af8992f78b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_09275ea6-7a54-4478-a3ff-51851aa6c8b9" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_8409f3ae-2c77-46e5-97eb-42af8992f78b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_ec8780b4-4525-4c02-b622-783aa121ab18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_09275ea6-7a54-4478-a3ff-51851aa6c8b9" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_ec8780b4-4525-4c02-b622-783aa121ab18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_0f8d4c9f-77fb-4d92-9374-02e3fdfe6f49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_09275ea6-7a54-4478-a3ff-51851aa6c8b9" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_0f8d4c9f-77fb-4d92-9374-02e3fdfe6f49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses_c25c3df5-6ba3-4dcf-ad9f-6515154ee397" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_09275ea6-7a54-4478-a3ff-51851aa6c8b9" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses_c25c3df5-6ba3-4dcf-ad9f-6515154ee397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_3dba2048-621c-439d-babd-ed45193c6dc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_09275ea6-7a54-4478-a3ff-51851aa6c8b9" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_3dba2048-621c-439d-babd-ed45193c6dc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/IncometaxesDeferredtaxassetsandliabilitiesDetails" xlink:type="simple" xlink:href="abus-20201231.xsd#IncometaxesDeferredtaxassetsandliabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/IncometaxesDeferredtaxassetsandliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_a473ac5e-3b0e-4025-9fad-2727458ac55b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_ComponentsofDeferredTaxAssetsTable_d3146c68-4e76-4455-9ea3-0fe83c715bbb" xlink:href="abus-20201231.xsd#abus_ComponentsofDeferredTaxAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a473ac5e-3b0e-4025-9fad-2727458ac55b" xlink:to="loc_abus_ComponentsofDeferredTaxAssetsTable_d3146c68-4e76-4455-9ea3-0fe83c715bbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_5ad175fd-0617-46d3-8500-290de8f6f0df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ComponentsofDeferredTaxAssetsTable_d3146c68-4e76-4455-9ea3-0fe83c715bbb" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_5ad175fd-0617-46d3-8500-290de8f6f0df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_a287c17d-40d9-42fc-944c-52e86cd8ead4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_5ad175fd-0617-46d3-8500-290de8f6f0df" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_a287c17d-40d9-42fc-944c-52e86cd8ead4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_a95b3d43-ec24-41dd-9ac2-d8adaf624a0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_a287c17d-40d9-42fc-944c-52e86cd8ead4" xlink:to="loc_us-gaap_DomesticCountryMember_a95b3d43-ec24-41dd-9ac2-d8adaf624a0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_fb819310-92cd-4ba2-bbea-b2f551ad349b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_a287c17d-40d9-42fc-944c-52e86cd8ead4" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_fb819310-92cd-4ba2-bbea-b2f551ad349b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_ComponentsofDeferredTaxAssetsLineItems_a675832f-af1f-4947-b525-ea36f9c7d388" xlink:href="abus-20201231.xsd#abus_ComponentsofDeferredTaxAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ComponentsofDeferredTaxAssetsTable_d3146c68-4e76-4455-9ea3-0fe83c715bbb" xlink:to="loc_abus_ComponentsofDeferredTaxAssetsLineItems_a675832f-af1f-4947-b525-ea36f9c7d388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_e468cff9-7388-4586-b9a8-54a1eeb0ff47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ComponentsofDeferredTaxAssetsLineItems_a675832f-af1f-4947-b525-ea36f9c7d388" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_e468cff9-7388-4586-b9a8-54a1eeb0ff47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_9309277a-3446-4c3d-af99-636be97f8473" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ComponentsofDeferredTaxAssetsLineItems_a675832f-af1f-4947-b525-ea36f9c7d388" xlink:to="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_9309277a-3446-4c3d-af99-636be97f8473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_DeferredTaxAssetBookAmortizationInExcessOfTax_0a0a19e9-4514-4587-9d57-08cc91e67a68" xlink:href="abus-20201231.xsd#abus_DeferredTaxAssetBookAmortizationInExcessOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ComponentsofDeferredTaxAssetsLineItems_a675832f-af1f-4947-b525-ea36f9c7d388" xlink:to="loc_abus_DeferredTaxAssetBookAmortizationInExcessOfTax_0a0a19e9-4514-4587-9d57-08cc91e67a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_DeferredTaxAssetRevenueRecognizedForTaxPurposesInExcessOfRevenueRecognizedForAccountingPurposes_14cbc74d-dc13-4dc3-a1f3-74a4025e2310" xlink:href="abus-20201231.xsd#abus_DeferredTaxAssetRevenueRecognizedForTaxPurposesInExcessOfRevenueRecognizedForAccountingPurposes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ComponentsofDeferredTaxAssetsLineItems_a675832f-af1f-4947-b525-ea36f9c7d388" xlink:to="loc_abus_DeferredTaxAssetRevenueRecognizedForTaxPurposesInExcessOfRevenueRecognizedForAccountingPurposes_14cbc74d-dc13-4dc3-a1f3-74a4025e2310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_DeferredTaxAssetTaxValueInExcessOfAccountingValueInLeaseInducements_2baa7940-a4d9-4821-b08b-4808d9d46a5b" xlink:href="abus-20201231.xsd#abus_DeferredTaxAssetTaxValueInExcessOfAccountingValueInLeaseInducements"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ComponentsofDeferredTaxAssetsLineItems_a675832f-af1f-4947-b525-ea36f9c7d388" xlink:to="loc_abus_DeferredTaxAssetTaxValueInExcessOfAccountingValueInLeaseInducements_2baa7940-a4d9-4821-b08b-4808d9d46a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInvestments_cc733bc9-83ed-4b46-94b8-fec99745b49b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ComponentsofDeferredTaxAssetsLineItems_a675832f-af1f-4947-b525-ea36f9c7d388" xlink:to="loc_us-gaap_DeferredTaxAssetsInvestments_cc733bc9-83ed-4b46-94b8-fec99745b49b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsEquityMethodInvestments_9d41559a-cd71-4b34-83d9-a31264bd9a32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsEquityMethodInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ComponentsofDeferredTaxAssetsLineItems_a675832f-af1f-4947-b525-ea36f9c7d388" xlink:to="loc_us-gaap_DeferredTaxAssetsEquityMethodInvestments_9d41559a-cd71-4b34-83d9-a31264bd9a32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_9e538fa5-1e95-4be1-8cc8-17c37fe188d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ComponentsofDeferredTaxAssetsLineItems_a675832f-af1f-4947-b525-ea36f9c7d388" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_9e538fa5-1e95-4be1-8cc8-17c37fe188d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsStockOptions_b7851294-5f15-4b44-b156-24c47399bafa" xlink:href="abus-20201231.xsd#abus_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsStockOptions"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ComponentsofDeferredTaxAssetsLineItems_a675832f-af1f-4947-b525-ea36f9c7d388" xlink:to="loc_abus_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsStockOptions_b7851294-5f15-4b44-b156-24c47399bafa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_be878d7b-5fa4-448e-a130-ac4acb34d275" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ComponentsofDeferredTaxAssetsLineItems_a675832f-af1f-4947-b525-ea36f9c7d388" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_be878d7b-5fa4-448e-a130-ac4acb34d275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_DeferredTaxAssetsLiabilitiesGross_7ddad8ab-a57c-4efe-93ff-9d206b3ea43b" xlink:href="abus-20201231.xsd#abus_DeferredTaxAssetsLiabilitiesGross"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ComponentsofDeferredTaxAssetsLineItems_a675832f-af1f-4947-b525-ea36f9c7d388" xlink:to="loc_abus_DeferredTaxAssetsLiabilitiesGross_7ddad8ab-a57c-4efe-93ff-9d206b3ea43b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_9e6711e2-195a-4d0c-9b5f-0cc921677ba1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ComponentsofDeferredTaxAssetsLineItems_a675832f-af1f-4947-b525-ea36f9c7d388" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_9e6711e2-195a-4d0c-9b5f-0cc921677ba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_eb36ca12-f76f-490f-bfa3-6749b4d702e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ComponentsofDeferredTaxAssetsLineItems_a675832f-af1f-4947-b525-ea36f9c7d388" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_eb36ca12-f76f-490f-bfa3-6749b4d702e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/Relatedpartytransactions" xlink:type="simple" xlink:href="abus-20201231.xsd#Relatedpartytransactions"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/Relatedpartytransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_725b7d83-ddb0-44a2-81c6-db17e9df71ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_b493bc8c-08d0-4ef7-891b-3ff32f6a90cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_725b7d83-ddb0-44a2-81c6-db17e9df71ef" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_b493bc8c-08d0-4ef7-891b-3ff32f6a90cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.tekmirapharm.com/role/RelatedpartytransactionsDetails" xlink:type="simple" xlink:href="abus-20201231.xsd#RelatedpartytransactionsDetails"/>
  <link:presentationLink xlink:role="http://www.tekmirapharm.com/role/RelatedpartytransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_32013d3b-d495-4420-8342-1594c3be8229" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_00692791-c589-4f45-bea3-2a2ae5539aaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_32013d3b-d495-4420-8342-1594c3be8229" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_00692791-c589-4f45-bea3-2a2ae5539aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_72e6851a-fc8f-4015-b30e-fca548ea1277" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_00692791-c589-4f45-bea3-2a2ae5539aaf" xlink:to="loc_srt_CounterpartyNameAxis_72e6851a-fc8f-4015-b30e-fca548ea1277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ed02ff27-0332-44ed-9087-1c908de86b9f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_72e6851a-fc8f-4015-b30e-fca548ea1277" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ed02ff27-0332-44ed-9087-1c908de86b9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_GenevantSciencesCorporationMember_8ad2f3f5-85be-4b07-80f9-8a8254451d44" xlink:href="abus-20201231.xsd#abus_GenevantSciencesCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ed02ff27-0332-44ed-9087-1c908de86b9f" xlink:to="loc_abus_GenevantSciencesCorporationMember_8ad2f3f5-85be-4b07-80f9-8a8254451d44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_d9f376c1-a58f-4498-9a36-88ae1dca42ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_00692791-c589-4f45-bea3-2a2ae5539aaf" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_d9f376c1-a58f-4498-9a36-88ae1dca42ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_a987c551-85a1-4058-9b00-f2dc87b7ecac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_d9f376c1-a58f-4498-9a36-88ae1dca42ff" xlink:to="loc_us-gaap_RelatedPartyDomain_a987c551-85a1-4058-9b00-f2dc87b7ecac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember_3e082a46-5513-4d84-9896-4ba102adb711" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_a987c551-85a1-4058-9b00-f2dc87b7ecac" xlink:to="loc_us-gaap_EquityMethodInvesteeMember_3e082a46-5513-4d84-9896-4ba102adb711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_914642ac-9498-4818-8ac8-9a52df7ca165" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_00692791-c589-4f45-bea3-2a2ae5539aaf" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_914642ac-9498-4818-8ac8-9a52df7ca165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_c45bb7fb-3263-4dd1-a50d-b58b2ac99e7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_914642ac-9498-4818-8ac8-9a52df7ca165" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_c45bb7fb-3263-4dd1-a50d-b58b2ac99e7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_AdministrativeAndTransitionalServicesMember_73d0a1c8-b7ba-493e-9884-771cf3efb561" xlink:href="abus-20201231.xsd#abus_AdministrativeAndTransitionalServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_c45bb7fb-3263-4dd1-a50d-b58b2ac99e7a" xlink:to="loc_abus_AdministrativeAndTransitionalServicesMember_73d0a1c8-b7ba-493e-9884-771cf3efb561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_SubleaseBurnabyFacilityMember_70853511-3d70-4551-ae1b-eb0ccac89724" xlink:href="abus-20201231.xsd#abus_SubleaseBurnabyFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_c45bb7fb-3263-4dd1-a50d-b58b2ac99e7a" xlink:to="loc_abus_SubleaseBurnabyFacilityMember_70853511-3d70-4551-ae1b-eb0ccac89724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_cc034318-a6f9-4c4d-acf2-7deec2eed0ab" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_00692791-c589-4f45-bea3-2a2ae5539aaf" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_cc034318-a6f9-4c4d-acf2-7deec2eed0ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_f9a49056-df7d-4ccd-a60f-e1cc69cf8195" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_cc034318-a6f9-4c4d-acf2-7deec2eed0ab" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_f9a49056-df7d-4ccd-a60f-e1cc69cf8195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_GenevantSciencesCorporationMember_c2c67079-bba9-4a3d-9027-2c5aab4cc2e4" xlink:href="abus-20201231.xsd#abus_GenevantSciencesCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_f9a49056-df7d-4ccd-a60f-e1cc69cf8195" xlink:to="loc_abus_GenevantSciencesCorporationMember_c2c67079-bba9-4a3d-9027-2c5aab4cc2e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_20ad3a68-aed8-4995-b577-9f341e118b71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_00692791-c589-4f45-bea3-2a2ae5539aaf" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_20ad3a68-aed8-4995-b577-9f341e118b71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_9c87b756-272b-4f0c-991e-8732cfe82f6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_20ad3a68-aed8-4995-b577-9f341e118b71" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_9c87b756-272b-4f0c-991e-8732cfe82f6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_41943542-2e75-4859-91c3-754d40fa7379" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_20ad3a68-aed8-4995-b577-9f341e118b71" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_41943542-2e75-4859-91c3-754d40fa7379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties_4d029a6c-e783-4af0-9c14-d5bd59131860" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_20ad3a68-aed8-4995-b577-9f341e118b71" xlink:to="loc_us-gaap_RevenueFromRelatedParties_4d029a6c-e783-4af0-9c14-d5bd59131860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_NetRentableAreaSublease_7634f922-3c1b-4fa0-a3fd-5e6377a0b8a8" xlink:href="abus-20201231.xsd#abus_NetRentableAreaSublease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_20ad3a68-aed8-4995-b577-9f341e118b71" xlink:to="loc_abus_NetRentableAreaSublease_7634f922-3c1b-4fa0-a3fd-5e6377a0b8a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
